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Abstract
CHARACTERIZATION OF MICROORGANISMS OF INTEREST TO HOMELAND
SECURITY AND PUBLIC HEALTH UTILIZING LIQUID
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Liquid chromatography/quadrupole time of flight mass spectrometry (LC/QTOF
MS) utilizing electrospray ionization was employed to monitor protein expression in
Escherichia coli and Shigella organisms. Automated charge state deconvolution, spectral
subtraction and spectral mirroring were used to reveal subtle differences in the LC/MS
data. Reproducible intact protein biomarkers were discovered based on their unique
mass, retention time and relative intensity. These markers were implemented to
differentiate closely related strain types, (e.g. two distinct isolates of E. coli O157:H7)
and to correctly identify unknown pathogens. Notable, was the distinction of multiple
serotypes of enterohaemorrhagic E. coli which cannot be distinguished by clinical

xxiv

xxv
manifestation alone. Additionally, speciation of Shigella was achieved, a task for which
no commercial real-time polymerase chain reaction (PCR) primers exist.
This method was subsequently applied to two pathogenic Clostridium species: C.
difficile and C. perfringens. Due to the increased difficulty during lysis, two new lysis
protocols were developed, and each extracted a distinct set of proteins (by both mass and
retention time). Extracts from both lysis procedures were utilized to discover biomarkers
useful for identification and characterization at the species and strain levels. These
biomarkers were successfully implemented to identify unknowns during a blind study
and would enhance serological and genetic approaches by serving as new targets for
detection. Two sets of the C. perfringens isolates that were deemed 100% similar by the
gold standard for strain differentiation, pulsed-field gel electrophoresis (PFGE), were
distinguished using LC/MS, demonstrating the high specificity of this approach.
The final part of this work demonstrated the application of ultra performance
liquid chromatography (UPLC) to this project to improve the throughput of the method.
Given that numerous small molecule applications of UPLC have been published, efforts
were made to examine the potential of UPLC to enhance the separation of intact proteins.
Beginning with typically employed conditions, column temperature and organic solvent
were optimized followed by an HPLC vs. UPLC comparison. When applied to a mixture
of ten protein standards, the optimized UPLC method yielded improved chromatographic
resolution, enhanced sensitivity, and a three-fold increase in throughput. Application of
this method to cell lysate analysis demonstrated no compromise in chromatographic or

xxvi
mass spectral data quality; a reduction in run time from 75 minutes to 25 minutes was
achieved.

CHAPTER 1 Overview and Objectives
Public health laboratories serve to aid in the event of exposure to harmful agents
such as pathogenic bacteria. Exposure to these bacteria can occur naturally (e.g.,
foodborne illness) or intentionally (e.g., terrorist attack). Each year in the United States,
an estimated 76 million foodborne illnesses cause over 325,000 hospitalizations and
5,200 deaths.1 In 1997 alone, costs from foodborne illnesses in America were estimated
at $35,000,000,000 based on medical expenses and lost productivity.2 With this much
harm occurring due to natural foodborne outbreaks, the intentional use of these agents
would be more severe. The gravity of these natural occurrences and potential terrorist
situations acts as a driving force for the development of improved techniques to enhance
current capabilities to respond to exposure events/outbreaks, and assist with forensic and
epidemiological investigations.
In the event of an infectious disease outbreak or a terrorist attack, key decisions
by hospital staff, public health officials and investigating authorities will have to be made
to guide medical treatment, prophylaxis and remediation. These decisions are best made
when they are data directed. The method described here employs liquid
chromatography/mass spectrometry (LC/MS) to find protein biomarkers useful for
characterization and identification of bacteria at the species and sub-species levels (e.g.
serotype and strain etc.). This approach is complementary and under certain conditions,
1
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advantageous in comparison to current methods. Incorporating additional
complementary techniques in conjunction with existing methods of detection and
characterization will yield a better overall understanding of the data collected and will
allow more confident data directed conclusions to be made.
Of particular interest to this study were bacterial select agents and food and
waterborne pathogens. Select agents are microorganisms/toxins that are considered to
have a high potential for serious illness and social disruption in the event of exposure.
These agents are further categorized according to a combination of factors such as ease of
dissemination, toxicity, etc. with Category A being the most potent including agents such
as Bacillus anthracis and Yersinia pestis.3 More simply, food and waterborne pathogens
are pathogens which may be transmitted through contaminated food or water.
The goal of the LC/MS method was to detect proteins that were unique to certain
bacterial pathogens and which could be used as biomarkers for identification and
characterization. As with many biomolecular diagnostic approaches, the first step in the
analysis was cultivation of the bacterial sample. After cultivation, a simple chemical
lysis procedure was performed to inactivate the cells and extract proteins.
The proteins were then separated using reversed phase liquid chromatography.
This type of chromatography gives hydrophobicity information in the form of retention
time where the most retained (having larger retention times) proteins are more
hydrophobic. Reversed phase chromatography also employs solvents that are easily
evaporated and are more amenable to electrospray ionization-mass spectrometry (ESIMS)4 than the solvents typically employed in capillary electrophoresis and other
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chromatography techniques such as ion exchange chromatography which tend to be
aqueous solutions containing non-volatile salts. The effluent from the liquid
chromatograph entered the directly into the ESI source of the mass spectrometer. Due to
its sensitivity in full-scan mode and wide mass range, quadrupole time of flight5 mass
spectrometry was utilized for mass analysis.
ESI produces protein spectra that contain multiply charged ions and the
interpretation of these spectra can be challenging even for a pure compound. To this end,
an automated computer-based approach6 was used to deconvolute the more than one
hundred proteins detected per lysate. This process yielded a single spectrum containing
the neutral (zero charge) masses of all of the observed proteins. Once the neutral masses
are calculated, there are a total of three pieces of information that have been obtained:
retention time, neutral mass and relative intensity.
During comparison, spectra from different bacteria were first mirrored along the
baseline to better view the differences, and then protein masses common between the two
bacteria being compared were removed using spectral subtraction. Spectral subtraction
removes common masses within a given mass tolerance (± 2 Da here) leaving only the
remaining unique masses which serve as potential biomarkers. Once detected, the
biomarkers were evaluated for their reproducibility in terms of mass, retention time and
relative intensity by repeating the entire experiment a minimum of three times on three
different days. Due to the dynamic nature of the proteome and the production of artifacts
during the charge state deconvolution step, not all unique masses observed after spectral
subtraction were reproducible. Only proteins which were found unique on all three
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repeated experiments were deemed biomarkers. Lastly, the marker proteins were further
challenged for their utility during the identification of unknown pathogens in a blind
study. This LC/MS method for biomarker discovery was

applied in Chapters 4 and 5

and then optimized in Chapter 6.
In Chapter 4, the efficacy of the LC/MS method for characterization of bacterial
pathogens was examined using Escherichia coli and Shigella species. These organisms
are leading causes of the food and waterborne illness shigellosis which infects millions
worldwide on an annual basis. Additionally, the toxin they produce, the Shiga toxin
(Stx), is considered a category B select agent. Both qualitative (by mass and retention
time) and quantitative (by relative abundance) biomarkers were discovered in this study
and found to be reproducible in five repeated experiments run on five different days.
These markers were implemented for Shigella speciation, and because no real-time PCR
primers are available for this task, the gene sequence encoding these marker proteins
could be used to design novel primers. Serotype and strain level discrimination was
achieved allowing the distinction of three serotypes of enterohaemorrhagic E. coli and
two different isolates of the same serotype (O157:H7), respectively. Strain level
discrimination as demonstrated by this approach could be utilized during forensic
traceback or food attribution investigations to pinpoint the source of an outbreak and to
help determine if a group of infections is random or related. This would require
examining clinical isolates from victims and isolates obtained from swabbing the crime
scene or suspected food items and comparing the results to determine if a relationship
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exists. The method developed and the biomarkers discovered identified over a dozen
unknown bacteria in approximately two hours per sample post culture.
In Chapter 5, this work was expanded to include other types of bacteria (e.g.,
Gram positive and endospore forming). The Clostridium species C. difficile and C.
perfringens were chosen because they are Gram positive, sporulate, and are of interest to
public health and homeland security. C. difficile is the leading cause of the nosocomial
illness antibiotic associated diarrhea (AAD) and has been stockpiled by a terrorist
organization with the intent of deliberate use. C. perfringens, a well known foodborne
pathogen, is also a cause of AAD and was stockpiled by the Iraq government’s biological
weapons program. Additionally, the epsilon toxin of C. perfringens is a category B select
agent. Because they are Gram positive, the Clostridia have greater structural rigidity and
therefore are more resistant to lysis than Gram negative bacteria such as E. coli.7 For this
reason, two new lysis methods were developed, with each extracting distinct proteins.
The first protocol utilized a combination of lysozyme digestion and repeated cycles of
freezing and thawing. The second utilized less lysozyme during the digestion step, but
was followed by a treatment with acetonitrile and trifluoroacetic acid after the
freeze/thaw step.
After lysis, the spores were removed by filtration and the extracts were analyzed
using the LC/MS method described above. Reproducible biomarkers were observed that
could distinguish both Clostridium species, something that in the case of AAD can not be
achieved by symptoms alone. Markers from both lysis protocols were utilized to identify
unknown isolates and to distinguish strains of each species. Strain level distinction of C.
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difficile could be used to direct treatment, as highly virulent drug-resistant strains have
been reported. In cases where isolates whose PFGE restriction patterns were
indistinguishable, differentiation was achieved using LC/MS. These findings encourage
modification of the current PFGE protocols used in this laboratory to include different or
multiple restriction enzymes for added information and specificity.
Finally, the work described in Chapter 6 incorporates the latest advancement in
liquid chromatography, i.e., ultra performance liquid chromatography (UPLC)8, in an
attempt to improve the overall method throughput. UPLC employs small (sub-2 μm
diameter) porous particles at very high back pressures to generate more efficient
separations in less time. As predicted from Van Deemter theory, the plate height
minimum in the plot of height equivalent to a theoretical plate vs. linear velocity is lower
for sub-2 μm particles than for larger particles sizes while the linear velocity region at
that minimum is also much longer.9 This means the use of sub-2 μm particles (1.7 μm
here) allows for improved resolution over a wide range of flow rates. The runtime can
then be significantly reduced because the flow rate can be significantly increased, at no
expense in resolution. However, since the column diameter remains constant, as the flow
rate is increased, there is a concomitant increase in back pressure. Thus, UPLC is a
combination of sub-2 μm particles used with a column and system that can withstand
much higher pressures (e.g. 1000 bar) than those utilized in conventional high
performance liquid chromatography (HPLC) experiments.
One novel aspect of this work is the application of UPLC to the separation of
intact proteins. Due to their slow diffusivities and greater structural complexity relative
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to small molecules, intact proteins have been problematic to chromatograph. This work
10

utilized ten protein standards of varying size and reversed phase retention behavior as a
model set for method development. In addition to particle size, column temperature and
organic modifier were adjusted for optimal performance. The optimal method involved a
combination of high temperature, a solvent of high eluotropic strength and small particles
at ultra high pressure. This method was then applied to an E. coli cell lysate and
demonstrated improved sensitivity, and a threefold reduction of data collection and data
analysis time compared to that of the original HPLC method.
The work performed and the ensuing results from these three projects will be
discussed at greater length in Chapters 4-6. Necessary background discussion of the
existing methods for bacterial identification and characterization is described in Chapter
2. Chapter 3 provides an introduction to and the rationale behind the protocols within the
LC/MS method which was later employed in Chapters 4 and 5, and optimized in Chapter
6. Finally, insights, implications and potential future work resulting from this
dissertation are detailed in Chapter 7. The work presented here represents advancement
in the study of diagnostic microbiology as it relates to public health and homeland
security, built upon a foundation in analytical chemistry and achieved through the
application of novel, cutting edge technology.

CHAPTER 2 Current Methods of Bacterial Characterization
2.1. Cultural Methods
Since the initial observation of bacteria in 1683 by Antoni van Leeuwenhoek11,
the means by which bacteria are observed and characterized has experienced tremendous
advancement. In the modern public health domain, three approaches dominate: culturebased, serological and genotypic. The culture of bacteria is a way of purifying the
bacteria from its matrix and increasing its concentration by growth. The time required to
reach the desired concentration depends on the generation time (doubling time) and
growing conditions (temperature, atmosphere and nourishment etc.). At optimal
conditions, the generation time can vary widely depending on the bacterium. Escherichia
coli for example has a generation time of 17 minutes compared to 1980 minutes (33
hours) for Treponema pallidum.12 Techniques that have been traditionally used to identify
bacteria post-culture include morphologic, chemotaxonomic, and biochemical tests, most
of which require several days to perform. The morphology of bacteria (shape, size, stain
response, etc.) viewed with a microscope is a useful tool for grouping bacteria.
Chemotaxonomic methods involve analysis of the chemical content of bacterial cells.
Biochemical approaches monitor the bacteria’s ability to ferment, metabolize, or cleave
certain compounds.13
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While it is desirable for detection methods to be sensitive enough so that culture is
not required (in order to improve assay speed), the majority of accepted methods in
diagnostic bacteriology culture the bacteria prior to analysis. In addition to purification
and concentration, there are other distinct advantages to culture such as the differentiation
of viable and non-viable cells; and cell stress or injury resulting from food processing or
the environment can be repaired.14
The culture process itself has diagnostic value. There are two principal methods
of culture-based diagnosis, both dependant upon the type of media used for growth –
selective or differential. The selective technique attempts to grow unknown samples on
different types of media, with each type designed to enhance the growth of a particular
kind of organism while containing inhibitors to inhibit the growth of others. The ensuing
results are then compared to the growth trends of known bacteria for identification. The
differential approach cultivates bacteria on a nonselective media but in the presence of
several indicator dyes so that different types of bacteria will be identified based upon the
different colors they produce.13 One very common medium, MacConkey agar, functions
as both selective and differential. This medium contains inhibitors for the growth of
Gram positive bacteria, thus selecting for Gram negative; and contains lactose and a pH
indicator dye that turns red under acidic conditions. Since acid is produced during
lactose fermentation, the ability of unknown bacteria to ferment lactose is discerned
based on the color (pH) of the medium after growth. Thus, common foodborne
pathogens such as E. coli which do ferment lactose are readily distinguished from
Salmonella which do not. While culture-based techniques are useful for classifying
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unknown bacteria and can serve to direct further testing, they are generally not specific
enough to differentiate between species or strains of bacteria and are not considered
confirmatory techniques.
2.2. Serological Approaches
Serological/immunological assays employ antibodies that react with antigens
produced by, or located on, the surface of bacteria. These antigens may be
lipopolysacharides or proteins for example. Bacteria of the same species with different
antigens are known as serotypes. Bacteria are often described by their serotype as in the
case of E. coli O157:H7 which is O (lipopolysacharide) antigen number 157 and H
(flagellar protein) antigen number 7. Since only certain serotypes of bacteria such as E.
coli may be toxic, serological methods are often used to distinguish between toxic and
non-toxic bacteria. There are two main serological techniques used to identify bacteria:
particle agglutination and enzyme-linked immunosorbent assays.
Particle agglutination assays adsorb antibodies to particles such as latex and as
multiple particles react with antigens on the same bacterium, the bound particles clump
together (agglutinate) to form a mass of particles that is visible to the naked eye. The
greater the size of the particles or beads (typically > 800 nm), the greater the ease in
which the agglutination reaction can be observed which may take up to 24 hours. Often
culture is not required for this technique; but contaminates can adversely effect the
reaction so often sample clean up is necessary.15
Unlike agglutination assays which are used to detect intact bacterial cells using
their surface antigens, enzyme-linked immunosorbent assay (ELISA) approaches can also
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be used to detect individual proteins such as toxins expressed by bacteria. ELISA, is an
indirect immunofluorescence assay where the bacteria adhere to a microtiter plate before
reacting with an unlabeled primary antibody. Next, the secondary antibody which binds
to the primary antibody, is coupled to an enzyme which after removal of unbound
antibody, cleaves a dye substrate added to the solution resulting in a color change in the
dye.13 Unlike agglutination assays which are used to detect intact bacterial cells using
their surface antigens, ELISA approaches can also be used to detect individual proteins
such as toxins expressed by bacteria.
The serological approaches are sufficiently sensitive such that culture is often not
required and analysis time is rapid (≤ 1 day). However, as with all antibody approaches,
cross reactivity between closely related samples can occur, and these techniques are only
applicable for bacteria to which antibodies have been made.16
2.3. Genetic Approaches
2.3.1. Real-Time Polymerase Chain Reaction
While culture and serology yield useful information, ultimately a genetic
approach is desired for confirmation of the microorganism’s identity. First presented by
Siaki et al. in 198817, polymerase chain reaction (PCR), is a method used to amplify small
amounts of DNA by making repeated copies of specific strands that can then be detected
by gel electrophoresis or fluorescence spectroscopy.13 This technique is used to
characterize and identify microorganisms by monitoring sequences of DNA unique to a
particular genus or species. Starting at the location of the primer, a replicate double
stranded DNA (dsDNA) molecule identical to the original one is produced. The process
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is then repeated, but this time with double the starting material and is thereby an
exponential process. This feature makes PCR a very sensitive technique and led to a
Nobel Prize in chemistry in 1993. In theory culturing is not required, however in
practice, the task of isolating the cells so that only bacterial DNA is used and purifying of
the cells from inhibitors in the matrix which can interfere with the polymerase reaction is
required. Purification can be accomplished by using immunoaffinity beads18 but these
require antibodies and for specificity reasons stated previously, most often cultural
enrichment is employed.
The cycling process can continue until a desired concentration is obtained or until
the reactants are consumed and the reaction plateaus. Some attempts to quantify the
DNA produced at the end of the reaction have been made but it is difficult to correlate the
amount of DNA during the plateau stage with the amount of starting material. For this
reason, Higuchi et al. used a fluorescent probe that emits signal only when bound to
dsDNA.19 The fluorescence intensity and therefore the reaction can be monitored in ‘realtime’ as dsDNA is continually produced. From the number of cycles required to reach
the plateau phase, the amount of DNA at the beginning of the reaction can be calculated.
This quantitative PCR is commonly referred to as real-time PCR.
Real-time PCR is categorized as a rapid technique because it can often be
performed after culturing in 0.5 - 4 hours. While sensitivity and speed are advantages,
some limitations are also present. One, this method requires that primers be available for
use. Bacteria with out available primers are not suitable for detection by real-time PCR.
Two, since it is a targeted approach the information obtained from the primers may be
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unreliable or insufficient if bacteria were genetically engineered for such purposes as
drug or heat resistance or had undergone natural or environmental mutagenesis. Finally,
small genetic differences unique to one strain of bacteria such as single nucleotide
polymorphisms (SNPs) could occur between the primer locations and be missed during
the comparison of two closely related strains.20
2.3.2. Pulsed-field Gel Electrophoresis
Another genomic approach that is widely used to characterize bacterial pathogens
is pulsed-field gel electrophoresis (PFGE). First presented in 1983, this technique
separates DNA fragments using gel electrophoresis in a pulsed electric field and has three
main steps.21 First, after culture of bacteria, the cells are lysed and the intact chromosome
is removed. Next, using a restriction endonuclease enzyme, the chromosome is digested
into fragments (usually 10-20) of DNA that range in size from 10-1000 kb (~ 3.13 – 313
MDa). Finally, these fragments are electrophoretically separated according to size using
a pulsed-field to create a pattern unique to that isolate of bacteria.22, 23
The electric field is pulsed in varying angles at different time intervals to better
separate the large DNA fragments which are not efficiently resolved using traditional
electrophoretic techniques. Using a traditional (continuous) field, these large
chromosomal fragments will elute together as a single band. But upon varying (pulsing)
the field at different angles and at different time intervals, the enough change in the
mobility the fragments occur to effect separation. Computer images of the gel patterns,
also known as restriction patterns, are then compared to historical samples or samples
from other laboratories etc. Highly similar or identical patterns indicate two isolates are
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related and differences in the restriction patterns signify differences in nucleotide
sequence.22
PFGE is considered a non-targeted screening approach and is therefore able to
detect subtle differences missed by targeted approaches such as serology and real-time
PCR. The specificity achieved by PFGE has made it the ‘gold standard’ technique for
strain typing and it is widely used for epidemiological purposes. Outbreaks are detected
and monitored through a program known as PulseNet which compares and certifies
PFGE patterns from public health laboratories around the country.24
The advantages of PFGE are that primers or antibodies are not required for
analysis and that strain-level typing is straightforward. However, because optimal
digestion for different types of bacteria require different restriction enzymes, prior
knowledge of the genus of the sample is required. Another limitation common to all
genotypic approaches is that the mere presence of a gene doesn’t necessarily correlate to
protein expression. This consideration is of particular importance for bacterial pathogens
which are known to contain genes that are not expressed25-27 which could result in a false
positive indication of pathogenicity. Furthermore, PFGE is not a rapid technique since it
requires a minimum of two days to perform after culturing.
2.4. Mass Spectrometric Approaches
2.4.1. Small Molecule Analysis
Mass spectrometry was first applied as a tool for the identification and
characterization of microorganisms in the 1970’s.28 Early approaches typically involved
gas chromatography/mass spectrometry (GC/MS) both for the information provided by
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chromatography as well as the added specificity and sensitivity afforded by MS
compared to a flame ionization detector (FID). Furthermore, using tandem mass
spectrometry (MS/MS) or selected ion monitoring (SIM) the background noise was
greatly reduced because only ions of interest were monitored increasing sensitivity.
Additionally, a GC/MS technique employing high temperature pyrolysis of intact bacteria
to introduce volatile compounds into the gas phase has also been utilized.28 The early
mass spectrometric approaches typically were chemotaxonomic in nature and monitored
small volatile molecules such as lipids and metabolites.20 For compounds that were less
volatile or were too polar, such as carbohydrates, derivatization reactions could be
employed to make them more amenable for GC analysis. Some specific techniques
utilized for speciation include monitoring the fatty acid content from phospholipid
backbones and detecting carbohydrate profiles.20 These fatty acid or sugar profiles were
then compared with other bacteria either manually or with the use of spectral libraries.28
Additionally muramic acid, one of the constituents of bacterial peptidoglycan, which is
not synthesized by mammalian enzymes, can be monitored by GC/MS to detect the
presence of bacteria in environmental or clinical samples and can also distinguish
bacterial from viral infections.20 To avoid the time consuming step of derivatization and
to monitor phospholipids directly, fast atom bombardment (FAB) mass spectrometry was
used in the early 1990’s due to its ability to analyze polar compounds.29 More recent
techniques such as desorption electrospray ionization (DESI) have been used to discover
sub-species distinctions in Salmonella typhimurium and E. coli by monitoring lipid
profiles.30

16
The analysis of small molecules such as lipids and carbohydrates can be
problematic because many of those compounds are not unique to a particular strain of
bacteria (unlike certain DNA or protein sequences) therefore limiting their overall
discriminatory power as biomarkers. Examples include fatty acids, some which are
shared over a wide range of bacteria, phospholipids which occur throughout nature
therefore possibly leading to background contamination or false positives, and hydroxy
fatty acids which are found in normal blood and tissues and could interfere during clinical
analysis.20 Furthermore, techniques that deal more directly with the function of the
organism such as genomic or proteomic information are more likely to gain acceptance in
the microbiology community.
2.4.2. Large Molecule Analysis
The advent of matrix assisted laser desorption ionization (MALDI) and
electrospray ionization (ESI) allowed soft ionization of highly polar compounds and both
have become the preeminent ionization techniques for the analysis of large biomolecules
e.g., DNA, by mass spectrometry.20 One example of the use of mass spectrometry to
classify bacteria by their DNA, is polymerase chain reaction – mass spectrometry (PCRMS).20 As described earlier, when PCR amplifies DNA, the products (amplicons) are
monitored by fluorescence spectroscopy (FS). However, the low level of specificity
obtained by FS makes it difficult to detect small differences in the nucleic acid sequence
such as a single A to T or G to C switch (SNPs) which yields mass differences of 9 and
40 Da, respectively. Mass spectrometry offers enhanced specificity thereby minimizing
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false positives. This technique has been used to distinguish two species of Bacillus using
the same PCR primers.31
MALDI and ESI have furthered the mass spectrometric analysis of proteins as
well. Interestingly, key differences between closely related strains may occur at the
proteome level that do not occur at the genome level. In fact, the data collected from
proteomic approaches is much more than just an indirect genetic analysis. This is
because the proteome is one to two orders of magnitude larger than what the genome
encodes.32 If an organism’s genome contains 20,000 genes, the number of unique
proteins in that organism may be as many as 200,000 to 2 million – information lost by
detecting DNA only. This large difference between the size of a genome and its
respective proteome is due to the various isoforms of proteins which are largely a result
of posttranslational modification (PTM). As their name implies, PTMs occur after the
genetic contribution to protein structure is complete. Examples of PTMs include the
adding of carbohydrates (glycosylation) or lipids (prenylation). One of the dominant
PTMs in bacteria is removal of the N-terminal methionine and is estimated to occur in
50% of bacterial proteins.33 In total, the differences that can be observed during the
comparison of bacterial proteins can be qualitative: the presence/absence of proteins,
protein sequence mutations and PTMs, or quantitative, i.e., varying levels of protein
expression.34
Often proteomic analysis by MS is coupled with a separation technique such as
liquid chromatography (LC) and two LC/MS workflows are commonly employed. The
first, known as the bottom-up approach, uses a protease such as trypsin to digest all of the
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proteins in the cell lysate. The resulting peptides are then analyzed by two dimensional
35

(2D) LC and MS and subsequent database searches are used to match the peptide masses
to known peptide sequences. The second approach is top-down, and first isolates intact
proteins of interest either by LC/MS or 2D gel electrophoresis so that only the proteins of
interest are sequenced.36 The last step of sequencing is performed either inside the mass
spectrometer or by analyzing peptides after proteolytic digestion.35, 36
The bottom-up approach is more time consuming because of the digestion (about
2 hours), the 2D LC separation and the added data analysis time due to the large number
of peptides produced. The method described here is a top-down approach where LC/MS
was used to identify the unique proteins rather than 2D gel electrophoresis. LC/MS is
automated and has improved dynamic range, resolution and reproducibility and is less
time consuming than gel electrophoresis.37 Moreover, the combination of mass and
retention time information means LC/MS could be considered a 2D approach. The topdown approach has the advantage of detecting the mass of the intact protein prior to
sequencing. Knowing the intact mass allows immediate detection of modified proteins
during comparative proteomic investigations.
The additional step of sequencing and database searching was not
employed in the method described here. The reason being unique and reproducible
biomarkers and protein profiles were observed allowing for identification at the species
and strain levels without knowing the actual identity of the proteins involved. Therefore,
this approach could potentially be applied to bacteria whose genomes have not been
sequenced. In contrast, proteomic approaches that rely upon database results for
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identification purposes are of little to no use for such bacteria. Finally, not sequencing
the proteins avoids a timely digestion step which resulted in a reduced analysis time.

CHAPTER 3 Overview of Analytical Procedures
3.1. Cultivation of Bacterial Cells
The bacterial pathogens that were investigated are: E. coli, Shigella species and
Clostridium species. Shiga toxin producing E. coli and Shigella are foodborne
pathogens, and the toxin they produce is a Category B select agent. These two pathogens
cause the enteric disease Shigellosis. Ubiquitous in the environment, Clostridium species
are toxin producers and cause illnesses such as gangrene and pseudomembranous colitis,
and are a common cause of nosocomial infection.38 In addition to the characteristics used
to identify these microorganisms as select agents and or foodborne pathogens; other traits
commonly used for their characterization are listed in Table 1.

Table 1. Characteristics used to describe the bacteria of interest to this study.

Bacteria
Shigella
spp.

Gram +/-

Aerobic

Shape

Sporogenic

Motile

-

Yes

Bacillus

No

No

E. coli

-

Yes

Bacillus

No

Yes

Clostridium
spp.

+

No

Bacillus

Yes

Yes

The bacteria were obtained from clinical isolates stored at the Virginia Division of
Consolidated Laboratory Services (DCLS) or were purchased from American Type
20
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Culture Collection (ATCC, Manassas, VA). Since no official nomenclature for
describing strains exists, in-house accession numbers were used to describe the clinical
isolates as different strains and the commercial strains were distinguished by their ATCC
product number Table 2.

Table 2. The isolates used in this study. NM = non-motile, NA = not applicable,
determined.

Family
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Enterobacteriaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae
Clostridiaceae

Genus
Escherichia
Escherichia
Escherichia
Escherichia
Escherichia
Escherichia
Shigella
Shigella
Shigella
Shigella
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium
Clostridium

Species
coli
coli
coli
coli
coli
coli
sonnei
sonnei
flexneri
flexneri
perfringens
perfringens
perfringens
perfringens
perfringens
perfringens
perfringens
perfringens
difficile
difficile
difficile
difficile
difficile

Serotype
O157:H7
O157:H7
ND
ND
O111:NM
O26:H11
NA
NA
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
A
B
C
F
ND

ND = not

Strain
06-1464
06-1439
06-0004
06-0006
06-1440
06-1418
06-1364
06-1362
04-0497
06-0967
06-0385
06-0387
05-0025
05-0070
05-0076
04-1464
04-1672
04-1665
43594
43593
43596
43598
700792

All bacteria were grown on trypticase soy agar plates containing 5% sheep’s
blood. The tryptone, soytone and sheep’s blood cells provide a source of nutrients
(sugar, nitrogen, minerals) to enhance cellular growth. Depending on the bacteria, either
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anaerobic or aerobic conditions were employed (Table 1). A temperature of 37 C was
o

maintained for all bacteria. Efforts were made to ensure that the growing conditions and
concentration of cells analyzed were kept constant. The Shigella, Escherichia and
Clostridium perfringens cells were grown for 24 hours, however the more fastidious
Clostridium difficile required 48 hours. To circumvent this, twice the number of plates
was used to cultivate C. difficle and after 24 hours, the cells from two plates were
combined and added to form one cell suspension.
After the 24 hour growth period, the cells were removed from the plate using a
sterile disposable swab and placed in a test tube containing 1 mL of sterile water until the
optical density reading reached 1.0 using a MicroScan Turbidity Meter (Dade Behring
West Sacramento, CA). The water used had been autoclaved and purified using the RiOs
5 Water Purification System (Milipore Billerica, MA). A 500 μL aliquot of the cell
suspension was added to a 1.5 mL protein LoBind micro-centrifuge tube (Eppendorf,
Westbury, NY) and washed three times with 500 μL of sterile water followed by
centrifugation (6000 × g at room temperature for 5 minutes) to remove residual media.
3.2. Cell Lysis
3.2.1. Gram Negative Bacteria
Bacteria are classified in various ways, one of them as being Gram positive or
Gram negative. This difference is based on the amount of peptidoglycan (linear
polysaccharide chains cross-linked by tetrapeptides) in the cell structure. Gram negative
cells have three layers. First, an outer membrane consisting of protein,
lipopolysaccharide and phospholipids, next, a peptidoglycan layer, followed by the
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cytoplasmic membrane. The cell envelope of Gram negative bacteria contains 10-20%
peptidoglycan compared to 50-80% in Gram positive.7 The name Gram positive/negative
arises from the results of a test known as the Gram stain. This test employs a dye that
turns red upon reacting with peptidoglycan. Since Gram negative cells have significantly
less peptidoglycan, they produce a faint pink color and are assigned a negative result,
while the Gram positive cells produce a deep red color indicating a positive result.
Initial work in this study involved Gram negative cells. After the final wash step
described above, the cells were resuspended in 150 μL of the lysis solution (1:1 H2O:
acetonitrile, 0.1% v/v trifluoroacetic acid (TFA)). Unlike detergents, which are
sometimes used for the chemical lysis of cells, the lysis solution (1:1 H2O:acetonitrile,
0.1% v/v TFA) is amenable to both MALDI and ESI analysis. After the lysis solution is
added, the samples are vortexed for a few seconds and lysis is complete. The suspected
mechanism of lysis involves the solubilization of cell wall lipids which may result in
swelling and bursting of the cells as well as denaturation of the cell wall and other
proteins. That the lysis solution denatures proteins is advantageous in that it will likely
inactivate protein toxins such as the Shiga toxin in addition to inactivating proteases
which will degrade other proteins of interest. It is expected that many of the proteins
extracted using this procedure are highly soluble cytosolic proteins.37 Many of the less
soluble proteins from the outer membrane and other cellular material precipitate
immediately after vortexing the samples. In order to prevent some of the cellular debris
from clogging the LC column, the samples are centrifuged at 4100 × g for 4 minutes at
room temperature prior to analysis, making a pellet of the debris and clarifying the
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supernatant. Following centrifugation, 65 μL of supernatant was removed and placed in
an autosampler vial containing a microvial insert for analysis.
3.2.2. Gram Positive Bacteria
Gram positive bacteria lack the outer membrane layer found in Gram negative
cells but have a significantly larger peptidoglycan layer. Since it is this layer that
provides the most structural strength and rigidity to the cell, Gram positive cells are much
more resistant to disruption and lysis. Applying the Gram negative lysis method to the
Gram positive Clostridia resulted in very few proteins being extracted. New methods
were attempted, and two protocols were successful with each extracting a distinct (by
both mass and retention time) set of proteins. After washing the cells as described above,
the first method involved adding 150 μL of 1 mg/mL lysozyme (HEWL) (Sigma-Aldrich
St. Louis, MO) in 20 mM NH4OAc and incubating at 37oC for 30 minutes. Lysozyme
disrupts peptidoglycan structure by hydrolyzing β-1,4 linkages of the polysaccharide
chains. This was followed by four cycles of freeze/thaw in liquid nitrogen and a 37oC
water bath respectively. The second lysis method began with 75 μL of 1 mg/mL
lysozyme in 20 mM NH4OAc and incubating at 37oC for 30 minutes, followed by four
cycles of freeze/thaw. Then, 75 μL of 1:1 H2O: acetonitrile, 5% v/v TFA was added.
The combination of these steps was required to recover a similar amount of proteins as
seen in the Gram negative protocol. Each individual step of lysis protocols resulted in
insufficient lysis, requiring a combination of disruption techniques.
In addition to Gram positive bacteria being more difficult to lyse, some Gram
positive bacteria (from the phylum Firmicutes) are known to sporulate posing greater
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difficulty in lysis and inactivation. Endospores are resistant to extremes of pH,
temperature, certain disinfectants and radiation. For this reason, endospores are regarded
as the most resistant of any known biological structure.39 Indeed, viability studies using
the lysis procedures described above revealed that neither lysis method was capable of
inactivating the endospores. Given that under idealized conditions (such as laboratory
cell culture) endospore forming bacteria may produce only a small amount of spores, it
was more straightforward to remove the endospores rather than attempting to lyse them.
To this end, after centrifugation at 4100 x g for 4 minutes at room temperature to pellet
the debris and clarify the supernatant, the supernatant was filtered using a disposable
syringe and blunt tip needle (BD, Franklin Lakes, NJ), and a 0.22 μm, 4 mm
polyvinylidene fluoride (PVDF) low protein binding GV filter (Milipore, Billerica, MA).
Subsequently, 65 μL of the filtered supernatant was transferred to an autosampler vial for
analysis.
3.3. Liquid Chromatography
3.3.1. High Performance Liquid Chromatography
Prior to detection by mass spectrometry, the proteins from the lysate are separated
using high performance liquid chromatography (HPLC). The purpose of this prior
separation is to simplify the detection process by reducing the number of proteins that
enter the mass spectrometer at any given time. Reversed phase chromatography was
chosen because of its use of volatile, water-miscible solvents. These solvents allow for
easy removal which is advantageous for down stream applications such as fraction
collection and detection by mass spectrometry. Gradient elution is most often used to
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separate protein mixtures and employs two mobile phases. The amount of organic
solvent (% B) is increased until a sufficient amount is present to displace the protein from
the site of adsorption causing elution from the column. Since the % B is increased slowly
over time and proteins with the larger amount of or more easily accessible hydrophobic
regions will stay adsorbed to the column longer, hydrophobicity is generally proportional
to retention time.40 However, other factors such as charge and conformation of the
protein can play a small role in the separation as well.
The liquid chromatograph used was an Acquity (Waters, Milford, MA). The
gradient conditions are listed in Table 3, where A = 1% formic acid in deionized water
and B = 1% formic acid in 2-propanol. The water was purified in house to yield organicfree 18.3 MΩ × cm using an E-pure purification system (Barnstead International
Dubuque, IA). The HPLC grade solvents 99% formic acid and 2-propanol were
purchased from Fisher Scientific (Fairlawn, NJ) and Honeywell Burdick and Jackson
(Morristown, NJ), respectively. The column used was a nonporous polymeric column
made from polystyrene-divinylbenzene (PSDVB), Prosphere P-HR 2.1 x 150 mm, 4 μm
particle size (Alltech, Columbia, MD) and was operated at a temperature of 50oC. To
help preserve the samples, the autosampler was maintained at a temperature of 15oC prior
to administering the injection volume of 20 μL. A typical chromatogram of an E. coli
O157:H7 isolate is shown in Figure 1.
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Table 3. LC gradient conditions used in this study. All steps in the gradient were linear.

Time (min)
0.00
60.00
65.00
70.00
70.01
75.50

A%
95
45
5
5
95
95

B%
5
55
95
95
5
5

30.52

100

26.83

%

64.83

25.33
1.83

70.73

62.96
3.11

20.04 21.84
8.23

10.00

20.00

58.11

44.05

18.16

0

70.50

32.56 34.45 38.23

30.00

40.00

50.00

60.00

70.00

Time

Figure 1. A typical HPLC/MS chromatogram from an E. coli cell lysate. Shown is E. coli O157:H7,
accession # 06-1439. The y-axis represents % relative intensity and the x-axis is time in minutes.

The gradient conditions in Table 3 are a compromise between improved
resolution and maintaining good peak shape. The slope of the gradient is one of the
simplest ways to control the peak shape of proteins with the larger the % B/min yielding
the sharpest peaks. However, it is the difference in % B at the point of elution that
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distinguishes the proteins so increasing the rate of change of organic content results in a
decrease in resolution. The majority of proteins elute prior to 55% B with only a few
eluting during the ramp to 95% B. The hold at 95% B is to help clean the column of
lipids and contaminates in the mobile phase such as polyethylene glycol, and is followed
by a hold at 5% B to allow the column to equilibrate to initial conditions prior to the next
injection.
3.3.2. Ultra Performance Liquid Chromatography
Ultra performance liquid chromatography (UPLC) involves the separation of
compounds using sub-2 μm particle sizes at pressures that exceed the capacity of
standard high performance liquid chromatographs. Van Deemter curves (plate height vs.
linear velocity) for applications utilizing sub-2 μm particles predict lower plate heights
(H) over a wider range of linear velocity than with larger particle sizes.8 The lower H
values occur because H is proportional to the particle diameter (dp). The optimum linear
velocity is higher and occurs over a wider range due to the reduced resistance to mass
transfer (C term in the Van Deemter equation); a consequence of using particles with a
smaller diameter.9 Lower plate heights result in better resolution (see Equations 1 and 2)
and the wide range of linear velocities at this plate height means the flow rate can be
increased while maintaining equal chromatographic resolution (Rs), yielding shorter
runtimes. Increased column back pressure has also been shown to improve protein
recovery from the column.41 To better ascertain the benefit received from UPLC vs.
HPLC, nearly identical columns were utilized. The HPLC column was the narrowbore
X-bridge C18 BEH 300 Å 2.1 × 150 mm, 3.5 μm (Waters, Milford, MA). According to
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the manufacturer, the UPLC column was identical (e.g., ligand density, pore size, carbon
load) to the HPLC column except in particle size (1.7 μm).

Chromatographic resolution (Rs) is described by the following equation:
N ⎛ α − 1 ⎞⎛ k ⎞
⎜
⎟⎜
⎟
4 ⎝ α ⎠⎝ k + 1 ⎠

Rs =

(1)

Where, N = separation efficiency (plate number), α = selectivity, and k = retention factor
(capacity factor).
The separation efficiency (N) equals:
N=

L
L
=
H
hd p

(2)

Where, L = column length, H = plate height, h = reduced plate height, and dp = particle
diameter.
Therefore, since N is proportional to N , Rs is inversely proportional to dp:
Rs ∝ N ∝

1
dp

While chromatographic separation helps to simplify the sample prior to detection
and yields information on individual protein reversed phase retention behavior,
chromatography alone is rarely enough to distinguish two closely related strains of
bacteria. Occasionally a unique peak can be observed in the chromatogram, but often
differences in the proteins are very minute such as a PTM or a single amino acid
substitution, either of which will likely not have a significant impact on the retention of
the protein. Furthermore, even with optimized conditions, in mixtures as complex as
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bacterial cell lysates, co-elution of proteins will occur. A sensitive, and specific detection
system such as mass spectrometry is needed that can further resolve co-eluted proteins.
3.4. Mass Spectrometry
The mass spectrometer for this project was a Q-TOF Premier (Waters, Milford,
MA). The Q-TOF has two quadrupoles (Q) prior to the orthogonal acceleration time of
flight (TOF). Table 4 lists the source conditions for the mass spectrometer. These and
the other parameters used in the MS method were optimized for best desolvation at 0.225
mL/min; and optimal sensitivity and resolution for bovine serum albumin. Positive ion
ESI was used to create ions that were monitored over a mass range of 620-2450 Da and
resolved in single reflectron (V) mode.

Table 4. Source conditions of the mass spectrometer.

Capillary
Cone voltage
Source Temperature
Desolvation Temperature
Desolvation Gas Flow

+ 3.9 kV
40 V
115oC
500oC
900 L/hr

ESI is an atmospheric pressure technique where liquid is passed through a
charged capillary causing the liquid to form an aerosol spray of fine charged droplets. As
the droplet sizes are reduced, the analyte molecules inside the droplets are removed and
thereby enter the gas phase.42 In full-scan mode (the mode used here), the two quads are
in radio frequency (RF) only mode and act as ion guides rather than mass analyzers.
Once the ions enter the quads, they have a trajectory that is hyperbolic in motion that is
governed by the Mathieu equation. Mass analysis in a TOF is based on the mass
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dependence of ion velocity and, that for a given velocity over a fixed distance, the time
43

taken to travel that distance is easily obtained. The set of equations44 that govern this
process is as follows:
The kinetic energy of an ion accelerating in an electric field (E) is given by:
mv 2
= zeE
2

(3)

Where, m = mass, v = finally velocity achieved during acceleration, z = number of
charges, e = charge of an electron.
It then follows that:
v =

2 zeE
m

(4)

If d, is the distance that an ion travels in the flight tube, then the time, t, taken to travel
this distance is given by:
t = d/v =

d
2 zeE
m

= d

(m / z )
2eE

(5)

Since d is fixed, e is a universal constant, and E is held constant in the mass spectrometer,
t is then directly proportional to the square root of (m/z) times a constant, C.
t = C (m / z )

(6)

Since t is proportional to (m/z), ions of a larger (m/z) take longer to travel to the detector
and vise versa.
When comparing results from different days, it is crucial that the instrument is
providing optimal and reproducible results. For this reason, prior to each analysis, the
instrument is calibrated and the mass resolution at full width half maximum (RFWHM) is
recorded as a quality control measure. The calibrant used was NaI because it produces a
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wide range of ions allowing the instrument to be calibrated from 300 – 2500 Da. The
daily specifications required of the instrument are: a mass error of no more than
approximately 5 ppm and a RFWHM ≈ 10,000. The mass accuracy is calculated as follows:
MA −MI
x 106 = mass error (ppm)
MA

(7)

Where MA and MI are the actual mass and indicated mass respectively, in units of Da.
The resolution is calculated as shown in equation 8:
MI
= RFWHM
ΔM I

(8)

Where ΔMI = the full peak width at half maximum height (in Da) of the ion of interest.
The Na8I7+ cluster ion at 1072.249483 Da was utilized for both calculations.

3.5. Data Analysis
3.5.1. Manual Interpretation
A critical aspect of this project was the data analysis and there are two key issues
pertaining to it: data complexity and the amount of data collected. Both hamper the data
analysis step by decreasing the throughput and increasing the time required to report
results to medical staff/investigating authorities. The complexity of the data largely
arises from the fact that as proteins undergo the electrospray process, multiply charged
ions are produced (Figure 2). While this aspect has been a major advantage of ESI by
allowing large biomolecules to be observed on inexpensive mass analyzers of moderate
mass range (< 3000 Da) such as quadrupoles, the envelope of multiply charged ions can
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be challenging to interpret even for a pure compound. Furthermore, a mixture of proteins
of different mass may have overlapping charge states in their envelopes and which charge
states belong to which protein may be unclear, making the spectral interpretation of a
protein mixture significantly more difficult. Even with the use of chromatography, this
scenario occurs often, for with complex mixtures like cell lysates, co-elution of proteins
will be common.

1590.20

100

1788.87

%

1431.27

1596.18
1301.23
1436.67
1441.66

1192.96

1446.69

1306.15

1601.52
1795.48
1801.48

1607.29

2044.35
0

1200

1300

1400

1500

1600

1700

1800

1900

2000

m/z
2100

Figure 2. A mass spectrum depicting the envelope of multiply charged ions produced by electrospray
ionization of a protein. The y-axis represents percent relative intensity and the x-axis indicates
mass/charge ratio (m/z).

The most common method of addressing the complexity of interpreting ESI mass
spectra of proteins is to employ computer-based algorithms. To evaluate their efficacy
for charge state deconvolution, one can initially test the method on standards of known
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mass. However for quality assurance purposes, some manual interpretation skills are
beneficial when proteins of unknown mass are being analyzed, as in a cell lysate analysis.
Some guidelines that can assist with the manual interpretation of protein mass spectra
acquired using ESI are given below. The mass/charge ratio (m/z) is obtained from mass
spectral analysis and the mass spectrum is a plot of intensity vs. m/z (Figure 2).
However, there are three unknowns in the mass spectrum: the number of charges (z), the
neutral (zero charge) mass (M), and the mass of the adduct ion (ma). The charges
received by a protein in positive ion mode are most often solvent adducts bonded by
ion/dipole force. The mobile phase used in this study is acidic (1% v/v formic acid, pH ≈
2.5). For this reason, the most common adduct is a proton (H+) weighing 1 Da. The
number of charges attributed to each peak (n) is discrete (where n is used for the number
of charges to avoid confusion with z), having only integer values with each peak in the
envelope being one charge away from its neighboring peak. The charge state can be
determined by using two adjacent peaks and solving a simultaneous equation beginning
with:
m/z =

( M + nm a )
n

(9)
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Given the mass spectrum in Figure 2, and letting ma be equal to H (1 Da), the
+

two adjacent m/z peaks at 1590.20 and 1431.27 (the latter having one more charge than
the former) can be used to determine the charge state as follows:

1590.20 =

( M + nH + )
n

1431.27 =

( M + ( n + 1) H + )
(n + 1)

Letting H+ = 1, solve for M:
1590.20n = M + n

1431.27(n + 1) = M + (n + 1)

1589.20n = M

1430.27(n + 1) = M
Since M = M,
1589.20n = 1430.27(n + 1)
Solve for n:
1589.20n = 1430.27n + 1430.27
158.93n = 1430.27
n=9
Recall that:
( M + nH + )
1590.20 =
n

Since H+ = 1, and n = 9, it then follows that:
1590.20 =

( M + 9)
9

Now solve for M:
14311.80 = M + 9
M = 14302.80
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Since there is a certain amount of error with each peak measurement, after the
charge state for two of the peaks has been determined, the charge states can then be
assigned to all peaks in the envelope. Once each peak has been assigned a charge state,
each one can be used to determine M and then determine the mean M value. The
unweighted average of the M values in Table 5 is 14302.89 Da.

Table 5. The M values determined from each peak in the envelope of multiply charged ions in Figure
2.

m/z
1192.96
1301.23
1431.27
1590.20
1788.87
2044.35

n
12
11
10
9
8
7

M
14303.52
14302.53
14302.70
14302.80
14302.96
14303.45

A simpler way to determine the charge state for a particular peak is to examine
the mass difference between the 12C and 13C isotopes. A singly charged species will have
an isotopic difference of 1 Da, 0.5 for doubly charged, 0.33 for triply charged, and so on.
As mentioned previously, once a charge state is determined, the neighboring peaks will
differ by one charge, allowing all peaks to be assigned a charge state. For a protonated
species, when the charge state (n) of a peak is known, the neutral mass (M) can be
determined by:
M = n[(m/z) – 1]

(10)

The problem with this method is that determining the isotopic difference is
dependant on the resolution of the mass spectrometer. Therefore, the utility of this
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method will decrease with decreasing MS resolution: ion cyclotron resonance > Orbitrap
> TOF > quadrupole. For the instrument used in this study, having a RFWHM ≈ 10,000 at
m/z 1000, the highest charge state that can be accurately be determined at m/z 1000 on a
centroided spectrum is +10 (Δ = 0.1). Figure 3 depicts a centroided version of the +10
charge state of the protein shown in Figure 2. This means that the above method of
charge state determination is only applicable to proteins weighing approximately 10,000
Da or less.
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Figure 3. Close inspection of the 1431.27 ion in Figure 2 allows charge state determination. The
spectrum is first smoothed (bottom) then centered (top). The isotopic separation of 0.1 Da indicates a
+10 charge state for this ion. The M value from this peak corresponds to 14302.70 Da.
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The arduous task of manually determining the neutral masses of hundreds of
proteins per isolate during cell lysate analysis and the limited ability of most commercial
instruments to allow visual charge state determination make clear the need for using
computer based approaches.
3.5.2. Chemometric Methods
Not long after the first protein was analyzed by ESI-MS, computer based
chemometric methods were used to deconvolute multiply charged protein ions into their
neutral masses (Figure 4). The first method was developed by Mann et al. 45 This
algorithm satisfied the two main goals of identifying the charge state of each ion in the
envelope and determining the neutral mass of the parent ion, but had the disadvantages
that in the deconvoluted spectrum, there were artifact peaks other than the protein of
interest and the baseline increased with mass range. Other algorithms were soon
developed46, 47 notably one developed by Hagen and Monnig which corrected the rising
of the baseline with mass and filtered out more noise giving cleaner deconvoluted
spectra, but all quantitative information was lost.48 Today, the most commonly used
method is known as Maximum Entropy (MaxEnt 1) developed by Ferrige et al.49, 50 This
method produces few artifacts, is quantitative and can effectively resolve mixtures of
proteins (Figure 4). While this algorithm has been in use for years, it can only process a
single or few chromatographic peaks at a time. For this reason a recently developed
software known as Protrawler6 (Bioanalyte, Portland, ME) can be employed. This
software automatically deconvolutes entire chromatograms by dividing the data into time
intervals, performing sequential deconvolutions, and then summing the centered data
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together into one text file containing neutral masses, intensities and retention times. As
6

seen in Figure 4, the calculated mass for the protein in Figure 2 is 14303.83 Da, which is
very similar to the unweighted average that was obtained by manual calculation,
14302.89 Da. The results from MaxEnt1 are slightly high (+ 0.94 Da), but reasonable
(mass difference < .01%). Protrawler6 uses an algorithm that is similar to MaxEnt 1 for
deconvolution, but requires less time for processing and adjusts for the slightly higher
mass estimates. For this reason, the values obtained from this algorithm are typically
lower, and after processing with Protrawler6, the neutral mass determined for the protein
in Figure 2 was 14303.20 Da.
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Figure 4. After processing with MaxEnt 1, the multiply charged spectrum in Figure 2 is
deconvoluted to a zero charge (neutral) mass spectrum.
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To apply Protrawler6 to LC/MS data, one must first build a model that accounts
for the resolution of the mass spectrometer, whether the deconvolution will be used for
peptides or proteins, and the typical background noise of the instrument. For this reason,
an analysis on peptides (which would require deisotoping and charge state
deconvolution) using an ion trap instrument (lower resolving power) would require a
different model than an analysis of intact proteins (requiring only charge state
deconvolution) using a TOF instrument (higher resolving power). The model is then
used to create a mock protein spectrum of known mass. This mock spectrum is used to
fit the raw data collected from the instrument, and is adjusted iteratively until the fit
reaches convergence. Since the mass of the mock spectrum is known (because it was
created by the software) once the mock spectrum satisfactorily fits the raw data, the mass
of the protein will be determined.
When an instrument of the same or highly similar resolution and background
noise is used and the model is applied to the same type of analysis, i.e., intact proteins
rather than peptides, the same model can be successfully applied to any type of protein
analysis on that instrument. The model is not dependant on the source of the proteins
(e.g. standards, Shigella lysates, Clostridium lysates). For this project, one model was
built and applied to all of the analyses thereafter. Since the proteins to be analyzed will
vary in size, models that are built for a large protein are more successful because they
more readily encompass small proteins than a small protein model can large proteins.
The model used here was applicable from 5 – 75 kDa. This mass range covered proteins
typically observed with this method and if after routine manual inspection of the data,
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proteins outside this range were observed, the model could be adjusted accordingly, but
that was not necessary here.
To verify the validity of the model, one can apply it to protein standards of known
mass or calculate the mass manually or use MaxEnt1 as described above. An ideal model
produces accurate charge state deconvolution and neutral mass determination, low noise
and few artifact peaks. Although parameters during model development were adjusted to
accurately account for the background noise and to minimize artifacts, the production of
some artifacts was unavoidable. All data compiled from Protrawler6 that was < 1%
relative intensity compared to the base peak was removed. This helps prevent artifacts
from subtracting out real peaks during spectral subtraction.
Once a model has been developed and its utility verified, it can then be applied.
Since the length of the chromatogram and width of the typical chromatographic peak may
change depending on which chromatographic method was used, the width of the time
slice and the trawl start and stop times are entered individually for each chromatogram.
The typical width used was 30 seconds. Because the first few minutes of the
chromatogram were from the solvent peak or system dead volume, and the last ~10
minutes were for column cleaning and re-equilibration, no proteins eluted during this
time. Therefore, to minimize processing times, Protrawler6 was typically set to process
from 2.5 – 62.5 minutes.
It is important to note the distinction between summing the MaxEnt data
iteratively as opposed to summing the entire chromatogram and doing a single MaxEnt
analysis. By summing time slices of MaxEnt data, the noise level is reduced because
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only formerly multiply charged ions are present in the MaxEnt results. This is in contrast
to summing the entire chromatogram which would be a summation of multiply and singly
charged data and given that the majority of background noise in LC/MS is singly
charged, this summation would drown out nearly all low abundance multiply charged
ions. The retention time information is tabulated in order to distinguish two proteins of
the same mass that have different retention times and if a protein is found to be
interesting, its retention time could then be utilized to isolate the protein for further study
by collecting fractions as they elute off of the column.
In addition to lessening the complexity of the data, the application of Protrawler6
also results in a significant reduction of the overall amount of data. The mass
spectrometer is set to acquire spectra at a rate of 2 spectra/second and the
chromatographic run time is 75.5 min (4,530 seconds) so each data file contains 9,060
summed spectra. But, after processing with Protrawler6, the data is reduced to one text
file which is then converted into a single mass spectrum representing all of the proteins
observed in the isolate.
3.5.3. Processing of Deconvoluted Spectra
Mass spectra are created from text files produced after Protrawler6 analysis using
MS Manager software (Advanced Chemistry Development Laboratories, Ontario, CA).
The data analysis process is then further simplified by using the spectral mirroring and
spectral subtraction tools in MS Manager. Spectral mirroring allows the comparison of
two spectra with one of them being inverted (Figure 4). Viewing the spectra in this
manner simplifies the search for unique masses by placing the baseline (where
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differences occur) at the center of view rather than overlaying them which places the
baseline at the bottom of the screen. The second tool, spectral subtraction, is useful for
comparisons of two spectra that have a high degree of similarity; such as two different
serotypes of the same species, referred to as spectrum A and B in Figure 5. Spectral
subtraction involves removing the peaks common in both spectra from one of the spectra
within a user-defined mass accuracy window (± 2 Da is used here), leaving a new
spectrum containing only unique masses (spectrum A2). This process is then reversed to
produce a spectrum containing masses only unique to spectrum B2. These two subtracted
spectra can then be mirrored, greatly simplifying the identification of unique masses
(Figure 6).
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Figure 5. Mirrored spectrum of E. coli O157:H7, accession # 06-1439 (top - A) and non-pathogenic
E. coli, accession # 06-0004 (bottom - B) showing many common peaks.
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Figure 6. Subtracted spectra of E. coli seen in Figure 5. Following subtraction, unique peaks become
much more obvious. A subtraction window of ± 2 Da was used.

One difficulty with the MS Manager program is that mirroring and subtraction
can only be performed with two spectra at a time. This is a problem if one needs to
compare groups of spectra such as comparing two of the O157:H7 spectra against the
eight other E. coli and Shigella spp. studied. One possible solution would be to compare
each E. coli O157:H7 spectra to each non E. coli O157:H7 spectra and tabulate the results
for each individual comparison; however, with 5 replicates of 10 isolates this would be
very time-consuming. To address this problem, theoretical spectra are made, i.e., the text
files for all non O157:H7 isolates are combined, and then this text file is converted into a
single mass spectrum. Since the hypothetical text file contains a large amount of masses,
some of which are actually artifacts from the MaxEnt 1 process, the hypothetical spectra
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are filtered by removing all peaks that are < 1% relative intensity of the most abundant
(base) peak in the mass spectrum. “Hypothetical” is used because analysis of a mixture
of all non O157:H7 isolates at roughly the same concentration as the individual isolates
was never performed. However, since all of the masses of each individual isolate are
included into the hypothetical spectrum’s text file, this new spectrum is valid for
comparison purposes. Furthermore, if a mixture as complex as the one described above
were to be analyzed, it is likely that many of the lower abundance proteins would be
missed and much poorer chromatographic resolution would occur, thereby yielding
poorer quality data than that present in the hypothetical spectrum.

CHAPTER 4 Characterization of Escherichia coli and Shigella Species
Utilizing Liquid Chromatography/Mass Spectrometry of Intact
Proteins
4.1. Introduction
4.1.1. Natural Routes Exposure
Foodborne illnesses are a significant cause of social and financial burdens even in
industrialized nations. In 1997, costs from foodborne illnesses in the United States alone
were estimated at $35 billion and were attributed to medical expenses and lost
productivity.2 Two of the top ten leading causes of food and waterborne illness outbreaks
reported to the Centers for Disease Control and Prevention from 1972 - 2000 were Shiga
toxin producing E. coli (STEC) and Shigella organisms.51 A particularly dangerous
subset of STEC are the enterohaemorrhagic E. coli (EHEC), which include serotypes
O157:H7, O26:H11 and O111:NM.52, 53 Annually, E. coli O157:H7 alone is responsible
for 73,000 cases of infection, 2,100 hospitalizations and 61 deaths in the U.S..54 Notable
was the recent outbreak of E. coli O157:H7 caused by the consumption of contaminated
spinach which infected 199 persons resulting in 102 hospitalizations and 3 deaths.55
Moreover, Shigella organisms cause an estimated 400,000 cases of shigellosis
each year in the U.S. More severe is the impact in developing countries where 163
million Shigella infections occur annually resulting in over 1 million deaths. Of the four
species of Shigella, S. sonnei and S. flexneri are the two most commonly implicated in
human illness.56, 57 Children, the elderly and the immunocompromised are most
46
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susceptible to the severe sequelae of Shigella and EHEC infections such as hemolytic
uremic syndrome (HUS), the principle cause of renal failure for U.S. children.54, 56
4.1.2. Potential for Deliberate Use
Since natural outbreaks of these organisms have had considerable public health
impact, of even greater concern is the threat of these pathogens being used intentionally
as biowarfare agents. Cultures of these organisms could easily be obtained from the
stools of animals or humans and only a small inoculum (as few as 10 organisms) is
required for infection. Additionally, both E. coli and Shigella infections can be
transmitted person to person allowing the impact to extend beyond those initially
exposed.54, 56 STEC and some species of Shigella produce a toxin that is classified as a
Category B select agent58 and deliberate use of these bacteria has been documented.
Shigella organisms were used in battle by the Japanese in WWII51 and by a disgruntled
hospital employee in Texas to infect co-workers.59 Furthermore, E. coli cultures were
found in possession of a Wisconsin man later arrested for possession of a toxin for use as
a weapon.60
4.1.3. Review of Current Methods of Analysis
In the event of an infectious disease outbreak or terrorist attack, key decisions by
hospital staff, public health officials and investigating authorities will have to be made to
guide medical treatment, prophylaxis and remediation. These decisions are best made
when they are data directed. Clinical manifestations (malaise, abdominal pain, diarrhea
etc.) of exposure do not unambiguously identify their cause. Therefore, rapid, sensitive
and specific analytical methods are needed to gain further insight. Rapid diagnoses of
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infections, such as those leading to HUS, are crucial as early treatment with intravenous
volume expansion has been shown to decrease kidney damage and augment patient
outcome.61 Sensitive and specific methods are desirable to minimize false negatives and
positives respectively. Three commonly used analytical methods in diagnostic
microbiology laboratories are: enzyme immunoassay (EIA), real-time polymerase chain
reaction (PCR), and pulsed-field gel electrophoresis (PFGE).
EIA methods are sensitive often eliminating the need for cultural enrichment, but
lack the specificity to be considered confirmatory. This was evident when public health
response was misguided during an outbreak of gastroenteritis in which two independent
laboratories found stool samples positive for Shiga toxin (Stx) by EIA, but further
investigation revealed norovirus as the cause.62 Real-time PCR is a rapid and sensitive
approach requiring 0.5 - 4 hours post culture to perform. However, strain specific and
often species specific primers are unavailable or impractical and for this reason the
specificity required in outbreak investigations is not typically afforded by this method.
Secondly, the mere presence of a gene does not guarantee that protein is being expressed.
This is an important consideration as bacterial pathogens have been shown to contain
genes that are not expressed.25-27 Finally, the gold standard for subtyping of bacteria
during outbreak investigations is PFGE. While this technique is capable of providing
strain level discrimination, it is not easily automated, is labor intensive and requires a
minimum of 2 days post culture.
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4.1.4. Specific Aims
Several different reviews on the techniques employed to analyze bacteria all had
one common conclusion – the strongest approach is polyphasic, combining information
from several different yet complimentary techniques.13, 16, 28, 63 The approach described
here is unique in that it utilizes liquid chromatography/mass spectrometry (LC/MS) of
intact proteins, to monitor protein expression in bacterial cells. Key differences between
closely related strains may occur within the proteome to which genetic approaches are
insensitive (e.g., posttranslational modifications, PTMs). One of the dominant PTMs in
bacteria, removal of the N-terminal methionine, is estimated to occur in 50% of bacterial
proteins.33 In total, the differences that can be observed during the comparison of proteins
can be qualitative: the presence/absence of proteins, protein sequence mutations and
PTMs, or quantitative, i.e., varying levels of protein expression.34
To examine the efficacy of this approach as a tool in diagnostic microbiology, a
brief comparison with MALDI/TOF-MS was performed, then a model set of ten of
Shigella and E. coli clinical isolates were studied (Table 6). From these ten isolates,
biomarkers based on protein mass, retention time and relative intensity were discovered
and evaluated for their reproducibility by performing five replicate analyses. Finally, the
validity of these markers was challenged by applying them to a blind test of clinical
isolates.
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Table 6. The ten known isolates examined in this study. ND = not determined, NM = non-motile and
NA = not applicable.
Enterobacteriaceae

Family
Genus

Escherichia

Species

E. coli

Serotype
Accession
Number

Shigella
S. flexneri

S. sonnei

ND
Stx (-)

O111:NM

O26:H11

O157:H7

ND

NA

06-0004

06-1440

06-1418

06-1439

04-0497

06-1362

06-1464

06-0967

06-1364

06-0006

4.2. Experimental
4.2.1. Materials
HPLC grade solvents (acetonitrile, formic acid and trifluoroacetic acid) were
purchased from Fisher Scientific (Fairlawn, NJ) and 2-propanol was purchased from
Honeywell Burdick and Jackson (Morristown, NJ). The water utilized for HPLC analysis
was purified in house to yield organic-free 18.3 MΩ × cm using an E-pure purification
system (Barnstead International Dubuque, IA). Sterile water that had been autoclaved
and purified with a RiOs 5 Water Purification System (Milipore Billerica, MA) was used
during bacteria preparation.
4.2.2. Growth and Lysis
Bacterial isolates were obtained from the Virginia Division of Consolidated
Laboratory Services. Cells were grown for 24 hours at a temperature of 37oC.
Trypticase soy agar plates containing 5% sheep’s blood in the presence of oxygen with
5% CO2 were used as the growth medium. After this growth period, cells were removed
from the plate and placed in a test tube containing 1 mL of water until the optical density
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reading reached 1.0 using a MicroScan Turbidity Meter (Dade Behring West Sacramento,
CA). A 500 μL aliquot of this suspension was washed three times with 500 μL of water
followed by centrifugation (6000 × g at room temperature for 5 minutes) to remove
residual media. Finally, the cells were resuspended in 150 μL of the lysis solution (1:1
H2O: acetonitrile, 0.1% v/v trifluoroacetic acid). After chemical lysis, the sample was
again centrifuged (4100 × g for 4 minutes) at room temperature. Following
centrifugation, 65 μL of supernatant was removed and placed in an autosampler vial for
analysis.
4.2.3. LC/QTOF MS Analysis
Intact proteins were separated by reversed phase chromatography using an
Acquity UPLC (Waters, Milford, MA). Gradient elution (5-55% B in 60 min) was used
at a flow rate of 0.225 mL/min where A = H2O (1% formic acid) and B = 2-propanol (1%
formic acid). The column was a non porous Prosphere P-HR 2.1 x 150 mm, 4 μm
particle size (Alltech, Columbia, MD) operated at 50oC. The autosampler was
maintained at 15oC prior to administering the injection volume of 20 μL.
A Q-TOF Premier (Waters, Milford, MA) utilizing positive ion electrospray
ionization was used for mass analysis. Ions were monitored over a mass range of 620 2450 Daltons (Da) and resolved in single reflectron (V) mode. The parameters employed
in the MS method were optimized for sensitivity and resolution using bovine serum
albumin.
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4.2.4. Data Processing
The LC/MS data was processed using two software packages: Protrawler6 and
MS Manager. Protrawler6 (Bioanalyte, Portland, ME) software provided automated
deconvolution of multiply charged ions by first dividing the full-scan data from the
chromatogram into time intervals (30 seconds) and summing the data from each interval.
Sequential deconvolutions were then performed to obtain neutral masses of the proteins
that eluted during each interval. A text file containing the neutral masses, intensities and
retention times was then created summarizing the results for each chromatogram.6
Retention time information can be used for further study (e.g., fraction collection) of
proteins of interest or to distinguish proteins of the same mass that differ in retention.
The masses and intensities were used to create a single spectrum representing all of the
proteins observed in the lysate using MS Manager (Advanced Chemistry Development
Laboratories, Ontario, CA).
To further facilitate biomarker discovery, MS Manager was employed for spectral
mirroring and spectral subtraction. Spectral mirroring allowed spectra to be mirrored
along the abscissa, placing the baseline at the center of view. Spectral subtraction
removed all common peaks between two spectra within a given mass accuracy so that
only unique ones remained. For group and strain level comparisons involving multiple
spectra, the text files of all isolates not in that group or strain were combined to create a
hypothetical spectrum which could then be used for subtraction. A subtraction window
of ± 2 Da was utilized.
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4.3. Results and Discussion
4.3.1. LC/MS vs. MALDI-TOF/MS Comparison
Since nearly all of the early work concerning the MS analysis of bacterial proteins
has centered on MALDI-TOF20, a brief comparison with the LC/MS technique described
here was made. MALDI-TOF exhibits certain advantages over LC/MS. One, by
producing primarily singly charged ions, data interpretation is greatly simplified relative
to ESI-MS. MALDI-TOF is also better suited for the analysis of complex mixtures
therefore prior separation (e.g., chromatography) is not required. Consequently, MALDITOF has a considerable throughput advantage ~two min (after deposition and drying)
compared to ~two hours (data acquisition and deconvolution) over LC/MS.
However, as can be seen in Figure 7, after automated charge state deconvolution
with Protrawler6, spectra from LC/MS are as simple to interpret as MALDI data, and are
much richer. In addition to providing more proteins (particularly >15 kDa), other
advantages to using LC/MS exist. These include improved mass resolution and mass
accuracy, reproducibility, and more reliable quantitative data. The last two advantages
stem from the uneven distribution of the sample across the spot on the MALDI target and
variance in the placement and number of laser shots acquired on the sample.
Having retention time information allows more to be known about the biomarker
candidates. MALDI-TOF data is analogous to that obtained from a 1D gel, while
LC/MS data is comparable to that acquired from a 2D gel (with obvious improvements in
mass resolution and mass accuracy over gel-based approaches). The LC/MS approach
also allows for distinctions of proteins of the same mass that differ in retention time. If
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the effluent from the LC is split, simultaneous fraction collection and MS analysis can be
performed and the collected fractions can be used for further study (e.g., sequencing).
Protein isolation for further study can not be performed by MALDI-TOF; either LC or
tandem mass spectrometry would be required.
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Figure 7. Comparison of MALDI/TOF-MS and LC/MS using the same S. sonnei lysate. More
proteins, particularly >15 kDa were observed using LC/MS.

Figure 7 shows a comparison of MALDI/TOF and LC/QTOF data using the same
sample preparation and protein extraction procedures for a S. sonnei isolate. Reasons for
the differences in observed proteins may include difficulty in optimizing MS conditions
over such a wide m/z range (4,000-20,000 Da, Δ = 16,000 Da) with MALDI-TOF
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compared to (620-2,450 Da, Δ = 1,830 Da) during ESI, and the complexity of the lysate
which may lead to ion suppression and/or detector saturation. Although the LC step
causes decreased throughput, this step is likely part of the reason more proteins are
observed. Often, distinctions between closely related strains may involve only one or a
few proteins and for this reason the increased information content and protein yield
observed by the LC/MS approach is likely advantageous and was deemed worthy of
further investigation.
4.3.2. Biomarker Discovery
The process of biomarker discovery is shown in Figure 8. First, chromatographic
data is collected in full-scan mode (8a). Next, automated charge state deconvolution is
performed to yield a single mass spectrum representing all of the proteins observed in the
chromatogram (8b). The spectra are then mirrored (8c) and subtracted revealing unique
masses (8d). As seen in Figure 8d, numerous peaks appear to be unique to each isolate
after subtraction. However, many of these peaks were not reproducible and may have
been artifacts from the deconvolution process. For this reason, a protein was deemed a
biomarker only if its unique mass, retention time and or relative intensity was observed in
each of the five repeated experiments. Spectra from the ten isolates listed in Table 6
were examined to find reproducible biomarkers whose presence or absence could be used
to identify unknown samples. To determine the specificity of the technique, a search for
biomarkers was made at each taxonomic level (e.g., genus, species, strain etc.).
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Figure 8. During biomarker discovery, LC/MS chromatograms were obtained in full-scan, positive
ion mode (8a). After automated charge state deconvolution using ProTrawler6, a single spectrum
showing all of the proteins observed in each chromatogram was generated (8b) and mirrored along
the abscissa using MS Manager (8c - top). As can be seen in 8c, a number of similar masses were
observed between the two serotypes. Mass spectral subtraction using a ± 2 Da window was
subsequently employed leaving only unique masses for each serotype (8d - bottom). The protein at
11,779 Da was reproducibly unique to E. coli O111:NM during the comparison of these two
serotypes.

59
4.3.3. Qualitative Markers: Mass and Retention Time
Historically, it has been difficult to distinguish Escherichia and Shigella by
genetic approaches due to cross-reactivity with primers and probes.64 In fact, it has been
argued that these two actually comprise one genus due to considerable overlap between
genomes.65 The protein expression profiles of either Shigella or Escherichia isolates were
easily distinguished from other genera (data not shown), but distinctions between
Shigella and Escherichia were few (Figure 9). While, no genus specific biomarkers were
observed, Shigella and Escherichia were distinguishable using the proteins unique to
either Shigella species.
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Figure 9. Mass spectral comparison of Shigella and Escherichia showed significant overlap between
these closely-related genera.
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PCR primers for Shigella speciation are commercially unavailable. However,
with LC/MS, distinctions between Shigella species were observed. Figure 10 depicts a
spectral comparison of S. flexneri and S. sonnei. The masses in bold marked with
asterisks were found in both isolates of that Shigella species, yet were not observed in
any of the other eight isolates studied. The protein at mass 7,287 unique to S. flexneri has
the same retention time (27.9 min) and nearly the same mass as a 7,273 Da protein
present in all of the E. coli and S. sonnei isolates studied. This mass difference of 14 Da
could be due to a PTM (e.g., methylation), an amino acid substitution (e.g., I for V) or
some combination of the two. Either way, such a small difference would likely go
unnoticed in a gel based approach or when using a detector with less specificity such as
ultra-violet or fluorescence spectroscopy.
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Figure 10. The mass spectra from two species of Shigella were both mirrored and subtracted to
detect biomarkers for speciation. Unique masses to each species are denoted in bold-type and with
an “*”.

As an example of serotype differentiation by this approach, the two E. coli
O157:H7 isolates were compared against the other eight isolates. During this comparison
a protein at mass 18,996 eluting at 43.3 minutes was discovered unique to this serotype
thereby demonstrating the ability of this method to distinguish EHEC serotypes which are
otherwise indistinguishable by clinical symptoms.53 Table 7 contains the masses and
retention times for proteins that were found unique to a group such as to both O157:H7 or
to both S. sonnei isolates etc.

62
Table 7. Group specific qualitative biomarkers. Mass (± 2 Da) is listed first followed by retention
time (± 0.5 min) in parentheses. * indicates a mass tolerance of ± 3 Da. These markers were present
in all 5 replicates.
Group

E. coli
O157:H7

non O157:H7
EHEC

S. flexneri

S. sonnei

Unique
Proteins

18,996 (43.3)

15,478 (27.1)
24,315 (38.5)

*35,250 (31.4)
16,886 (26.8)
7,287 (27.9)

11,795 (27.3)
12,235 (45.4)

The two non-O157:H7 EHEC have peaks that identify them as a group as well
(Table 7), but when each individual isolate (06-1440 or 06-1418) was compared against
the other 9, no unique peaks were found. It was suspected however, that one of the
isolates might share a genetic similarity with some of the other eight isolates that was not
shared with the other non-O157:H7 EHEC. For this reason, the O111:NM (non-motile)
and O26:H11 spectra were subtracted only against each other. During this comparison, a
protein at 11,779 Da having a retention time of 27.0 minutes was found unique to
O111:NM (Figure 8). A protein of this same mass and retention time has also been
observed in S. flexneri and E. coli O157:H7 isolates. Accordingly, during a blind test
these two E. coli serotypes could be distinguished first by looking for the group specific
peaks listed in Table 7 which would classify them as a non-O157:H7 EHEC, then
observing a protein at 11,779 Da with a retention time of 27.0 minutes would indicate the
sample was E. coli O111:NM.
In epidemiological and forensic investigations, techniques that can characterize
bacteria at the strain level are desirable for establishing cluster or outbreak relationships
via strain relatedness. Highly specific characterization is needed to detect and pinpoint
the source of an outbreak such as a particular produce manufacturer or suspected
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bioweapons facility. To this end, strain level comparisons between E. coli O157:H7
isolates were made. One O157:H7 isolate studied, accession # 06-1464, has shown a
reproducible protein at 14,880 Da eluting at 26.9 minutes not observed in the other
O157:H7 isolate, accession # 06-1439, or any of the other E. coli or Shigella samples.
The differences observed between these two O157:H7 isolates indicates that the method
described here is not only capable of identifying bacteria, but also of discerning small
phenotypic differences which could be indicative of the pathogen’s origin and growth
environment. With the exception of PFGE, which indicated ~ 98% similarity, other
established techniques (e.g., serology) found these two isolates to be identical. In
addition to the value of establishing strain relatedness during outbreak investigations, the
ability to distinguish two strains (such as the ones described above) that while genetically
similar are epidemiologically unrelated, is also significant. Figure 11 depicts the
comparison of the two E. coli O157:H7 spectra with PFGE results in the inset.
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Figure 11. Strain-level comparison of two E. coli O157:H7 isolates revealed a reproducible
difference at mass 14,880 that was unique to accession # 06-1464. This distinction is noteworthy
considering serological and PCR analysis would not be able to distinguish the two isolates from one
another. The gold standard method, PFGE analysis, determined ~ 98% similarity between the two
isolates after 48 hours (inset).

Analogous to PFGE, in which sequencing of the chromosomal fragments is not
performed66, this approach does not involve sequencing of the biomarkers. The
justification being reproducible biomarkers have been observed allowing for
characterization at the strain level without knowing the actual identity of the proteins
involved. Therefore, this approach could potentially be applied to bacteria whose
genomes have not been sequenced. In contrast, proteomic approaches that rely upon
database results for identification purposes would have little utility for such bacteria.
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Finally, circumventing protein sequencing eliminates a timely digestion step resulting in
a reduced analysis time.
4.3.4. Distinction of Isobars Differing in Retention
Since proteins with larger quantities of, or more easily accessible, hydrophobic
regions will stay adsorbed to the column longer,40 retention time can therefore be used to
distinguish two different isobaric proteins. This is critical when a sample has two or
more different proteins of approximately the same mass. Such was found to be the case
for S. flexneri 04-0497. This strain of S. flexneri has two proteins within 2 Da of mass
18,121 that differ in retention time by nearly 16 minutes (13% B). One protein which
eluted at 37.1 minutes had been observed in both E. coli O157:H7 and both S. flexneri
isolates studied. The other protein however, eluted at 21.3 minutes and was present only
in S. flexneri 04-0497. Techniques yielding only mass and intensity information (e.g.,
MALDI-TOF) would likely not detect this protein or mistake it as common. Table 8
contains masses and retention times for proteins found unique to an individual isolate and
absent from the other nine isolates. Tables 7 and 8 could be used to identify unknowns
based on the presence or absence of these proteins.
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Table 8. Strain level qualitative biomarkers. Mass (± 2 Da) is listed first followed by retention time
(± 0.5 min) in parentheses. These markers were also present in all 5 replicates. ND = not
determined.
Species/
Serotype

E. coli
O157:H7

E. coli
ND

E. coli
ND

S. flexneri
ND

S. flexneri
ND

Accession
Number

06-1464

06-0004

06-0006

04-0497

06-0967

Unique
Proteins

14,880 (26.9)

11,694 (28.5)
15,931 (30.2)
9,066 (16.3)

11,707 (28.0)

10,119 (27.7)
18,860 (41.9)
18,121 (21.1)

10,089 (28.9)
18,151 (21.5)
18,874 (40.7)

4.3.5. Quantitative Markers
In addition to qualitative aspects (e.g., mass and retention time) that signify
biomarkers, proteins that differ in intensity are also informative and may be caused by up
or down regulation or possibly genetic engineering (to produce more toxin etc.). The
utility of quantitative biomarkers was evident during the analysis of the two nonO157:H7 EHECs. In the other eight samples, the intensity of a protein at 15,406 Da is
much greater than one at 15,423 Da, but the trend was reversed for the two non-O157:H7
EHECs. Interestingly, this difference involved two of the most abundant proteins in the
lysate. For this reason, the quantitative difference was immediately obvious and no
spectral subtraction of common peaks was required.
Strain level quantitative differences were also observed. In S. flexneri 04-0497, a
protein at mass 9,737 eluting at 26.4 minutes and highly abundant in all 9 other isolates,
was barely detected. Additionally, in E. coli 06-0006 a protein which elutes at 30.6
minutes weighing 35,171 Da, common to other E. coli and S. sonnei isolates, is
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completely absent– most likely underexpressed below the limit of detection.
Alternatively, the gene for this protein could be damaged or turned off or possibly absent
so that no protein is being expressed at all making this a qualitative distinction.
4.3.6. Analysis of Unknowns
To challenge the validity of the biomarkers discussed above, a blind study of
thirteen isolates distinct from the original ten was performed. In an attempt to identify
each unknown, the mass spectra obtained from each of the thirteen isolates were
individually screened for the biomarkers listed in Table 7. Upon inspection of the blind
study data, one initial observation was shifting retention times for the markers. During
the early investigation of known isolates, a retention time window of ± 0.5 minutes was
observed. However, during the blind study, analyte retention times seemed more variable
indicating an average window of ± 1.0 minute was more suitable. Possible explanations
for this variation include degradation of the column or minor differences in the mobile
phase composition. This variation was consistent within each run however, thus not
affecting the relative retention times of the analytes. When used in conjunction, the
retention time, mass and relative intensity (RI) information allowed the biomarkers to be
detected with confidence.
Another observation was made concerning two of the three biomarkers for S.
flexneri, one at 7,287 and one at 35,250 Da. These markers have counterparts in E. coli
and S. sonnei exhibiting the same retention times but at decreased masses of 7,273 and
35,170 Da. During the blind study, these two S. flexneri proteins were observed in small
amounts (2 - 5% RI) in some of the E. coli and S. sonnei isolates. There were two
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possible reasons for this. One, there was a small amount of S. flexneri present in these
isolates and they were therefore technically a mixture. Two, the mass spectrometer
displayed higher total ion counts during the blind study than in any of the five previous
replicates of the known isolates. However, even with the greater ion counts, the E. coli
and S. sonnei counterparts were not observed in any of S. flexneri isolates. Since the
exact reason(s) was not determined, these two S. flexneri proteins were at least for the
unknown isolates examined here, best used as quantitative biomarkers rather than
qualitative.
Using the two S. flexneri proteins as quantitative markers, all biomarkers were
present and absent as expected allowing all thirteen unknown isolates to be correctly
identified. In total, there were three S. sonnei, three S. flexneri, four E. coli O157:H7, one
E. coli O26:H11 and two E. coli O111:NM isolates identified. The time required to
collect, process and examine the data to determine the identity of the unknown isolates
was approximately two hours per sample post culture.
4.4. Conclusions
Using LC/MS, a technique commonly found in analytical chemistry laboratories
but rarely found in diagnostic microbiology laboratories, a complementary approach with
certain advantages over typical microbiological methods has been developed. This study
used as a proof of concept ten isolates of Shigella and Escherichia including the species
most often implicated in human disease to examine the efficacy of the LC/MS approach
to characterize microorganisms. This approach has demonstrated greater specificity than
obtainable using current real-time PCR protocols, allowing for distinctions at the strain
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level. Furthermore, this method is automated and is less labor intensive compared to
PFGE, the gold standard for subtyping. Analogous to PFGE data, LC/MS results from
various public health laboratories could be uploaded into a public database such as
PulseNet which is utilized to detect outbreaks around the country.67
Using a combination of automated charge state deconvolution and spectral
subtraction, reproducible intact protein biomarkers were observed at the species and subspecies (serotype, strain, etc.) levels, and were successfully implemented for the
identification of unknown pathogens. These biomarkers and their corresponding protein
expression profiles could be used to enhance public health response (treatment,
remediation, etc.) by yielding insight into the identification of unknown bacteria. Highly
specific and accurate identification of microbial pathogens in a timely manner is essential
to guide the data directed decision making of hospital staff, public health officials and
investigating authorities. No primers, antibodies, or proteomic database searches were
required for this study. This was of particular interest for Shigella speciation for which
PCR primers are commercially unavailable. Although no sequencing was performed
here, these protein biomarkers could be sequenced, and that information could be used to
reverse-engineer novel PCR primers.37, 68, 69 Likewise these biomarkers could be purified
for the production of antibodies to enhance serological investigations (e.g. protein
microarrays).70
Ultimately, this method would be ideal as a complementary technique adding
another dimension to the polyphasic approach of bacterial identification. This enhanced
polyphasic approach would then lead to more confident results which are required to
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cease production and distribution during an outbreak, or for the prosecution of suspected
terrorists. Additionally, this LC/MS method could be expanded to monitor biomarkers
for other foodborne pathogens and implemented to screen food items before they enter
the market to prevent possible outbreaks from occurring.

CHAPTER 5 Characterization of Clostridium Species Utilizing Liquid
Chromatography/Mass Spectrometry of Intact Proteins
5.1. Introduction
5.1.1. Natural Routes Exposure
Ubiquitous in the environment, Clostridium species can be found in soil, dust and
in the intestinal flora of humans and animals.71 They are anaerobic, rod-shaped
sporeformers72 and produce more toxins than any other genus of bacteria.73 In addition to
their role in human disease (e.g. gastroenteritis), pathogenic Clostridia also cause illness
in both domestic and wild animals.74 Of the approximately forty-five species that cause
clinical conditions,75 of particular interest to this study were the species C. difficile and C.
perfringens.
C. difficile is the leading cause of the nosocomial illness antibiotic associated
diarrhea (AAD), a significant cause of morbidity and mortality particularly among
hospitalized elderly and immunocompromised.76 C. difficile related AAD is responsible
for increased hospital stays, resulting in an annual economic burden of $1.1 billion in the
U.S. alone.77 Outbreaks in both long-term care facilities and hospitals have been
reported.78 Although not typically recognized as a foodborne pathogen, C. difficile has
been found in retail ground meat79 and commercially vacuum-packed raw meat.80
Additionally, PCR ribotypes 017 and 027, which have been implicated in outbreaks, were
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isolated from both humans and cattle raising concerns that C. difficile may be an
emerging foodborne pathogen and indicating the possibility of zoonotic transmission.81
Although less common, C. perfringens is also a causative agent of AAD,76, 82
responsible for up to 15% of the cases.83 More known for its role in foodborne disease, C.
perfringens was listed in the top ten by the Centers for Disease Control and Prevention
(CDC) for microbial causes of foodborne outbreaks from 1972-2000.51 Additionally,
from 1993-1997 alone, fifty-seven outbreaks of C. perfringens food poisoning were
reported causing an estimated 250,000 cases per year, yielding costs of approximately
500 million dollars. Although C. perfringens has a high infectious dose (~ 108 cells), it is
fast growing, with generation times in ground beef at 41oC, as small as 7.1 minutes being
reported.84 At this rate, a single C. perfringens cell can grow to over the infectious dose
in just 3.5 hours. Beyond the problems associated with ready-to-eat foods, infection
control is challenging, as normal cooking temperatures which kill most bacteria, are
insufficient for killing C. perfringens spores.85
5.1.2. Potential for Deliberate Use
If natural outbreaks of these organisms have had such considerable public health
impact, of even greater concern is the threat of these pathogens being used intentionally.
The ease of access, and the toxin producing and spore forming capabilities of Clostridia
make them viable options as bioweapons, and their cultivation for deliberate use has been
documented. The epsilon toxin of C. perfringens is considered by the CDC a category B
select agent51 and spores of C. perfringens were stockpiled by the Iraqi government
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during the first Gulf War. Additionally, cultures of C. difficile were grown by the
Japanese terrorist organization Aum Shinrikyo in the mid 1990s.87
5.1.3. Review of Current Methods of Analysis
In the event of an infectious disease outbreak or terrorist attack, key decisions by
hospital staff, public health officials and investigating authorities are required to guide
medical treatment, prophylaxis and remediation. These decisions are best made when
they are data directed. Since individuals with C. difficile and C. perfringens infections
would exhibit similar symptoms, molecular differentiation is needed. Two common
molecular approaches for diagnosing Clostridia are enzyme immunoassay (EIA) and
real-time PCR.
EIA methods are rapid and sensitive, and are typically used to target toxins.
However, cross reactivity is a common problem leading to a high false positive rate
which can misguide public health response. Additionally, the toxins of C. perfringens
and C. difficile are unstable and can degrade quickly, which can lead to false negatives if
stool samples are not analyzed soon after collection or properly refrigerated.88, 89 Realtime PCR methods, are typically employed to amplify toxin genes. Difficulties with this
method can arise since many of the toxin genes in Clostridium spp. reside on
extrachromosomal elements (e.g. plasmids or phages) and can be horizontally transferred
to other types of bacteria or even within different Clostridium species.90 The transfer of
genetic material between C. perfringens and C. difficile has been reported91 and this
could be problematic for methods targeting only one or few genes of a single species.
Furthermore, the mere presence of toxin genes does not guarantee that the genes are
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actually being expressed, which could result in a false positive indication of
pathogenicity. This is noteworthy since many bacterial pathogens possess genes that are
not expressed.25-27
Both EIA and real-time PCR are targeted approaches and not capable of providing
strain level typing which is desired during outbreak investigations. Due to its high degree
of specificity, the gold standard during outbreak investigations is pulsed-field gel
electrophoresis (PFGE). Although highly specific, PFGE is labor intensive, not easily
automated and time consuming - requiring a minimum of two days post culture. Since
each of these molecular methods has its strengths and weaknesses, several reviews
regarding the identification and characterization of bacteria have all reported a common
conclusion: the highest confidence approach is polyphasic i.e., combines information
from several complementary yet distinct techniques.13, 16, 28, 63 One molecular technique
which can add a dimension to the polyphasic approach is mass spectrometry.92
5.1.4. Using Mass Spectrometry to Characterize Bacteria
Mass spectrometry was first applied to the problem of microbial characterization
in the 1970s93 and subsequent books and review articles have been dedicated to the
subject.28, 94, 20 Since that early application, mass spectrometry has been used to
characterize bacteria by detecting lipids,95 carbohydrates,96 and nucleic acids.97 The
approach described here is distinct in that it uses reversed phase liquid
chromatography/mass spectrometry (LC/MS) to monitor intact proteins and is capable of
providing information regarding protein mass and relative hydrophobicity (retention
time). Key differences between closely related bacteria may occur within the proteome
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to which genetic approaches are insensitive (e.g. posttranslational modifications, PTMs)
making this a complementary approach. PTMs are common in bacteria and one of the
more dominant PTMs, removal of the N-terminal methionine, results in a mass shift of 131 Dalton (Da)98 and is estimated to occur in 50% of bacterial proteins.33
5.1.5. Specific Aims
The advantages of the polyphasic approach to characterizing bacteria, the
significant socio-economic burden posed by pathogenic Clostridia, and the need of public
health officials to have sound data to assist with decision making, all act as a driving
force for the continuing research and development of novel molecular assays. The aim of
this study was to examine the efficacy of the LC/MS approach for characterizing
pathogenic Clostridium species. The goal was to develop a method that can provide
complementary information compared to existing protocols and yield information that
may also be used to enhance current approaches. The method described here is threefold:
discovery of reproducible protein biomarkers, implementation of those biomarkers for the
speciation of C. perfringens and C. difficile and characterization of each species at the
strain level. Finally, the validity of the species specific markers was further challenged
by applying them for the identification of unknowns in a blind study.
5.2. Methods
5.2.1. Materials
HPLC grade solvents (acetonitrile, formic acid and trifluoroacetic acid (TFA))
were purchased from Fisher Scientific (Fairlawn, NJ) and 2-propanol was purchased from
Honeywell Burdick and Jackson (Morristown, NJ). The water utilized for HPLC analysis
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was purified in-house to yield organic-free 18.3 MΩ × cm using an E-pure purification
system (Barnstead International, Dubuque, IA). Sterile water that had been autoclaved
and purified with a RiOs 5 Water Purification System (Milipore, Billerica, MA) was used
during bacteria preparation.
5.2.2. Growth and Lysis
C. perfringens clinical isolates were obtained from the Virginia Division of
Consolidated Laboratory Services and C. difficile isolates were purchased from American
Type Culture Collection (ATCC, Manassas, VA). Since no official nomenclature for
describing strains exists, in-house accession numbers were used to describe the eight C.
perfringens isolates as different strains and the five C. difficile strains were distinguished
by their ATCC product number. The following strains were utilized during the portion of
this study where the isolates’ identity was known: C. perfringens (06-0385, 06-0387, 050025, 05-0070, 05-0076, 04-1664, 04-1672 and 04-1665); C. difficile (43593, 43594,
43596, 43598 and 700792).
The C. perfringens cells were grown for 24 hours; however, the more fastidious
C. difficile required 48 hours. To shorten the time required to reach the desired cell
concentration, twice the number of plates were used to cultivate C. difficle and after 24
hours, the cells from two plates were combined and added to form one cell suspension.
Both species were grown at a temperature of 37oC. Trypticase soy agar plates containing
5% sheep’s blood under anaerobic conditions were used as the growth medium. After
this growth period, cells were removed from the plate and placed in a test tube containing
1 mL of sterile water until the optical density reading reached 1.0 using a MicroScan
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Turbidity Meter (Dade Behring, West Sacramento, CA). A 500 μL aliquot of this
suspension was washed three times with 500 μL of water followed by centrifugation
(6000 × g at room temperature for 5 minutes) to remove residual media.
Two protocols for lysis were employed. After washing the cells as described
above, the first method (lysis protocol 1, LP1) involved adding 150 μL of 1 mg/mL
lysozyme (HEWL) (Sigma-Aldrich, St. Louis, MO) in 20 mM NH4OAc and incubating at
37oC for 30 minutes. This was followed by four cycles of freeze/thaw in liquid nitrogen
and a 37oC water bath respectively. The second lysis protocol (LP2) began with 75 μL of
1 mg/mL lysozyme in 20 mM NH4OAc and incubating at 37oC for 30 minutes, followed
by four cycles of freeze/thaw. Then, 75 μL of 1:1 H2O: acetonitrile, 5% (v/v) TFA was
added.
Neither lysis protocol was capable of inactivating spores, so they were removed
by filtration. After centrifugation at 4100 × g for 4 minutes at room temperature to pellet
the debris and clarify the supernatant, the supernatant was filtered using a disposable
syringe, a blunt tip needle (BD, Franklin Lakes, NJ), and a 0.22 μm, 4 mm
polyvinylidene fluoride (PVDF) low protein binding GV filter (Milipore). Following
centrifugation, 65 μL of supernatant was removed and placed in an autosampler vial for
analysis.
5.2.3. LC/QTOF MS Analysis
Intact proteins were separated by reversed phase chromatography using an
Acquity liquid chromatograph (Waters, Milford, MA). Gradient elution (5-55% B in 60
min) was used at a flow rate of 0.225 mL/min where A = H2O (1% formic acid) and
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B = 2-propanol (1% formic acid). The column was a non porous Prosphere P-HR 2.1 ×
150 mm, 4 μm particle size (Alltech, Columbia, MD) operated at 50oC. The autosampler
was maintained at 15oC prior to administering the injection volume of 20 μL.
The LC was directly interfaced to a Q-TOF Premier (Waters) mass spectrometer
utilizing positive ion electrospray ionization. The capillary and cone voltages were 3900
and 40 V respectively. The desolvation gas (900 L/h) was heated to 500oC and the
source temperature was 115oC. Ions were monitored over a mass range of 620 - 2450 Da
and resolved in single reflectron (V) mode. An acquisition rate of two spectra/sec was
utilized. Other parameters employed in the MS method were optimized for sensitivity
and resolution using bovine serum albumin. Data was collected using MassLynx
software version 4.1 (Waters).
5.2.4. Data Processing
LC/MS data was processed using two software packages: Protrawler6 and MS
Manager. Protrawler6 (Bioanalyte, Portland, ME) software provided automated
deconvolution of multiply charged ions by first dividing the full-scan data from the
chromatogram into time intervals (30 seconds) and summing the data from each interval.
Sequential deconvolutions were then performed to obtain neutral masses of the proteins
that eluted during each interval. A text file containing the neutral masses, intensities and
retention times was then created summarizing the results for each chromatogram.6
Retention time information can be used for further study (e.g. fraction collection) of
proteins of interest or to distinguish proteins of the same mass that differ in retention.
The masses and intensities were used to create a single spectrum representing all of the
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proteins observed in the lysate utilizing MS Manager (Advanced Chemistry Development
Laboratories, Ontario, CA).
To further facilitate biomarker discovery, MS Manager was employed for spectral
mirroring and spectral subtraction. Spectral mirroring allowed spectra to be mirrored
along the abscissa, placing the baseline at the center of view. Spectral subtraction
removed all common peaks between two spectra within a given mass accuracy so that
only unique ones remained. For group and strain level comparisons involving multiple
spectra, the text files of all isolates not in that group or strain were combined to create a
hypothetical spectrum which could then be used for subtraction. A subtraction window
of ± 3 Da was utilized.
5.3. Results and Discussion
5.3.1. Development of Gram Positive Lysis Protocols
Early work in this laboratory using LC/MS to discover biomarkers for pathogenic
bacteria involved Gram negative enterics (e.g. Escherichia coli and Shigella spp.). The
lysis procedure used in that study was straightforward and involved reconstituting the cell
pellet in a solution of 50% acetonitrile with 0.1% (v/v) TFA. This lysis procedure
yielded complete inactivation of the cells and efficient protein extraction. However, upon
applying the same method to the Gram positive Clostridia, the cells were neither
inactivated nor allowed sufficient protein recovery for characterization. For this reason, a
new lysis procedure was developed. Several attempts were made using methods such as
lysozyme incubation, freeze/thaw cycles and adding more acid to the Gram negative
protocol. Individually neither of the methods yielded protein recovery similar to that
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found with the Gram negative bacteria, but when used in conjunction, two protocols
emerged that provided sufficient protein recovery.
The first protocol (lysis protocol 1, LP1) began with a 30 minute incubation at
37oC after suspending the cells in 150 μL of lysozyme. This was followed by four cycles
of freeze/thaw in liquid nitrogen and a 37oC water bath respectively. The second
protocol (lysis protocol 2, LP2) was the same as LP1, only 75 μL of lysozyme was used
and after the freeze thaw cycles, 75 μL of 50% acetonitrile (50% water) with 5% (v/v)
TFA was added for a total volume of 150 μL. Both of these protocols enabled sufficient
protein recovery, but interestingly, each method extracted a distinct set of proteins (i.e.,
by mass and retention time). As depicted in Figure 12, the proteins from LP1 were
generally larger in mass and retained longer on the column (were more hydrophobic),
while the proteins from LP2 were generally lower in mass and exhibited less retention
(were more hydrophilic).
After failed attempts to combine the lysates prior to injection, it was clear that
most of the proteins from LP1 were not soluble in the acid/organic solution used in LP2
as a precipitate was formed after combination. This explains why few proteins from LP1
were observed in LP2. Since the proteins from LP2 were absent from LP1, LP2 must be
further altering the cellular structure in a way that LP1 is not. LP1 employs lysozyme
incubation which hydrolyzes the β-1,4 linkages of the polysaccharide chains within the
peptidoglycan layer and when combined with four freeze/thaw cycles, weakens the
overall structural integrity of the cell. LP2 utilizes essentially the same two initial steps,
but by adding a denaturing solvent containing 50% organic and 5% acid, further disrupts
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intracellular components and/or complexes (e.g., ribosomes) and extracts only acid and
organic soluble proteins. Three of the four marker proteins found for each species using
LP2 (vide infra) matched masses in the ribosomal protein list within the Rapid
Microorganism Identification Database (http://www.RMIDb.org/), while none of the
species marker masses from LP1 matched. Sequencing however, would provide more
conclusive information regarding the types of proteins extracted by each protocol.
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Figure 12. Mass vs. Retention Time plot demonstrating the differences in proteins extracted by the
two lysis protocols: LP1 and LP2. Data from C. perfringens 05-0070 is shown. For clarity, all
proteins below 10% relative intensity were not included in this figure.

Given that the Gram negative protocol was unsuccessful for Gram positives and
the two newly developed Gram positive protocols LP1 and LP2 had not been tested on
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Gram negative bacteria, prior to the analysis of an unknown, a Gram stain would be
required. To address this issue, both of the Gram positive lysis protocols were applied to
the Gram negative E. coli and S. sonnei. Both protocols enabled sufficient lysis and
inactivation and yielded similar protein extraction results in terms of mass and retention
behavior as seen with the Gram positive Clostridia. New proteins were observed that
were not previously observed using the Gram negative lysis protocol. While neither
method displayed all of the biomarkers found during the Gram negative study, when the
results from both methods were combined, all previously observed biomarkers were
present (data not shown).
Combined, LP1 and LP2 can be employed regardless of the type of bacteria,
precluding the need for a Gram stain. While not very time consuming (~ 10 min) and
informative, during an outbreak or terrorist event, the elimination of any unnecessary
steps would be beneficial. In addition, these lysis methods would be beneficial for Gram
variable bacteria or ones that are unresponsive to the Gram stain. It also important to
note that unlike some lysis procedures that employ detergents (e.g. SDS) or chaotropes
(e.g. urea), the lysates from LP1 and LP2 are amenable to mass spectrometry analysis
without further preparation. Furthermore, these methods are simple and can be easily
performed under a hood preventing issues with containment and aerosolization that may
occur with mechanical techniques (e.g. French press).
5.3.2. Biomarker Discovery
As mentioned previously, the work described herein has three elements:
biomarker discovery, speciation and strain level characterization. After lysis, the process
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of biomarker discovery begins with chromatographic separation of the intact proteins.
Reversed phase chromatography separates proteins based on their ability to interact with
a hydrophobic stationary phase, with the more hydrophilic proteins being less retained.
This type of chromatography was employed rather than ion exchange or size exclusion
chromatography because the mobile phases are amenable to mass spectrometry analysis
and are easily removed during fraction collection.
Since electrospray ionization was used in this study, multiply charged ions were
produced. In order to determine the neutral mass of the proteins, the mass spectra
containing multiply charged ions were deconvoluted using Protrawler6 software. This
process is performed throughout the entire chromatogram and the information is summed
forming a single mass spectrum depicting the neutral masses of all of the observed
proteins from the lysate. A mass spectrum shows the mass of the proteins on the X-axis
and the intensity or abundance of the proteins on the Y-axis. The mass spectrum contains
the same information as a one dimensional gel, only that the abundance is indicated by
the height of the peak rather than the color intensity of the spot. It should be noted
however that the mass accuracy and precision using a TOF mass spectrometer is
significantly greater than using a 1D gel, and the improved mass resolution allows
proteins to be confidently distinguished that are 3 Da apart.99
After a single mass spectrum was created from the cell lysate, the mass spectra
were compared by spectral mirroring and spectral subtraction using MS Manager
software. Mirroring allows viewing two spectra along the same baseline to better observe
differences. Then, proteins common to both spectra were removed by subtraction using a
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user defined mass window (± 3 Da was used here). After subtraction, only unique
proteins remain that may qualify as biomarkers. A protein was deemed a biomarker only
if its combined mass (± 3 Da) and corresponding retention time (± 0.5 min) were found
unique after three repeated experiments performed on three different days indicating it
was reproducibly unique.
5.3.3. Speciation
Both lysis protocols enabled the two Clostridium species to be distinguished. As
seen in Figure 13a and 13b, all of the markers from LP2 weigh < 14 kDa, but when LP1
was used the markers for each species contained a unique protein weighing > 30 kDa.
Additionally, each species specific marker from LP1 eluted after 28.6 minutes while all
markers from LP2 eluted prior to 28.6 minutes. Although both lysis protocols enabled
the species to be distinguished, if rapid speciation is the goal, only LP2 could be used due
to the earlier elution of its proteins. Since patients with AAD would exhibit similar
clinical presentation regardless which species of Clostridium was responsible,
identification of the cause by symptoms alone is not possible. While similar symptoms
are produced, speciation is important as the risk factors for each species are different and
for this reason species specific control measures have been recommended.76
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Figure 13. Speciation using both lysis protocols LP1 (top) and LP2 (bottom). Only the biomarker
masses are labeled. All markers extracted from LP2 eluted prior to 28.6 minutes, while all markers
from LP1 eluted after 28.6 minutes. While many other proteins appear unique after subtraction,
only the labeled masses were reproducibly unique.
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5.3.4. Sub-species Determinations
In addition to inter-species comparisons, intra-species comparisons were also
performed. One example using C. difficile 700792 is shown in Figure 14. In this figure,
the results from both lysis protocols were combined in order to view them
simultaneously. The bottom shows the remaining four C. difficile isolates with 700792
on top. The masses marked in bold and denoted with an asterisk were reproducibly
unique to this strain. The lower molecular weight protein at 8,933 Da eluted at 16.4
minutes and was extracted using LP2, while the larger protein at 19,548 Da eluted at 40.7
minutes was obtained using LP1. Strain level discriminations were achieved for both
species. This type of analysis is beneficial especially for C. difficile since highly virulent,
drug-resistant strains have been reported. These strains have been deemed ‘superbugs’
similar to methicillin-resistant Staphylococcus aureus (MRSA), but in the UK have
caused more illness and mortality than MRSA.100 Additionally, C. difficile superbugs are
potentially more challenging to disinfect since unlike S. aureus, C. difficile is sporogenic.
Identification of these strains would direct treatment towards specific antibiotics and due
to the virulence of these strains, would likely expedite infection control measures such as
quarantining infected individuals etc.
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Figure 14. The data from both lysis protocols are combined to display proteins unique to the 700792
strain of C. difficile (marked in bold with *). These proteins were observed in all three repeated
experiments performed on three different days. The protein weighing 8,933 Da eluted at 16.4
minutes and was obtained using LP2, while the protein weighing 19,547 Da eluted at 40.7 minutes
and was obtained using LP1.

5.3.5. Isolates Indistinguishable by PFGE
As mentioned previously, the gold standard for strain typing during outbreak
investigations is PFGE. For this reason, comparisons were made between the strain
typing capabilities of PFGE and LC/MS. Two sets of the C. perfringens isolates studied
(06-0835 and 06-0387; and 04-1464, 04-1465, 04-1672 and 05-0070) were
indistinguishable by PFGE. Figure 15 depicts the restriction patterns for all of the C.
perfringens isolates examined in this study, obtained using SmaI as the restriction
enzyme. Utilizing LC/MS, the strains in both of these sets could be distinguished
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incorporating proteins from both lysis protocols (Table 9), indicating the high
discriminatory power of this approach. Since more markers were obtained using LP1,
this method was more informative for strain typing than LP2. Though beneficial, the
reversed phase chromatography step rarely exhibits the specificity needed to distinguish
strains. However, a clear difference was observed in the chromatograms of 06-0385 and
06-0387 (Figure 16).

Figure 15. Restriction patterns obtained after PFGE analysis of the eight C. perfringens strains
employed in this study. SmaI was the restriction enzyme used.
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Table 9. Proteins found unique to each strain when compared with the other strains that yielded
100% similar restriction patterns. Proteins marked I, were obtained from LP1 and proteins marked
II were obtained using LP2. The masses are (± 3 Da) and the retention times listed in parentheses
are (± 0.5 min). These proteins were observed in all three repeated experiments performed on three
different days.

06-0385
9,400 (22.8)II
13,503 (25.7)II
22,160 (34.9)I
32,344 (54.0)I
42,218 (42.8)I
04-1664
11,031 (31.9)II
18,849 (43.1)I
52,948 (45.3)I

06-0387
12,334 (28.6)II
34,086 (42.2)I
42,674 (43.4)I
51,374 (37.2)I

04-1665

04-1672

51,398 (37.5)I

9,136 (18.9)II
9,159 (31.0)I

05-0070
29,532 (30.7)I
30,706 (38.2)I
41,998 (45.8)I
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Figure 16. Overlaid chromatograms of two C. perfringens strains (06-0385 and 06-0387) that were
indistinguishable by PFGE. 06-0385 had protein weighing 32,346 Da which eluted at 54.9 minutes,
while 06-0387 had a protein weighing 32,385 which eluted at 52.4 minutes.
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In addition to biomarker discovery and speciation, the LC/MS method described
here could be used to assist forensic and epidemiological investigations into a terrorist
event or outbreak. Being able to distinguish isolates that were indistinguishable by
PFGE, the information obtained from this method could not only serve to discriminate
between strains, but may also provide insights into phenotypic differences such as the
growing conditions or traveling patterns of a single strain. These findings also encourage
modification of the current PFGE protocols used in this laboratory to include different or
multiple restriction enzymes for added information and specificity. One additional
restriction enzyme that could be included is SacII, which has proven useful for the
analysis of both C. perfringens and C. difficile.101
5.3.6. Identification of Unknowns
To further challenge the biomarkers that were utilized for speciation, they were
applied for the identification of unknowns in a blind study. Both lysis protocols were
used during this study and the markers from each protocol correctly identified the species
for every unknown tested. Although several months had elapsed in between the time that
the known isolates were initially examined and the unknown study was performed, all
markers were present within the accepted tolerances of mass accuracy (± 3 Da) and
retention time (± 0.5 min) (Table 10). It is important to note that not only was the
presence of the biomarkers for each species informative, but also, their absence in the
other species provided supporting evidence toward an unknown’s identity. In total, ten
unknowns which had not been previously analyzed by this method (six C. perfringens
and four C. difficile isolates) were correctly identified indicating that these markers were
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both reproducible and applicable for the speciation of unknown Clostridium isolates. The
time required to collect, process and examine the data to determine the identity of the
unknown isolates was approximately two hours per sample post culture.

Table 10. Species specific biomarkers. The masses are (± 3 Da) and the retention times listed in
parentheses are (± 0.5 min). These proteins were observed in all three repeated experiments
performed on three different days. LP1 = lysis protocol 1, LP2 = lysis protocol 2.

C. difficile

C. perfringens

LP1

9,888 (43.5)
13,599 (40.0)
44,233 (43.5)

9,092 (28.8)
13,509 (39.4)
30,298 (44.0)

LP2

7,847 (25.1)
9,650 (16.9)
11,082 (14.6)
13,959 (28.4)

6,926 (13.7)
8,133 (26.6)
8,965 (25.3)
10,324 (24.0)

5.3.7. Potential Utility for Biomarkers
In total, seven biomarkers were found unique to each species (Table 10). Beyond
their applicability in LC/MS, they could also assist other established techniques. Realtime PCR and EIA methods are rapid and sensitive approaches for biomarker detection,
but neither are capable of biomarker discovery. The protein markers found in this study
could be sequenced and then that sequence information be utilized to reverse engineer
novel real-time PCR primers.37, 68, 69 These marker proteins were consistently found
during both the known and unknown portion of this study indicating that not only are
their gene sequences unique to their respective species, but that these are genes that are
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actually expressing the proteins they encode for. Additionally, these markers could be
fraction collected as they elute off of the column and have antibodies made for them.
These proteins could then aid EIA techniques by increasing the number of analytes that
need to be detected in order to be considered a positive result. Since many EIA methods
suffer from non-specific binding, having more analytes required for confirmation will
likely reduce false positives. One manner in which EIA approaches could detect multiple
analytes in a high throughput fashion would be in the form of protein microarrays, which
have shown promise as a novel approach for the analysis of bacteria.70, 102
5.4. Conclusions
A multifaceted LC/MS method combined with novel data analysis software was
examined for its efficacy to characterize and identify pathogenic Clostridium species.
The capabilities of this method are three-fold: discovering intact protein biomarkers,
speciation and strain level typing. Using two newly developed MS amenable lysis
protocols, reproducible biomarkers were discovered that enabled speciation and strain
level characterization. Discrimination at the species and strain levels may help guide
treatment, prophylaxis and the implementation of proper control measures during
outbreaks or exposure events. This method is highly specific and was used to distinguish
strains that were 100% similar by PFGE analysis. The biomarkers discovered in this
study were successfully implemented during the identification of unknowns in a blind
study and could be utilized as new targets for detection by either EIA or real-time PCR
approaches.

CHAPTER 6 Ultra Performance Liquid Chromatography/Mass
Spectrometry of Intact Proteins
6.1. Introduction
6.1.1. Applications of Protein Chromatography
The study of proteins is an integral part of biochemistry. Efforts to understand
protein origin, structure and function require efficient means of extraction, purification
and characterization – all of which employ some type of separation. For this reason,
there exists a correlation between advancements in separation techniques (e.g. liquid
chromatography) and advancements in biochemistry.103 Intact protein separations have
utility in numerous applications. Separation and characterization of therapeutic proteins
is of increasing concern in the pharmaceutical industry as biopharmaceuticals (e.g.
recombinant proteins and monoclonal antibodies) now account for 25% of the new
molecular entities entering the market.104 Manufacturers of foodstuffs need to determine
the protein content of their products as well as monitor the quality of protein
supplements. Moreover, public health, clinical and forensic laboratories require
capabilities to monitor food allergens (e.g. peanut, soy and milk), disease states
(hemoglobinopathies) and various protein toxins from sources such as plants (e.g. ricin
and abrin), venom (e.g. helothermine) and bacteria (e.g. botulinum toxin).
A rapidly emerging area for intact protein separations is top-down proteomic
analysis. This approach has some advantages over the more popular bottom-up method
93
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where proteins are digested and analyzed. The complexity of the peptide mixture makes
the bottom up approaches (e.g. shotgun proteomics) often less discerning of protein
isoforms which are more readily observed using a top-down approach.105 Protein
isoforms may provide insight into cell regulation and disease states and can be caused by
coding polymorphisms, alternative splicing and posttranslational modification.106 Other
advantages of the top-down approach include greater sequence coverage of individual
proteins, and that intact molecular weight information is obtained.105, 107 Knowing the
intact mass allows immediate detection of modified proteins during comparative
proteomic investigations.
Top-down approaches typically isolate unique proteins either by two-dimensional
(2D) gel electrophoresis (GE) or with liquid chromatography/mass spectrometry
(LC/MS). Drawbacks to using GE compared to LC/MS include greater difficulty in
analyzing highly acidic, basic and hydrophobic proteins, decreased mass resolution and
accuracy, poorer reproducibility, and being more labor intensive. Advantages of using
reversed phase LC/MS are improved quantitation, ease of automation, samples are
enriched on column and isolated protein fractions are amenable to further MS analysis
without sample preparation.99, 108 Reversed phase LC/MS can be considered a 2D
approach since distinctions are made according to hydrophobicity in the first dimension
and mass in the second.109 Using split-flow LC/MS, unique proteins can simultaneously
be observed and fraction collected into a well plate. Proteins in the collected fractions
can then be infused and investigated by mass spectrometry for structural information or
digested in-well110 and then analyzed. Despite the advantages of the top-down approach,
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it is less often used due to difficulties during both mass analysis and in the
chromatographic separation of intact proteins. Improvements in both areas of analysis
are needed to enhance the widespread use of the top-down approach.105, 107
6.1.2. Challenges with Intact Protein Chromatography
Relative to small molecules and peptides, the reversed phase chromatography of
proteins has been problematic - displaying carryover, multiple peak formation (splitting)
and broad, misshapen peaks. These difficulties arise in part due to slow intrapore
diffusion times, the presence of unresolved structural microheterogeneity and
conformational isomers, and secondary interactions with the stationary phase.10 Broad
peaks have resulted in poorer resolution and therefore longer gradients resulting in
increased run times and decreased throughput. One potential method of improving intact
protein chromatography is the use of smaller particles.111 Reducing the particle diameter
(e.g. below 2 μm) can afford enhanced resolution and shorter run times. Improved
resolution is predicted from the lower plate height minimum in Van Deemter plots of
sub-2 μm particles and faster separations are a result of the elongated linear velocity
region at that minimum.8, 9, 112
6.1.3. Porous vs. Nonporous Particles
Early work using sub-2 μm particles for intact protein separations involved
nonporous particles113 because they are mechanically strong and relatively easy to
manufacture. Jorgenson et al. used 1.5 μm nonporous particles and achieved peak widths
and run times that were comparable to perfusion chromatography114 but with increased

113

sensitivity.
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However, nonporous particles have decreased surface area compared to

porous material. This reduction in surface area results in decreased loading capacity
causing mass overload at lower concentrations.9 When comparing 1 μm nonporous
particles to 1 μm particles with 10 nm pores, porous particles possess approximately 100
times more surface area resulting in a 22-fold increase in loading capacity.115 Increased
sample loading capacity is important for preparative applications, for quantifying
impurities or degradation products and when trying to detect low abundance proteins as
more will need to be injected in order to detect them. Additionally, the decreased surface
area of nonporous columns typically results in lower retentivity112, 116 which may hamper
the separation of difficult to retain highly hydrophilic analytes.
6.1.4. Chromatography at Ultra High Pressure
While the above drawbacks of nonporous particles may limit certain applications,
some researchers prefer nonporous material citing relatively reduced carryover.117 To
address this issue, Eschelbach and Jorgenson employed an in-house ultra high pressure
liquid chromatography (UHPLC) system and columns with 1.5 μm particles and
examined the effect of increased pressure on carryover. Using a pressure range from 160
- 1600 bar, it was found that as the pressure was increased, carryover was diminished –
an important finding for intact protein chromatography.41 Other possible advantages such
as increased throughput, resolution and sensitivity were not described.
Since the advent of commercial ultra performance liquid chromatography (UPLC)
systems, much interest has been generated regarding the prospect of achieving increased
resolution and throughput. The use of commercially available columns and systems is
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vital for laboratories lacking the expertise to manufacture them in-house. Typically,
UPLC refers to applications using porous sub-2 μm particles, at high linear velocities and
pressures of 400 – 1000 bar on commercial systems. UHPLC is similar, but is typically
utilized at > 1000 bar with custom built systems in academic or research laboratories.9
6.1.5. Specific Aims
Many small molecule applications utilizing commercial UPLC systems have been
reported118-123 and have described benefits such as increased throughput, resolution and
sensitivity. The aim of this manuscript was to explore whether these same successes
could be observed with the much more problematic and difficult to chromatograph intact
proteins. Using ten protein standards ranging in mass from 6 - 66 kDa, and mobile
phases amenable to electrospray ionization, efforts were made to examine the
performance of UPLC relative to high performance liquid chromatography (HPLC) using
columns differing only in particle size. The original method employing typical
conditions was demonstrated and then parameters such as temperature, organic solvent
and particle diameter were optimized. The optimized method was then applied to a more
complex cell lysate to determine the overall efficacy of the method.
6.2. Experimental
6.2.1. Materials
HPLC grade solvents (acetonitrile, methanol, formic acid and trifluoroacetic acid)
were purchased from Fisher Scientific (Fairlawn, NJ) and 2-propanol was purchased from
Honeywell Burdick and Jackson (Morristown, NJ). Organic mobile phases were filtered
using 0.2 μm PTFE filters (Pall Corporation, Ann Arbor, MI). The water utilized for
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LC/MS analysis was purified in-house to yield organic-free 18.3 MΩ × cm using an Epure purification system (Barnstead International, Dubuque, IA). The sterile water used
during bacteria preparation was autoclaved and purified with a RiOs 5 Water Purification
System (Milipore, Billerica, MA).
6.2.2. Protein Standards Preparation
Bovine serum albumin (BSA), horse heart myoglobin, cytochrome C,
chymotrypsinogen A and ovalbumin were purchased from MP Biomedicals (Solon, OH).
Trypsin inhibitor (soybean), insulin (bovine pancreas), ribonuclease A (RNase A, bovine
pancreas), α-lactalbumin (bovine milk) and lysozyme (HEWL) were purchased from
Sigma-Aldrich (St. Louis, MO). Individual stock solutions of each protein were prepared
at 1 mg/mL in 20 mM NH4OAc. An equalmolar mixture of the ten proteins was prepared
at 1.5 μM in 50% methanol and 0.1% formic acid.
6.2.3. Cell Culture and Lysis
Escherichia coli serotype O157:H7 isolates were obtained in-house. The cells
were grown for 24 hours on trypticase soy agar plates containing 5% sheep’s blood at
37oC. Cells were then removed from the plate and placed in a test tube containing 1 mL
of water until the turbidity reading reached 1.0 using a MicroScan Turbidity Meter (Dade
Behring, West Sacramento, CA). A 500 μL aliquot of this suspension was placed in a 1.5
mL protein LoBind tube (Eppendorf, Westbury, NY) and washed three times with 500
μL of sterile water followed by centrifugation (6000 × g at room temperature for 5
minutes) to remove residual media. Finally, the cells were resuspended in 150 μL of the
lysis solution (1:1 H2O: acetonitrile, 0.1% (v/v) trifluoroacetic acid). After chemical
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lysis, the sample was again centrifuged (4100 × g for 4 minutes) at room temperature.
The supernatant was filtered using a 0.22 μm, 4 mm PVDF low protein binding GV filter
(Milipore, Billerica, MA) and 65 μL of the filtered supernatant was transferred to an
autosampler vial for analysis.
6.2.4. Chromatography and Mass Spectrometry
Intact proteins were separated by reversed phase chromatography using an
Acquity UPLC (Waters, Milford, MA). The HPLC column was the narrowbore X-bridge
C18 BEH 300 Å 2.1 × 150 mm, 3.5 μm (Waters). The use of these porous BEH (EthylBridged Hybrid) particles has been described.115, 124 For comparison purposes, the UPLC
column was identical (e.g. pore size, ligand density, carbon load) except in particle size
(1.7 μm). To achieve maximum column life time and to ensure a robust method,
manufacturer recommendations were followed by maintaining backpressures near or
below 690 bar (10 kpsi) and column temperatures were kept below 70oC.125 The gradient
for HPLC was linear: 5 – 55% B in 60 minutes for a slope of 0.83%B/min. All mobile
phases contained 1% (v/v) formic acid. The autosampler was maintained at 15oC. For
the 1.5 μM protein standard mixture and cell lysates, injection volumes of 2 μL (3 pmol)
and 20 μL respectively were utilized.
The LC was directly interfaced to a Q-TOF Premier (Waters) mass spectrometer
utilizing positive ion electrospray ionization. The capillary and cone voltages were 3900
and 40 V respectively. The desolvation gas (900 L/h) was heated to 500oC and the
source temperature was 115oC. Ions were monitored over an m/z range of 620 - 2450 Da
and resolved in single reflectron (V) mode. An acquisition rate of two spectra/sec was
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utilized. Other parameters employed in the MS method were optimized for sensitivity
and resolution using BSA. Data was collected using MassLynx software version 4.1
(Waters).
6.2.5. LC/MS Data Analysis
LC/MS data was processed using two software packages: Protrawler6
(Bioanalyte, Portland, ME) and MS Manager (Advanced Chemistry Development
Laboratories, Ontario, Canada). Protrawler6 provided automated deconvolution of
multiply charged ions by first dividing the full-scan data from the chromatogram into
time intervals (30 seconds) and summing the data from each interval. Sequential
deconvolution events were then performed to obtain neutral masses of the proteins that
eluted during each interval. A text file containing neutral masses, intensities and
retention times was then created summarizing the results for each chromatogram.6 The
masses and intensities were utilized to create a single mass spectrum representing all of
the proteins observed in the chromatogram using MS Manager. MS Manager was also
used for spectral mirroring. For ease of comparison, spectral mirroring allows spectra to
be mirrored along the abscissa.
6.3. Results and discussion
6.3.1. Original Method
Figure 17 depicts a chromatogram of the ten protein standards using the original
method. The use of protein standards is beneficial for three reasons. First, they are
inexpensive and easy to obtain; therefore, more convenient for method development
purposes than expensive or difficult to procure analytes or lysates. Second, protein
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standards have been implemented by several researchers in the past making it easy to
compare this work with previous efforts in protein chromatography.40, 126, 127 Finally,
protein standards are useful for quality control standards and in this laboratory, are run at
the beginning and end of each day’s work to ensure the LC, column and MS are working
properly. Examination of Figure 17 shows over 20 minutes of dead time prior to elution
of RNase A and 15 minutes after the elution of ovalbumin. It should be noted that the
focus was to develop a method applicable to cell lysate analysis and during this type of
analysis several proteins will elute during the aforementioned regions.
The original method incorporated an HPLC column with a C18 alkyl chain ligand
and 3.5 μm diameter particles that was operated at a moderate column temperature
(35oC). This column is consistent with small molecule applications; however, the column
utilized in this study had a larger pore diameter (300 Å) to account for the larger size of
the analytes. In addition, the flow rate (75 μL/min) was lower than what is typically
implemented in small molecule applications for a column having a 2.1 mm internal
diameter. Given that the optimal linear velocity is proportional to the diffusion
coefficient of the analyte128, the reduction in flow rate accounts for the lower diffusivity
of macromolecules. Acetonitrile, the most commonly used organic modifier for intact
protein separations10, was initially used. A long, shallow gradient (5 - 55% B over 60
minutes) was utilized to maximize resolution. However, despite the long gradient, the
resolution was insufficient, particularly for proteins 5 - 8 (BSA - trypsin inhibitor) the
most problematic region of the chromatogram.
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Figure 17. Results obtained using typically employed HPLC conditions (column temperature = 35oC
and acetonitrile was the organic modifier used). Poor resolution and distorted peak shape was
observed for the ten protein standards used in this study. These ten standards and their masses are
provided in the inset table. The numbers assigned to each protein were kept regardless of retention
order.

6.3.2. The Effect of Temperature
The first parameter investigated was temperature. The use of elevated column
temperature, as in high temperature liquid chromatography (HTLC)129 has been
demonstrated to improve intact protein separations.130, 131 Increasing the temperature may
modify the properties of the column surface and alter protein structure thus affecting
analyte retention.10 Secondly, analyte sorption kinetics increase with temperature which
is important for slowly diffusing proteins. Increasing diffusivity both into and out of the
pores minimizes band broadening; consequently, column efficiency has been shown to
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132

increase with temperature.

Finally, increased temperature reduces mobile phase

viscosity causing a concomitant decrease in back pressure. Decreased back pressure
allows scaling to higher flow rates resulting in reduced run times in UPLC experiments.
Three temperatures at constant flow rate (75 μL/min) were utilized for
comparison (Figure 18). An increase in sorption kinetics was indicated by the slight
decrease in retention time for proteins such as RNase A (#1), which eluted at 28.09
minutes at 35oC and 25.97 minutes at 65oC. Selectivity differences were also apparent.
As temperature increased, the retention order of two sets of proteins – α-lactalbumin (#6)
and myoglobin (#7), and insulin (#3) and lysozyme (#4), were reversed. While lysozyme
clearly lost retention as temperature increased, insulin was less susceptible to this change
and in fact showed a slight increase in retention (36.12 minutes at 35oC and 36.44
minutes at 65oC). This property of insulin was also observed by Szabelski et al. where
the unfolding kinetics of insulin may have increased with temperature, allowing a greater
area of contact with the stationary phase.133 Thus, proteins such as RNase A must either
be more resistant to unfolding at these temperatures allowing increased sorption kinetics
to dominate, or upon unfolding, more hydrophilic regions are exposed which shield or
inhibit previous binding interactions. At 65oC four peaks were observed in the most
problematic region of the chromatogram, proteins 5 – 8. For this reason, the optimal
temperature was chosen to be 65oC. To maximize column lifetime and ensure a robust
method, higher temperatures (> 65oC) were not attempted.
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Figure 18. Results from the HPLC temperature study using acetonitrile as the organic modifier. As
the temperature was increased from 35°C to 65°C the resolution for proteins 5-8 improved.

6.3.3. The Role of Organic Modifier - HPLC
In addition to temperature, two different organic modifiers, acetonitrile (ACN)
and isopropanol (IPA) were examined. These two solvents exhibit different properties
which may alter their displacement performance resulting in selectivity differences.
Acetonitrile is aprotic, more polar, less viscous and has a lower eluotropic strength than
isopropanol (Table 11). ACN and propyl alcohols have different effects on the
conformation of proteins which can subsequently cause distinct retention behaviors.134
IPA is less denaturing than ACN and has shown improved solubility of hydrophobic
proteins.10 Dillon et al., while characterizing antibodies, found using stronger solvents
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(e.g. propanol) improved resolution and recovery by reducing secondary column
interactions. Additionally, an increased electrospray response was also observed when
using propanols relative to ACN.135, 136

Table 11. Different solvent properties of acetonitrile and isopropanol. The combination of these
properties result in selectivity differences for the analytes in this study.

H+
ε0
Viscosity (25 oC)
Eluotropic strength

ACN
Aprotic
37
0.34
3.1

IPA
Protic
18
1.90
8.3

The stronger eluting power of IPA is evident from Figure 19. Using the same
column, gradient, flow rate and the optimal temperature of 65oC, ovalbumin (#10) elutes
14 minutes earlier with IPA, with less peak splitting also being observed. This could
result in shorter gradients and less solvent consumption due to a lower %B being required
for elution. The resolution was also improved for proteins 5 – 8 (BSA – trypsin inhibitor)
with IPA while proteins 2 (cytochrome C) and 3 (insulin) were better resolved with ACN.
Often, when attempting to better resolve a pair of proteins, changes will be made to the
gradient or perhaps a different column will be used. However, the selectivity differences
from temperature and organic solvent may be potentially more useful or convenient and
in the case of using a different column, less expensive. To further explore the
performance of these two solvents, their comparison was continued throughout the HPLC
vs. UPLC comparison.
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Figure 19. Using the same column, column temperature, flow rate and gradient, the HPLC
performance for ACN (top) was compared to IPA (bottom). Due to its stronger eluotropic strength,
all ten proteins eluted in less time when IPA was used as the organic modifier.

6.3.4. Ultra Performance Liquid Chromatography
In addition to the potential benefits of increased resolution, throughput and
sensitivity which have been observed during small molecule applications, certain aspects
of using UPLC relative to HPLC may prove particularly attractive for intact protein
separations. As described above, protein carryover is reduced by operating at higher
back pressures.41 Additionally, smaller particles have less resistance to mass transfer
which is beneficial for slowly diffusing macromolecules.132 Furthermore, shorter
runtimes mean less time on column for each analyte. As time on column decreases, oncolumn limited acid hydrolysis is minimized136 and recovery of hydrophobic proteins is
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improved. Shorter runtimes also decrease the amount of time a batch of samples spends
10

in the autosampler prior to analysis. Reducing this time may prevent sample degradation
if the autosampler is insufficiently chilled and decrease the extent of unwanted
proteolytic digestion if proteases are present in the sample. For the UPLC vs. HPLC
comparison, the effect of particle size was examined first, followed by examining the
response of the separation to using scaled gradients. These two factors were inspected
for both acetonitrile and isopropanol.
Figures 20a and 20b depict the effect of particle size at constant temperature
(65oC) and flow rate (75 μL/min) using acetonitrile. Although these columns were
identical with the exception of particle size, some selectivity differences were observed
with proteins 3 (insulin) and 4 (lysozyme). With the smaller particle size, the elution
order was reversed for these proteins and the resolution enhanced. Less resistance to
mass transfer is likely demonstrated by the slightly lower retention times and the sharper
peak shape for proteins such as chymotrypsinogen A (#9). The same comparison using
isopropanol is shown in Figures 21a and b. Here, the decreased resistance to mass
transfer is evident again from lowered retention times (e.g. chymotrypsinogen A (#9))
and peak shape enhancement for BSA (#5). Also a selectivity difference occurred for
proteins 2 (cytochrome C) and 3 (insulin). However, with IPA, the overall increase in
resolution is more clear - particularly between proteins 5 (BSA) and 6 (α-lactalbumin);
and 7 (myoglobin) and 8 (trypsin inhibitor). Using extracted ion chromatograms to better
measure peak widths, the HPLC resolution between 7 and 8 (myoglobin and trypsin
inhibitor) was 0.74 compared to 1.18 for UPLC.
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Figure 20a-c. HPLC vs. UPLC comparison using acetonitrile. Figures 20a and 20b demonstrate a
modification in selectivity and enhancement in resolution from decreasing the particle size from 3.5
μm (Figure 20a) to 1.7 μm (Figure 20b). All other parameters were kept constant. Despite the sixfold increase in throughput, this increase in resolution was not maintained upon scaling of the
gradient from a 60 minute gradient at 75 μL/min to a 10 minute gradient at 450 μL/min (Figure 20c).
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Figure 21a-c. HPLC vs. UPLC comparison using isopropanol. Figures 21a and 21b demonstrate a
modification in selectivity and enhancement in resolution from decreasing the particle size from 3.5
μm (Figure 21a) to 1.7 μm (Figure 21b). All other parameters were kept constant. Additionally the
peak shape of BSA (#5) was greatly improved when smaller particles were utilized. Upon scaling of
the gradient (Figure 21c) from a 60 minute gradient at 75 μL/min to a 20 minute gradient at 225
μL/min, a three-fold increase in throughput was observed with no loss in resolution.

As expected, the decrease in particle size yielded improved resolution. To further
explore the benefits of smaller particles, the flow rate was increased and the gradient was
scaled accordingly. Figures 20b and 20c depict a six-fold increase in flow rate and
decrease in gradient time from 0 – 55 %B in 60 minutes at 75 μL/min to 0 – 55 %B in 10
minutes at 450 μL/min. Scaling the gradient during UPLC separations first involves
increasing the flow rate, and then decreasing the time for each gradient segment (e.g.
initial separation, column cleaning and re-equilibration) by that same factor. For
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example, in Figure 20c, the flow rate was increased six-fold therefore, the time for each
segment in the gradient was decreased six-fold. Scaling in this manner holds the number
of column volumes per gradient segment constant.
The scaling of the gradient stopped at 450 μL/min for ACN because it approached
the limit of the mass spectrometer to effectively desolvate. Other problems associated
with using higher flow rates may include greater solvent consumption and more dilute
fractions during fraction collection. While the elution time for ovalbumin (#10) was 1/6
of its original value, the resolution was not maintained during the scale up process
(proteins 3 and 4, insulin and lysozyme respectively). This is in contrast to IPA in which
the resolution was maintained and even increased for proteins 2 (cytochrome C) and 3
(insulin) (Figure 21b and 21c). In addition, the elution time of ovalbumin (#10) was
approximately 1/3 of its original value. The gradient could only be scaled by 1/3 because
IPA is much more viscous than ACN. Near the end of the gradient at 225 μL/min, the
back pressure began to exceed 690 bar, the manufacturer’s recommended limit for
maximizing column life time, with maximum pressures being approximately 745 bar
(10,800 psi).
6.3.5. The Role of Organic Modifier - UPLC
A final comparison of the two solvents using the scaled UPLC gradients is shown
in Figure 22. In terms of the elution time of ovalbumin (#10), using ACN provides
increased throughput. However IPA, which elutes ovalbumin four minutes later than
with ACN exhibits a pronounced increase in resolution. As mentioned previously, these
standards have been commonly used by other researchers, and some have found the
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separation of cytochrome C and insulin
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and BSA and myoglobin to be challenging.
41

However, with the IPA method described here, cytochrome C (#2) and insulin (#3) are
separated and not only are BSA (#5) and myoglobin (#7) baseline resolved but αlactalbumin (#6) is baseline resolved in between them. Increased resolution allows for
reduced ion suppression, cleaner mass spectra, purer fractions to be collected and
simplifies chromatographic comparison and peak area determination. For these reasons,
the enhanced resolution with IPA was deemed more valuable than the improvement in
throughput observed with ACN.
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Figure 22. UPLC solvent comparison using the scaled gradients for each solvent but the same UPLC
column and column temperature of 65°C. While the elution time of ovalbumin (#10) is four minutes
later, the resolution with IPA (bottom) is significantly improved relative to ACN (top).
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6.3.6. Original vs. Optimized Method
Figure 23 compares the original and optimized methods for the protein standards.
The original conditions were typical, utilizing a moderate column temperature of 35oC,
acetonitrile as the organic solvent, 3.5 μm particles and a shallow gradient of 5 – 55 %B
in 60 minutes at a flow rate of 75 μL/min. After systematic optimization of the method,
enhanced resolution was achieved and the elution time of ovalbumin (#10) was 1/4 of its
original value. In fact, the entire method was completed prior to the elution of the first
compound in the original method. Additionally, a significant decrease in peak width was
observed. The baseline peak width of chymotrypsinogen A (#9) was approximately 45
seconds in the original method compared to 15 seconds after optimization. In addition to
the 2/3 reduction of the peak width, the gradient time for the original method (60
minutes) was also reduced by 2/3 compared to the optimized method (20 minutes).
Likewise, the time required for column cleaning and re-equilibration was equally
abridged from fifteen minutes to five minutes for a total runtime reduction from
approximately 75 minutes to 25 minutes. Moreover, since IPA is a much stronger solvent
than ACN, the gradient and therefore the runtime could be further reduced. Any protein
eluting at 55 %B with ACN would require a much smaller %B when using IPA.
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Figure 23. Method optimization before and after. The optimized method (column temperature =
65oC, IPA as organic modifier, 1.7 μm particle size and 20 min gradient) is completed prior to the
elution of the first compound in the original method (column temperature = 35oC, ACN as organic
modifier, 3.5 μm particle size and 60 min gradient). The inset more clearly reveals the resolution
advantage afforded by the optimized method.

6.3.7. Sensitivity Enhancement with UPLC
Since the peak widths were reduced when the gradient was scaled, it was likely
that there would be a concomitant sensitivity increase. The change in sensitivity was
calculated by taking the individual peak heights from the optimized method and dividing
them by the corresponding peak height in the original method. However, only a small
increase in sensitivity was observed. One possible explanation was that as the flow rate
increased, the desolvation efficiency of the electrospray source decreased resulting in
lowered MS signal. To test this, both the 60 minute and 20 minute gradients were
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compared using the UPLC column and IPA as the organic modifier, but at the same flow
rate of 225 μL/min for both gradients. During this comparison, the average increase in
sensitivity was two-fold when using the scaled gradient. However, when the signal
intensities from the 60 minute gradient at 225 μL/min and 75 μL/min were compared, the
intensity was elevated with the lower flow rate. Thus, while the scaled gradient yielded
narrower peaks and therefore increased sensitivity, this increase in sensitivity was
compromised by poorer desolvation at higher flow rates. Consequently, an increase in
overall sensitivity of (1.4X) was observed from the HPLC vs. UPLC comparison.
6.3.8. Application of the Optimized Method
To explore the benefits of the optimized method on a more complex sample, an E.
coli O157:H7 cell lysate was analyzed. Using the optimal temperature and organic
solvent, a comparison was made between HPLC and UPLC to determine what impact the
increased resolution would have on mass spectral data quality. The results of this
comparison are shown in Figure 24. The enhanced chromatographic resolution which
was obvious when only ten proteins were analyzed is difficult to discern due to the
complexity of the lysate containing > 100 proteins. Two instances of improved
resolution with UPLC are denoted by asterisks in Figure 24a. Despite careful
optimization of the method, significant co-elution was evident. The representative mass
spectra for each technique were very similar (Figure 24b) and even upon close inspection,
no significant differences were detected.

Both spectra exhibited a biomarker unique to

the O157:H7 serotype of E. coli weighing 18,996 Da138, which eluted at 38.8 minutes
with HPLC and 13.3 minutes with UPLC.
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Figure 24. A region of the chromatogram (Figure 24a -top) is used to compare the chromatographic
results between the two lysate analyses. Other proteins eluted during the times not shown. * denotes
instances of improved resolution with UPLC. Figure 24b (bottom). Mass spectral comparison of the
lysate data. No significant differences were observed between the two methods however, the data
collection and analysis time with UPLC was 1/3 that of HPLC.

Due to the overwhelming complexity of the cell lysate, the increase in resolution
afforded by UPLC was not enough to allow more proteins to be observed, as both mass
spectra contained approximately 150 proteins. To this end, further efforts to reduce the
complexity of the lysate could be made. For instance, differential solubilization139 or
sub-cellular proteomics140 extraction techniques could be applied. This would yield
multiple extracts based on differential protein solubility or different components of the
cell being specifically lysed and extracted. These multiple extracts could then be
separately analyzed using the optimized method. Additionally, UPLC could be
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implemented to enhance 2D separations where in the first or second dimension an
orthogonal separation such as capillary isoelectric focusing141, chromatofocusing142 or
size exclusion chromatography143 was employed. Relative to 1D separation, 2D
separations afford much higher peak capacities, and the extension of this technology to E.
coli lysates has been demonstrated.144
While more proteins were not observed using UPLC, the run time was reduced by
2/3, at no cost in data quality. In addition, not only was the data collection time reduced,
but the data analysis time was also reduced using the UPLC method. For the 75 minute
HPLC chromatogram, the time required to perform automated charge state deconvolution
with Protrawler6 was approximately 30 minutes. This is in contrast to the 25 minute
UPLC chromatogram which required only 10 minutes per chromatogram. The step of
charge state deconvolution is crucial when using electrospray ionization to analyze intact
proteins from complex cell lysate samples and streamlines the data interpretation process.
Reducing the deconvolution time minimized the gap between data collection and
interpretation allowed data directed decisions to be made in less time.
6.4. Conclusions
Separation is an essential aspect of protein biochemistry and numerous
applications for intact protein chromatography exist. Beginning with typically employed
conditions, the parameters of temperature, organic modifier and particle size were
optimized. Using a combination of high temperatures, strong solvents and small particles
at very high pressure yielded optimal results, which included enhanced resolution,
sensitivity and a three-fold increase in throughput. Increased throughput saves time and
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money in industry applications and during forensic or public health analyses allows faster
reporting of results to investigating authorities and hospitals. The optimized method was
applied to a bacterial cell lysate and a reduction in both data collection and analysis time
was observed with no compromise in the quality of the data. The utilization of porous
particles, as in UPLC, provides a useful alternative to nonporous columns for researchers
looking for greater sample loading capacities and larger retention factors.

CHAPTER 7 Conclusions and Future Work
The overall goal of this project was the development of a novel method to detect
and characterize microbial pathogens. Of particular interest was developing a method
that is complementary and at times advantageous compared to commonly employed
assays. When used in conjunction with existing methods, the combined approach would
yield increased confidence prior to reporting results to investigating authorities. Initial
investigations involved the analysis of the Gram negative enteric pathogens Escherichia
coli and Shigella species. Next, the method was extended to other types of bacteria
(Gram positive and endospore forming) during the analysis of Clostridium species. Both
projects discovered intact protein biomarkers for identification which were evaluated for
their reproducibility and subsequently their utility during blind studies. The method was
then optimized for throughput utilizing ultra performance liquid chromatography.
For the E. coli and Shigella species work, a simple chemical lysis method,
analysis by LC/MS, followed by automated charge state deconvolution and spectral
subtraction was employed to discover biomarkers. Reproducible intact protein markers
that displayed unique retention times, masses and or relative intensities allowed the
speciation of Shigella. This is significant because real-time PCR primers for this task are
commercially unavailable. Serotype level distinctions were also observed. Three
serotypes of enterohaemorrhagic E. coli, which typically display identical symptoms,
were investigated. Because of the similar symptoms they produce, they can’t be
119
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distinguished by symptoms alone; therefore a molecular approach must be employed.
Markers were discovered that easily distinguished E. coli O157:H7 from O126:H11 and
O111:NM. Once this distinction was made, a protein weighing 11,779 Da which eluted
at 26.2 minutes was utilized to distinguish the two non-O157:H7 serotypes from each
other.
Beyond serotypic discrimination, the specificity of the method was displayed
when two distinct isolates of E. coli O157:H7 were distinguished by a single protein.
This level of specificity is required during epidemiological investigations of food or
waterborne outbreaks and during forensic traceback efforts to pinpoint the source of
exposure. Given that thousands of people are infected with E. coli O157:H7 each year in
the United States, assays with strain level specificity are beneficial for establishing strain
relatedness - needed to indicate whether a series of infections were random or connected.
The makers discovered during this investigation were then employed to correctly identify
thirteen unknown isolates during a blind study.
Currently, identification of unknowns by this method is achieved through
association with previously examined (known) pathogens, and is therefore limited to the
types of pathogens listed in Table 2. However, this does not limit the strain typing ability
of the method as typically in outbreak situations where PFGE is relied upon, general
information such as genus, species and serotype have already been determined before
attempting to establish strain relatedness. Future work specific to the E. coli and Shigella
project could comprise of extending the list of pathogens investigated to other species of
Shigella and Escherichia and additional serotypes of E. coli known to cause shigellosis.
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Examples include S. dysenteriae, E. vulneris
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and E. coli O91:H21. Extension to these

pathogens should be straightforward due to the successful proof of concept work
described in Chapter 4. Initial expansions of the method should be focused on areas
where established techniques are lacking e.g., species for which no commercial real-time
PCR primers exist, serotypes with no commercial antibodies and strains not previously
typed by PFGE.
In an effort to develop a method applicable to all types of bacteria, endospore
forming Gram positive Clostridium species were investigated. Thirteen isolates of two
species (five C. difficile and eight C. perfringens), for which no commercial real-time
PCR primers exist, were used. Both of these pathogens are known causes of antibiotic
associated diarrhea (AAD). Initially the lysis method utilized for Gram negative bacteria
was implemented and found incapable of yielding sufficient protein recovery and lysis of
Clostridia. Therefore, two lysis methods were developed that enabled sufficient lysis and
protein extraction. Interestingly, each lysis method extracted two sets of proteins
differing in both mass and retention time. Due to the structural integrity of endospores,
neither method was able to lyse them, thus they were removed by filtration with a 0.22
μm PVDF filter designed to minimize protein loss during filtration.
After their efficacy for Gram positive bacteria was demonstrated, both lysis
methods were then applied to the Gram negative E. coli and Shigella samples and yielded
sufficient lysis and protein recovery. Therefore, the above lysis methods are equally
suitable for Gram positive or Gram negative bacteria thus precluding the need for a Gram
stain prior to the analysis of unknown bacteria. While the Gram stain is not a lengthy
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process (approximately ten minutes) and yields useful information, when rapid results are
needed, the elimination of any unnecessary step may be beneficial.
Not only did both lysis methods yield sufficient protein recovery, proteins from
both lysis methods enabled the speciation of Clostridium. Their speciation allows for
diagnosis of which species of Clostridium is the causative agent for AAD in hospital
settings, and can direct future treatment and pretreatment as distinct infection control
measures for each species have been recommended. As with the Gram negative bacteria,
the markers found during this project were further challenged for their reproducibility and
were then successfully implemented for the speciation of ten unknown isolates during a
blind study.
A clear display of the specificity of the LC/MS approach described here occurred
during the analysis of two different sets of C. perfringens isolates, which were
indistinguishable by PFGE, the gold standard for strain differentiation. In particular, one
set of two isolates, accession numbers: 06-0385 and 06-0387, were distinguished not only
by differences observed in the mass spectrum, but also by differences in the
chromatogram. These results indicated that LC/MS could yield further insight in to the
history of an exposure than current PFGE protocols allow. For this reason, these results
serve as basis for the recommendation that current PFGE protocols for the analysis of C.
perfringens be amended to include different or additional restriction enzymes which may
give more informative restriction patterns.
Specific to the Clostridium project, future work could include the analysis highly
virulent, drug resistant strains of C. difficile that have been classified as ‘superbugs’.
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Since strain level discrimination of C. difficile was demonstrated in Chapter 5, the
extension of the method to these strains of C. difficile would likely be successful.
Markers that could distinguish drug resistant strains could direct the administration of
antibiotics appropriate for treatment. Furthermore, if distinctions are observed that
implicate highly virulent strains, their detection could serve to expedite remediation
processes such as disinfecting hospitals and quarantining infected patients etc.
Since both projects described in Chapters 4 and 5 had the same goal and other
than the lysis and endospore filtration procedures, utilized the same methods, they have
many common applications and implications. The work that has been performed is two
fold: one, discovering biomarkers that can be used for the identification of unknowns at
the species and serotype level; two, molecular subtyping of strains that may be useful for
outbreak or source identification studies. The first area uses LC/MS to complement and
at times outperform immunoassays and real-time PCR. These two techniques are
targeted approaches often used for identification, but not strain level typing. It would be
impractical to develop primers or antibodies for every strain of E. coli O157:H7 for
example. For this reason, a screening approach that does not require primers or
antibodies such as PFGE is used for strain typing. LC/MS however, can accomplish
target detection and strain differentiation in a single analysis. Due to the two fold nature
of this method; its implications will be discussed separately.
As mentioned previously, the LC/MS approach is complementary to existing
techniques by providing proteome information and is advantageous for bacteria for which
primers or antibodies are commercially unavailable. However, in addition to being well
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established, compared to LC/MS, EIA and real-time PCR methods are less expensive to
use and maintain and more amenable to multiplexing for high throughput applications
making them ideal for biomarker detection. On the other hand, neither of these
techniques have the capabilities for biomarker discovery. The LC/MS approach here is
ideal for biomarker discovery having the ability to detect hundreds of proteins in a single
analysis and can detect subtle differences between closely related isolates. Once
discovered, the biomarkers mentioned in Chapters 4 and 5 could be purified and used for
antibody formation to enhance serological approaches or be sequenced and used to
reverse engineer novel real-time PCR primers. By monitoring intact proteins,
information useful for both primer design and antibody formation are collected
simultaneously. In addition to antibody formation, another way to assist clinical
immunological assays using these markers would be to have them sequenced, then grown
recombinantly and used in assays to detect host antibodies – indicating exposure.
Of the biomarkers discovered in this work, the best candidates for antibody
formation or primer synthesis would be ones that are not isoforms of proteins common to
other species or serotypes and rather, are completely unique. For example, as described
in Chapter 4, one protein useful for the speciation of Shigella was a marker found only in
S. flexneri weighing 7,287 Da which eluted at 27.9 minutes. In all of the other E. coli and
S. sonnei isolates examined however, a protein of similar mass (7,273 Da) and the same
retention time was observed. Because of the similar mass and identical retention
behavior, these proteins are likely isoforms of one another. The mass difference of 14 Da
could be a PTM (methylation) or an amino acid substitution (e.g. I for V) indirectly
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caused by a SNP. Since EIA techniques already suffer from low specificity yielding a
high false positive rate, they would not likely be able to discern these two proteins.
Likewise, it has been demonstrated that using the same primers, real-time PCR will
amplify two strands of DNA that differ by one base, as is the case when a SNP has
occurred. This will be most problematic if the SNP occurs between the primer locations.
Once more this demonstrates the specificity of the LC/MS approach, which unlike realtime PCR or immunoassays, can readily distinguish most protein isoforms.
An example of a protein that has no clearly observed isoforms in the isolates
studied and would therefore be a best initial candidate for primer or antibody formation is
the 18,996 Da E. coli O157:H7 marker which eluted at 43.3 minutes. Developing new
primers will allow novel determinations by real-time PCR such as discriminating S.
flexneri from S. sonnei or allow more confident identifications of bacteria for which only
one or few primers exist. Likewise, if more qualifiers for identification are added, the
lack of specificity of EIA methods can be reduced. For example, a serological approach
for E. coli O157:H7 may involve diagnosis for only the O and H antigens. To help
alleviate the high false positive rate, an antibody could be made for the 18,996 Da protein
and the EIA assay be modified so that a positive result would be reported only if all three
antigens were detected.
In addition to assisting the well established techniques (e.g. real-time PCR) the
biomarkers discovered in this study could also be used to enhance the less well known,
but promising technique of protein microarrays.146-149 Protein microarrays involve the
immobilization labeled proteins (e.g. antibodies, enzymes) to a chip. Samples can then
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be applied to the chip and reactions detected by fluorescence or radioactivity etc. Recent
efforts have also reported the combination MS and microarray technology.150, 151 By
being in array format, these devices are high throughput and can be utilized for to
quantify and detect hundreds or thousands of specific protein-protein or other proteinligand interactions simultaneously. Performing an EIA experiment using a chip-based
microarray would be an ideal platform for detecting multiple antigens for the same
bacteria as described above for E. coli O157:H7. Extension of this technology to the
diagnosis of bacteria has been demonstrated.70, 102
As for strain typing, the second area of this work, the method described here has
shown strain level typing capabilities which at times exceed those of PFGE.
Additionally, LC/MS is easily automated, less labor intensive, provides complementary
information by examining the proteome instead of the genome, and for small sample
sizes, has higher throughput. Like PFGE data, the data from this approach could be
uploaded to a database such as PulseNet, which monitors outbreaks by analyzing PFGE
data from public health laboratories across the nation.
To better encourage other public health laboratories to consider LC/MS
technology, efforts could be made to reduce the initial cost of the instrument. The
method as described here operates in full-scan mode in order to detect as many proteins
as possible and since currently no sequencing is performed, MS/MS capabilities are not
required. For this reason, a single TOF instrument could be used rather than a QTOF. In
addition to being less expensive, single TOF instruments are more sensitive because they
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lack the two additional quadrupole mass analyzers and therefore would suffer less loss
from transmission within the quadrupole region.5
Another issue that should be addressed before extending this approach to other
public health laboratories is intra and inter-lab variability. Intra-lab variability may
include differences in the samples run at the beginning of a batch vs. those run at the end
as well as day-to-day variability. These variations may result from lab temperature
fluctuation which could affect mass accuracy, degradation in the cleanliness of the
column and source which could affect retention behavior and intensity, sample
degradation with time and minor variations in mobile phase composition which would
also alter retention time. Examples of inter-laboratory variability would mainly stem
from differences in LC or MS instrumentation such as discrepancies in the tubing size
used to connect the LC and MS causing changes in dead volume or in column oven
heating efficiencies altering retention times, or in the performance of the mass
spectrometer used which would affect intensity and mass accuracy. Differences in
growing or lysis procedures may also result in variability therefore to minimize
variability, partner labs should use methods and instrumentation as similar to this one as
possible, i.e. an SOP should be formulated and followed as closely as possible.
Besides using as similar as possible methods and instrumentation across
laboratories, another way to address intra and inter-laboratory variability would be to add
a standard protein to the lysate prior to analysis. Being a standard, this protein’s mass
and retention time would be well characterized before use. To address retention time
shifts, the biomarker retention times would not only be reported as ± 0.5 min, but also as
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on a system where on average myoglobin eluted at 32.4 minutes e.g. If another
laboratory uses a system with more dead volume than the one described here and
myoglobin elutes at 32.9 minutes, 0.5 minutes could be subtracted from all of the results
in that lab prior to searching for the biomarkers observed in this laboratory. This
standard could also be utilized as an internal calibrant to correct for mass shifts. Finally,
since the same concentration would be added to all lysates, the intensities of the proteins
in the lysates could be held relative to this standard and these relative intensities be used
to better ascertain quantitative differences between lysates. This is in contrast to using
absolute intensities which may vary based on source cleanliness etc.
Future work for strain typing analysis would involve applying the LC/MS method
to numerous isolates from a known outbreak to see what if any new information is
provided from this technique. Samples from both exposed individuals and from the
organisms collected from the actual foodstuffs responsible and other related samples such
as the soil where the produce was grown etc., should be tested. This experiment would
use LC/MS to compare the differences and similarities amongst strains known to be
common and or unrelated by both epidemiological investigation and PFGE data. The
isolates studied should also come with detailed case information to help answer the
questions: “If a pattern is different, did it come from a different state, a different route of
exposure etc.? Was the patient administered antibiotics prior to sample collection?”
Case history would be implemented to compare and classify data sets and to examine
how well proteomic data correlate to known case history and
demographic/epidemiological information.
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Much could be learned from the analysis of superbugs. Beyond finding markers
for identification, unique proteins could be sequenced and if the protein and
corresponding gene function is known, this could yield insight into the mechanism of
resistance. If the marker protein function is unknown, some understanding can be
ascertained by determining the sequence homology with known proteins in homology
databases. Better understanding the mechanism of a bacterium’s aptitude for developing
resistance (drug, heat, or otherwise) could be used to predict future resistances by
common pathogens and may assist with: antibiotic drug design and delivery, the
development of novel disinfectant and infection control measures or possibly learning
how to reverse the resistance process.
After successful implementation of the method for the characterization and
identification of bacteria described in Chapters 4 and 5, the method was optimized to
improve throughput. Chapter 6 describes the optimization of the separation of ten protein
standards using UPLC and the application of that optimized method to cell lysate
analysis. Temperature, organic modifier and particle size were adjusted for optimal
resolution, speed and sensitivity. The optimized method incorporated a combination of
high temperature, a strong solvent and small particles at very high pressure. This
optimization resulted in a slight increase in sensitivity and a 2/3 reduction in runtime
from 75 minutes to 25 minutes. Furthermore, the reduction in the size of the data file
resulted in a concomitant decrease in data analysis time by Prowtrawler6. For this
reason, the total post culture and lysis time required for data collection and analysis
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decreased by 2/3 from 120 minutes (two hours) to 40 minutes. This increase in
throughput allows data directed decisions to be made in less time.
In addition to the expected sensitivity increase gained by narrowing the protein
peak width to 1/3 of its original value, utilizing UPLC yielded an unforeseen increase in
sensitivity. Protrawler6 software has a data file size limit of 2.1 GB. If a file contains
more than that amount of information, Protrawler6 will stop processing after 2.1 GB and
ignore any remaining information. During tuning of the mass spectrometer, the optimal
detector voltage was found to be 1900 V. However, since the data file size is
proportional to the number of ions counted and the time spent counting them, the 75
minute chromatograms required a detector voltage of 1750 V or less to remain under 2.1
GB. But after optimization of the method with UPLC, a 25 minute chromatogram could
be obtained using a detector voltage of 1900 V and the ensuing data file have a size of 2.1
GB or less. Thus, incorporating UPLC not only increases the throughput three fold, it
also allows analysis at the optimized detector voltage which will increase sensitivity and
likely enhance the observation of lower abundance proteins.
Relative to small molecule analysis, intact protein chromatography is challenging.
For this reason, there was some initial skepticism from within this group and even from
more than one scientist from the UPLC vendor as to whether the advantages typically
observed with the UPLC of small molecules could also be observed with intact proteins.
Chapter 6 reports the first successful separation of intact proteins using commercial
UPLC equipment and demonstrates the advantages typically observed for small
molecules (increased throughput, improved resolution etc.). The potential applications of
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this work are broad and include: biopharmaceuticals, protein supplements, food
allergens, protein toxins and various top-down proteomic investigations. One particularly
interesting application that could be pursued is coupling the most recent advances in
chromatography (e.g. UPLC) with the most recent advances in top-down proteomics
(top-down sequencing on a chromatographic time scale).152-154 Combined, these two
advancements could provide sequence analysis on a complex mixture of proteins in
approximately 30 minutes post lysis – an unheard of feat.
In addition to the throughput enhancement using UPLC, modifications could be
made to the HPLC gradient to shorten the runtime. In the E. coli O157:H7
chromatogram in Figure 1, it appears that much time is wasted between 45 and 58
minutes. However, proteins extracted using LP1 did elute during this time, with the most
well retained biomarker eluting at 54.9 minutes (Figure 16). The tail end of this peak
occurs at approximately 56.5 minutes and the dead volume as seen by the small non
retained peaks at the beginning of the chromatogram in Figures 1 and 16 requires ~ 1.5
minutes. Therefore, the peak which finished eluting at 56.5 minutes in the
chromatogram, actually left the column at 55 minutes. Allowing an extra minute for
retention time shifts, the gradient which currently stops at 60 minutes (Table 3) need only
run to 56 minutes. Since the current gradient runs from 5-55%B in 60 min (0.83
%B/min) subtracting four minutes (3.32 %B) would make the new gradient from 551.68%B in 56 minutes while keeping the same slope (0.83 %B/min). Maintaining a
constant slope allows the runtime to be reduced without affecting previous separation
results.
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With the last biomarker eluting at 55 minutes, the step in Table 3 of 55-95%B
from 60-65 minutes could be removed - saving another 5 minutes. The new gradient
would begin pumping 95%B at 56.01 minutes. The remaining 10.5 minutes in Table 3
would remain unchanged allowing the total runtime to be 66.5 minutes, a 9 minute
reduction from the gradient in Table 3. This new gradient could then be reduced by 2/3
using UPLC to approximately 22.2 minutes.
Although applied only to bacterial cell lysates in this work, the approach
described here using UPLC/MS combined with automated charge state deconvolution
and spectral subtraction would be well suited to aid any comparative proteomics analysis.
Examples include: the comparison of diseased cells vs. non diseased, treated diseased
cells vs. non-treated diseased cells, as well as plant and wildlife proteomic analysis e.g.,
before and after environmental stresses or exposure to pollutants etc.
Using LC/MS (a technique commonly found in analytical chemistry laboratories
but rarely found in diagnostic microbiology laboratories), a complementary approach
with certain advantages over typical microbiological methods has been developed. This
study used as a proof of concept ten isolates of Shigella and Escherichia and thirteen
isolates of Clostridium including the species most often implicated in human disease to
examine the efficacy of the LC/MS approach to characterize microorganisms. This
approach has demonstrated greater specificity than obtainable using current real-time
PCR protocols, allowing for distinctions at the strain level, and is automated and less
labor intensive than PFGE, the gold standard for subtyping. No primers, antibodies or
proteomic database searches were required for this study. Using a combination of
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automated charge state deconvolution and spectral subtraction, reproducible intact protein
biomarkers were observed at the species and sub-species (serotype, strain) levels, and
were successfully implemented for the identification of unknown pathogens.
This method could be used to enhance public health response (treatment,
remediation, etc.) by guiding the data directed decision making of hospital staff, public
health officials and investigating authorities. Ultimately, this method would be ideal as a
complementary technique adding another dimension to the polyphasic approach of
bacterial identification. This enhanced polyphasic approach would then lead to more
confident results which are required to cease production and distribution during an
outbreak, or for the prosecution of suspected terrorists. Additionally, this LC/MS method
could be expanded to monitor biomarkers for other foodborne pathogens or biowarfare
agents, and implemented to screen food items before they enter the market to prevent
possible outbreaks from occurring. In addition to its complementary nature, the
biomarkers discovered using this approach could be utilized to enhance current and future
methods in the field of diagnostic microbiology.

References

134

135

References

1. Foodborne Illness.
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/foodborneinfections_g.htm
(Accessed 04/22/07).
2. Food Safety and Foodborne Illness.
http://www.who.int/mediacentre/factsheets/fs237/en/ (Accessed 04/22/07).
3. Rotz, L.D.; Khan, A.S.; Lillibridge, S.R.; Ostroff, S.M.; Hughes, J.M. Emerg.
Infect. Dis. 2002, 8, 225-230.
4. Fenn, J.B.; Mann, M.; Meng, C.K.; Wong, M.G.; Whitehouse, C.M. Science
1989, 246, 64-71.
5. Chernushevich, I.V.; Loboda, A.V.; Thomson, B.A. J. Mass Spectrom. 2001, 36,
849-865.
6. Williams, T.L.; Leopold, P.; Musser, S. Anal. Chem. 2002, 74, 5807-5813.
7. Harrison, S.T.L. Biotech. Adv. 1991, 9, 217-240.
8. Mazzeo, J.R.; Neue, U.D.; Kele, M.; Plumb, R.S. Anal. Chem. 2005, 460A-467A.
9. Nguyen, D.T.T.; Guillarme, D.; Rudaz, S.; Veuthey, J.L. J. Sep Sci. 2006, 29,
1836-1848.
10. Schluter, H. In Protein Liquid Chromatography; Kastner, M. Ed.; Elsevier:
Amsterdam; New York, 2000; Chapter 3.
11. Bacteriology, The History Channel Website.
http://www.history.com/encyclopedia.do?articleId=202006 (Accessed 01/30/08).
12. Todar, K. Growth of Bacterial Populations, Todar’s Online Textbook of
Bacteriology. http://www.textbookofbacteriology.net/growth.html (Accessed
01/29/08).
13. Sutherland, J.B.; Rafii, F. In Identification of Microorganisms by Mass
Spectrometry; Wilkins, C.L.; Lay, J.O., Eds.; John Wiley & Sons, Inc.: Hoboken,
2006; Chapter 1.
14. Feng, P. Bacteriological Analytical Manual, 8th Edition, Final Revision: 2001Jan-25. http://www.cfsan.fda.gov/~ebam/author (Accessed 03/02/07).
15. Forbes, B.A.; Sahm, D.F.; Weissfeld, A.S. Bailey & Scott’s Diagnostic
Microbiology, Eleventh Ed.; Mosby: St. Louis, 2002; Chapter 13.
16. Houpikian, P.; Raoult, D. Emerg. Infect. Dis. 2002, 8, 122-131.
17. Saiki, R.K.; Gelfand, D.H.; Stoffel, S.; Scharf, S.J.; Higuchi, R.; Horn, G.T.;
Mullis, K.B. Erlich, H.A. Science 1988, 239, 487-491.
18. Lekowska-Kochaniak, A.; Czajkowska, D.; Popowski, J. Acta Microbiol. Polon.
2002, 51, 327-337.

136
19. Higuchi, R.; Fockler, C. Dollinger, G.; Watson, R. Biotechnology 1993, 11,
1026-1030.
20. Fox, A. In Identification of Microorganisms by Mass Spectrometry; Wilkins,
C.L.; Lay, J.O., Eds.; John Wiley & Sons, Inc.: Hoboken, 2006; Chapter 2.
21. Schwartz, D.C.; Saffran, W.; Welsh, J.; Haas, R.; Goldenberg, M.; Cantor, C.R.
Cold Spring Harbor Symp. Quant. Biol. 1983, 47, 189-195.
22. Forbes, B.A.; Sahm, D.F.; Weissfeld, A.S. Bailey & Scott’s Diagnostic
Microbiology, Eleventh Ed.; Mosby: St. Louis, 2002; Chapter 12.
23. Goering, R.V. In Molecular Microbiology: Diagnostic Principles and Practice;
Persing, D.H.; Tenover, F.C.; Versalovic, J.; Tang, Y.; Unger, E.R.; Relman,
D.A.; White, T.J., Eds.; ASM Press: Washington, D.C., 2004; Chapter 15.
24. Swaminathan, B.; Barett, T.J.; Hunter, S.B.; Tauxe R.V. Emerg. Infect. Dis.
2001, 7, 382-389.
25. Monday, S.R.; Whittam T.S.; Feng, P.C. J. Infect. Dis. 2001, 184, 918-921.
26. Tominaga, A.; Mahmoud, M.A.; Mukaihara, T.; Enomoto, M. Mol. Microbiol.
1994, 12, 277-285.
27. Monday, S.R.; Minnich, S.A.; Feng, P.C. J. Bacteriol. 2004, 186, 2319-2327.
28. Fenselau, C. In Mass Spectrometry for the Characterization of Microorganisms;
Fenselau, C., Ed.; ACS Symposium Series 541; American Chemical Society:
Washington, DC, 1994. Chapter 1.
29. Drucker, D.B. In Mass Spectrometry for the Characterization of Microorganisms;
Fenselau, C., Ed.; Chapter 3. ACS Symposium Series 541; American Chemical
Society: Washington, DC, 1994.
30. Song, Y.; Talaty, N.; Tao, W.A.; Pan, Z.; Cooks, R.G. Chem. Commun. 2007, 6163.
31. Johnson, Y.A.; Nagpal, M.; Krahmer, M.T.; Fox, K.F.; Fox, A. J. Microbiol.
Meth. 2000, 40, 241-254.
32. Walsh, C.T. In Posttranslational Modifications of Proteins: Expanding Nature’s
Inventory; Roberts and Company Publishers: Colorado, 2006; Preface.
33. Fenselau, C.; Pribil, P. In Identification of Microorganisms by Mass
Spectrometry; Wilkins, C.L.; Lay, J.O., Eds.; John Wiley & Sons, Inc.: Hoboken,
2006; Chapter 12.
34. Williams, T.L.; Callahan, J.H.; Monday, S.R.; Feng, P.C.H.; Musser, S.M. Anal.
Chem. 2004, 76, 1002-1007.
35. Dworzanski, J.P.; Syder, A.P. Expert Rev. Proteomics 2005, 2, 863-878.
36. Demirev, P.A.; Feldman, A.B.; Lin, J.S. Johns Hopkins APL Tech. Dig. 2004, 25,
27-37.
37. Williams, T.L.; Monday, S.R.; Edelson-Mammel, S.; Buchanan, R.; Musser, S.M.
Proteomics 2005, 5, 4161-4169.
38. Petit, L.; Gibert, M.; Popoff, M.R. Trends Microbiol. 1999, 7, 104-110.
39. Schaechter, M.; Ingraham, J.L.; Neidhardt, F. Microbe; ASM Press:
Washington, DC 2006; Chapter 14.

137
40. Simpson, C.F. In High Performance Liquid Chromatography: Principles and
Methods in Biotechnology; Katz, E.D., Ed.; John Wiley & Sons Ltd: West
Sussex, 1996; Chapter 1.
41. Eschelbach, J.W.; Jorgenson, J.W. Anal. Chem. 2006, 78, 1697-1706.
42. Nguyen, S.; Fenn, J.B. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 1111-1117.
43. Willoughby, R.; Sheehan, E.; Mitrovich, S. A Global View of LC/MS: How to
Solve Your Most Challenging Analytical Problems. First ed. Global View
Publishing: Pittsburg, 1998; Chapter 2.
44. The Mass Spectrometer: Instrument Architectures and Main Characteristics.
http://www.waters.com/watersdivision/ContentD.asp?ref=EGOO%2D66MNYR
2007 Waters Corporation. (Accessed 02/28/07).
45. Mann, M; Whitehouse, C.; Fenn, J.B. Anal. Chem. 1989, 61, 1702-1708.
46. Reinhold, B.B.; Reinhold, V.N. J. Am. Soc. Mass Spectrom. 1992, 3, 207-215.
47. Labowsky, M.; Whitehouse, C.; Fenn, J.B. Rapid Commun. Mass Spectrom. 1993,
7, 71-84.
48. Hagen, J.J.; Monnig, C.A. Anal. Chem. 1994, 66, 1877-1883.
49. Ferrige, A.G.; Seddon, M.J.; Jarvis, S.A. Rapid Commun. Mass Spectrom. 1991,
5, 374-379.
50. Ferrige, A.G.; Seddon, M.J.; Green, B.N.; Jarvis, S.A.; Skilling, J. Rapid
Commun. Mass Spectrom. 1992, 6, 707-711.
51. Khardori, N. In, Bioterrorism Preparedness; Khardori, N., Ed.; WILEY-VCH
Verlag GmbH & Co. KGaA, Weinheim, 2006. Chapter 1.
52. Smith, J.L.; Fratamico, P.M. In Foodborne Pathogens Microbiology and
Molecular Biology; Fratamico, P.M.; Bhunia, A.K.; Smith, J.L., Eds.; Caister
Academic Press: Wymondham, 2005; Chapter 18.
53. Nataro J.P.; Kaper, J.B. Clin. Microbiol. Rev. 1998, 11(1), 142-201.
54. Escherichia coli O157:H7. Centers for Disease Control and Prevention.
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/escherichiacoli_g.htm (Accessed
07/27/07).
55. Congressional testimony by Lonnie J. King, D.V.M. U.S. Department of Health
and Human Services. http://www.hhs.gov/asl/testify/t061115.html (Accessed
07/27/07).
56. Shigellosis. Centers for Disease Control and Prevention.
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/shigellosis_t.htm (Accessed
07/27/07).
57. Kotloff, K.L; Winickoff, J.P.; Ivanoff, B.; Clemens, J.D.; Swerdlow, D.L.;
Sansonetti, P.J.; Adak, G.K.; Levine, M.M. Bull. World Health Organ. 1999, 77
(8), 651-666.
58. CDC Select Agent Program. http://www.cdc.gov/od/sap/docs/salist.pdf
(Accessed 07/27/07).
59. Kolavic, S.A.; Kimura, A.; Simons, S.L.; Slutsker, L.; Barth, S.; Haley, C.E.
JAMA 1997, 278, 396-398.

138
60. Carus, S.W. Bioterrorism and Biocrimes: The Illicit Use of Biological Agents in
the 20th Century. Center for Counterproliferation Research, National Defense
Univ., Washington, DC, 2002.
61. Ake, J.A.; Jelacic, S.; Ciol, M.A.; Watkins, S.L.; Murray, K.F.; Christie, D.L.;
Klein, E.J.; Tarr, P.I. Pediatrics 2005, 115, e673-680.
62. Centers for Disease Control and Prevention (CDC). MMWR Morb. Mortal. Wkly.
Rep. 2006, 55 (38), 1042-1045.
63. Busse, H.J.; Denner, E.B.M.; Lubitz, W. J. Biotechnol. 1996, 47, 3-38.
64. Sabat, G.; Rose, P.; Hickey, W.J.; Harkin, J.M. Appl. Environ. Microbiol. 2000,
66, 844-849.
65. Pupo, G.M.; Lan, R.; Reeves, P.R. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 1056710572.
66. Schwartz, D.C.; Saffran, W.; Welsh, J.; Haas, R.; Goldenberg, M.; Cantor, C.R.
Cold Spring Harbor Symp. Quant. Biol. 1983, 47, 189-195.
67. Swaminathan, B.; Barett, T.J.; Hunter, S.B.; Tauxe R.V. Emerg. Infect. Dis.
2001, 7 (3), 382-389.
68. Williams, T.L.; Musser, S.M.; Nordstrom, J.L.; DePaola, A.; Monday, S.R. J.
Clin. Microbiol. 2004, 42, 1657-1665.
69. Williams, T.L.; Monday, S.R.; Feng, P.C.H.; Musser, S.M. J. Biomol. Tech.
2005, 16, 134-142.
70. Mezzasoma, L.; Bacarese-Hamilton, T.; Di Cristina, M; Rossi, R.; Bistoni, F.;
Crisanti, A. Clin. Chem. 2002, 48 (1), 121-130.
71. Todar, K. The Pathogenic Clostridia, from Todar’s Online Textbook of
Bacteriology, 2006. http://www.textbookofbacteriology.net/clostridia.html
(Accessed 03/04/08).
72. Stackebrandt, E.; Rainey, F.A. In The Clostridia: Molecular Biology and
Pathogenesis; Rood, J.I.; McClane, B.A.; Songer, J.G., Titball, R.W., Eds.;
Academic Press: San Diego, 1997; Chapter 1.
73. Johnson, E.A. In The Clostridia: Molecular Biology and Pathogenesis; Rood,
J.I.; McClane, B.A.; Songer, J.G., Titball, R.W., Eds.; Academic Press: San
Diego, 1997; Chapter 3.
74. Borriello, S.P.; Carman, R.J. In Clostridia in Gastrointestinal Disease; Borriello,
S.P., Ed.; CRC Press: Boca Raton, 1985; Chapter 10.
75. European Commission, Directorate-General for Research. In Clostridia in
Medical, Veterinary and Food Microbiology: Diagnosis and Typing; Mainil, J.;
Duchesnes, C.; Granum, P.E., Minozzi, M.G.; Peck, M.; Pelkonen, S.; Popoff, M.;
Stackebrandt, E.; Titball, R., Eds.; European Communities: Luxembourg, 2006;
pp 7.
76. Asha, N.J.; Tompkins, D.; Wilcox, M.H. J. Clin. Microbiol. 2006, 44, 27852791.
77. Schroeder, M.S. Am. Family Phy. 2005, 71, 921-928.
78. Barbut, F.; Petit, J.C. Clin. Microbiol. Infect. 2001, 7, 405-410.
79. Rodriguez-Palacios, A.; Staempfli, H.R.; Duffield, T.; Weese, J.S. Emerg. Infect.
Dis. 2007, 13, 485-487.

139
80. Broda, D.M.; DeLacy, K.M.; Bell, R.G.; Braggins, T.J.; Cook, R.L. Int. J. Food
Microbiology 1996, 29, 335-352.
81. Rodriguez-Palacios, A.; Staempfli, H.R.; Duffield, T.; Peregrine, P.S.; TrotzWilliams, L.A.; Arroyo, L.G.; Brazier, J.S.; Weese, J.S. Emerg. Infect. Dis. 2006,
12, 1730-1736.
82. Ackerman, G.; Thomalla, S.; Ackerman, F.; Schaumann, R.; Rodloff, A.C.; Ruf,
B.R. J. Med. Microbiol. 2005, 54, 149-153.
83. Asha, N.J.; Wilcox, M.H. J. Med. Microbiol. 2002, 51, 891-894.
84. Novak, J.S.; Peck, M.W.; Juneja, V.K.; Johnson, E.A. In Foodborne Pathogens:
Microbiology and Molecular Biology; Fratamico, P.M.; Bhunia, A.K.; Smith,
J.L., Eds.; Caister Academic Press: Wymondham, 2005; Chapter 19.
85. Juneja, V.K.; Novak, J.S.; Huang, L.; Eblen, B.S. Food Control 2003, 14, 163168.
86. Davis, C.J. Emerg. Infect. Dis. 1999, 5, 509-512.
87. Garret, L. Foreign Affairs 1996, 75 (1), 66-79.
88. Krt, B. FEMS Immunol. Med. Micrbiol. 1999, 24, 293-297.
89. Pelleschi, M.E. Crit. Care Nurse 2008, 28, 27-35.
90. Bruggemann, H. Curr. Opin. Microbiol. 2005, 8, 601-605.
91. Andreesen, J.R.; Bahl, H.; Gottschalk, G. In Clostridia; Minton, N.P.; Clarke,
D.J., Eds.; Plenum Publishing Corporation: New York, 1989; Chapter 2.
92. Graham, R.L.J.; Graham, C.; McMullan, G. Microb. Cell. Fact. 2007, 6, 26.
93. Anhalt, J.P.; Fenselau, C. Anal. Chem. 1975, 47, 219-225.
94. Fox, A. J. Clin. Microbiol. 2006, 44, 2677-2680.
95. Black, G.E.; Snyder, A.P.; Heroux, K.S. J. Micriobiol. Meth. 1997, 28, 187-199.
96. Simpson, R.C.; Fenselau, C.C.; Hardy, M.R.: Townsend, R.R.; Lee, Y.C.; Cotter,
R.J. Anal. Chem. 1990, 62, 248-252.
97. Hurst, G.B.; Doktycz, M.J.; Vass, A.A.; Buchanan, M.V. Rapid Commun. Mass
Spectrom. 1996, 10, 377-382.
98. Greis, K.D.; Zhou, S.; Siehnel, R.; Klanke, C.; Curnow, A.; Howard, J.; LayhSchmitt, G. Antimicrob. Agents Chemother. 2005, 49, 3428-3434.
99. Wall, D.B.; Parus, S.J.; Lubman, D.M. J. Chromatogr. B 2001, 763, 139-148.
100. Wren, B.W. Future Microbiol. 2006, 1 (3), 243-245.
101. Tenover, F.C.; Arbeit, R.D.; Goering, R.V.; Mickelsen, P.A.; Murray, B.E.;
Persing, D.H.; Swaminathan, B. J. Clin. Microbiol. 1995, 33, 2233-2239.
102. Steller, S.; Angenendt, P.; Cahill, D.J.; Heuberger, S.; Lehrach, H.;
Kreutzberger, J. Proteomics, 2005, 5, 2048-2055.
103. Regnier, F. E. Science 1983, 222, 245-252.
104. Walsh, G. Trends Biotechnol. 2005, 23, 553-558.
105. Yates, J.R. Annu. Rev. Biophys. Biomol. Struct. 2004, 33, 297-316.
106. Roth, M.J.; Forbes, A.J.; Boyne, M.T.; Kim, Y.; Robinson, D.E.; Kelleher, N.L.
Mol. Cell Proteomics 2005, 4, 1002-1008.
107. Kelleher, N.L. Anal. Chem. 2004, 197A- 203A.
108. Issaq, H.J.; Conrads, T.P.; Janini, G.M.; Veenstra, T.D. Electrophoresis 2002,
23, 3048-3061.

140
109. Zolla, L.; Rinalducci, S.; Timperio, A.M.; Huber, C.G. Eur. J. Mass Spectrom.
2004, 10, 321-333.
110. Dauly, C.; Perlman, D.H.; Costello, C.E.; McComb, M.E. J. Proteome Res.
2006, 7, 1688-1700.
111. Martin, A.J.P.; Synge, R.L.M. Biochem. J. 1941, 35, 1358-1368.
112. Swartz, M.E. J. Liq. Chromatogr. Rel. Technol. 2005, 28, 1253-1263.
113. MacNair, J.E.; Patel, K.D.; Jorgenson, J.W.; Moseley, M.A., III. Rapid
Commun. Mass Spectrom. 1997, 11, 1279-1285.
114. Garcia, M.C.; Marina, M.L.; Torre, M. J. Chromatogr. A 2000, 880, 169-187.
115. Mellors, J.S.; Jorgenson, J.W. Anal. Chem. 2004, 76, 5441-5450.
116. Wu, N.; Liu, Y.; Lee, M.L. J. Chromatogr. A 2006, 1131, 142-150.
117. Lubman, D.M.; Kachman, M.T.; Wang, H.; Gong, S.; Yan, F.; Hamler, R.L.;
O’Neil, K.A.; Zhu, K.; Buchanan, N.S.; Barder, T.J. J. Chromatogr. B 2002,
782, 183-196.
118. Rainville, P.D.; Stumpf C.L.; Shockcor J.P.; Plumb R.S.; Nicholson J.K. J.
Proteome Res. 2007, 6, 552-558.
119. Kaufmann, A.; Butcher, P.; Maden, K.; Widmer, M. Anal. Chim. Acta 2007,
586, 13-21.
120. Zhang, Y.; Jiao, J.; Cai, Z.; Zhang, Y.; Ren, Y. J. Chromatogr. A 2007, 1142,
194-198.
121. Salquebre, G.; Bresson, M.; Villain, M.; Cirimelle, V.; Kintz, P. J. Anal. Tox.
2007, 31, 114-118.
122. Bendahal, L.; Hansen, S.H.; Gammelgaard, B.; Sturup, S.; Nielsen, C. J. Pharm.
Biomed. Anal. 2006, 40, 648-652.
123. O’Connor, D.; Mortishire-Smith, R.; Morrison, D.; Davies, A.; Dominguez, M.
Rapid Commun. Mass Spectrom. 2006, 20, 851-857.
124. Wyndham, K.D.; O’Gara, J.E.; Walter, T.H.; Glose, K.H.; Lawrence, N.L.;
Alden, B.A.; Izzo, G.S.; Hulda, C.J.; Iraneta, P.C. Anal. Chem. 2003, 75, 67816788.
125. Acquity UPLC BEH Column - Care and Use
Instructions. http://www.waters.com/WatersDivision/pdfs/715001371CU.pdf
(Accessed 09/18/07).
126. Paliwal, S.K.; De Frutos, M.; Regnier, F.E. In, Methods in Enzymology, Vol.
270; Karger, B.L.; Hancock, W.S. Eds.; Academic Press Inc.: San Diego, 1996;
Chapter 6.
127. Benedek, K. In, High Performance Liquid Chromatography: Principles and
Methods in Biotechnology; Katz, E.D. Ed.; John Wiley & Sons Ltd.: Chichester,
1996; Chapter 9.
128. Wren, S.A.C.; Tchelitcheff, P. J. Chromatogr. A 2006, 1119, 140-146.
129. Greibrokk, T.; Andersen, T. J. Chromatogr. A 2003, 1000, 743-755.
130. Wang, Y.; Balgley, B.M.; Rudnick, P.A.; Lee, C.S. J. Chromatogr. A 2005,
1073, 35-41.
131. Yang, Y.; Ma, L.; Carr, P.W. J. Chromatogr. A 2005, 1079, 213-220.
132. Chen, H.; Horvath, Cs. J. Chromatogr. A. 1995, 705, 3-20.

141
133. Szabelski, P.; Cavazzini, A.; Kaczmarski, K.; Liu, X.; Van Horn, J.; Guiochon,
G. J. Chromatogr. A 2002, 950, 41-53.
134. Oroszlan, P.; Wicar, S.; Teshima, G.; Wu, S.L.; Hancock, W.S.; Karger, B.L.
Anal. Chem. 1992, 64, 1623-1631.
135. Dillon, T.M.; Bondarenko, P.V.; Rehder, D.S.; Pipes, G.D.; Kleemann, G.R.;
Speed Ricci, M. J. Chromatogr. A 2006, 1120, 112-120.
136. Rehder, D.S.; Dillon, T.M.; Pipes, G.D.; Bondarenko, P.V. J. Chromatogr. A
2006, 1102, 164-175.
137. Neville, W.A. In Methods in Molecular Biology, vol. 244: Protein Purification
Protocols: Second Edition; Cutler, P. Ed.; Humana Press Inc.: Totowa, 2004;
Chapter 28.
138. Everley, R.A.; Mott, T.M.; Wyatt, S.A.; Leopold, P.; Croley T.R. In,
Proceedings of the 55th ASMS Conference, Indianapolis, 2007; MPT-322, 561
(CD).
139. Molloy, M.P.; Herbert, B.R.; Walsh, B.J.; Tyler, M.I.; Traini, M.; Sanchez, J.C.;
Hochstrasser, D.F.; Williams, K.L.; Gooley, A.A. Electrophoresis, 1998, 19,
837-844.
140. Dreger, M. Mass Spectrom. Rev. 2003, 22, 27-56.
141. Zhou, F.; Hanson, T.E.; Johnston, M.V. Anal. Chem. 2007, 79, 7145-7153.
142. Park, K.H.; LiPuma, J.J.; Lubman, D.M. Anal. Chim. Acta 2007, 592, 91-100.
143. Simpson, D.C.; Ahn, S.; Pasa-Tolic, L.; Bogdanov, B.; Mottaz, H.M.; Vilkov,
A.N.; Anderson, G.A.; Lipton, M.S.; Smith, R.D. Electrophoresis 2006, 23,
2722-2733.
144. Zheng, S.; Schneider, K.A.; Barder, T.J.; Lubman, D.M. Biotechniques 2003,
35, 1202-1212.
145. Chaudhury A.; Nath, G.; Tikoo, A.; Sanyal, S.C. J. Diarrhoeal Dis. Res. 1999,
17 (2), 85-87.
146. Poetz, O.; Schwenk, J.M.; Kramer, S.; Stoll, D.; Templin, M.F.; Joos, T.O.
Mech. Age Dev. 2005, 126, 161-170.
147. Templin, M.F.; Stoll, D.; Schwenk, J.M.; Poetz, O.; Kramer, S.; Joos, T.O.
Proteomics 2003, 3, 2155-2166.
148. Kricka, L.J.; Master, S.R.; Joos, T.O.; Fortina, P. Ann. Clin. Biochem. 2006, 43,
457-467.
149. Cretich, M.; Damin, F.; Pirri, G.; Chiari, M. Biomolec. Eng. 2006, 23, 77-88.
150. Evans-Nguyen, K.M.; Tao, S.C.; Zhu, H.; Cotter, R.J. Anal. Chem. 2008, 80,
1448-1458.
151. Pal, M.; Moffa, A.; Sreekumar, A.; Ethier, S.P.; Barder, T.J.; Chinnaiyan, A.;
Lubman, D.M. Anal. Chem. 2006, 78, 702-710.
152. Parks, B.A.; Jiang, L.; Thomas, P.M.; Wenger, C.D.; Roth, M.J.; Boyne, M.T.;
Burke, P.V.; Kwast, K.E.; Kelleher, N.L. Anal. Chem. 2007, 79, 7984-7991.
153. Bunger, M.K.; Cargile, B.J.; Ngunjiri, A.; Bundy, J.L.; Stephenson, J.L. Anal.
Chem. 2008, 80, 1459-1467.
154. Chi, A.; Bai, D.L.; Geer, L.Y.; Shabanowitz, J.; Hunt, D.F. Int. J. Mass
Spectrom. 2007, 259, 197-20

142

Appendix I Measurement of Aflatoxin and Aflatoxin Metabolites in
Urine by Liquid Chromatography Tandem Mass Spectrometry

In addition to the previously described work on bacteria, the toxins produced from the
fungi Aspergillus flavus, known as aflatoxins, were also investigated. The subsequent
material was reproduced from the Journal of Analytical Toxicology (J. Anal. Toxicol.
2007, 31 (3), 150-156) by permission of Preston Publications, a division of Preston
Industries, Inc. The figure, table and reference numbers apply only to this appendix.

Abstract
Automated immunoaffinity solid phase extraction followed by liquid
chromatography/tandem mass spectrometry (LC/MS/MS) and chemical analogue internal
standardization was employed to detect and quantify the aflatoxins AFB1, AFB2, AFG1,
AFG2 and the metabolites AFM1 and AFP1 in urine. The dynamic range of the method is
nearly three orders of magnitude with limits of detection in the low femtogram on column
range. The method has been validated over a 12 day period by eight analysts. This
method is suitable for agricultural, forensic and public health laboratories during an
accidental outbreak or a chemical terrorism event where a rapid and accurate diagnosis of
aflatoxicosis is needed.
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Introduction
Due to the ever increasing threat of terrorist attacks around the globe and more
specifically the threat of a chemical terrorism attack, analytical chemistry laboratories
that would aid in forensic investigations and public health domains must be prepared to
provide quality laboratory results quickly and efficiently. In such an event, the number of
victims could be large and the type of warfare agent may not be immediately obvious.
To this end, analytical methods that can provide rapid and sensitive confirmation and
quantitation of the agent are vital in determining which agent was used, each individual’s
degree of exposure and the extent of the population that was exposed.1
Of the many toxins that could be used in an attack, those previously weaponized
are of particular interest. One example is aflatoxins, which were weaponized by the Iraq
government during the first Gulf War. According to a United Nations Special
Commission (UNSCOM) report, the Salman Pak weapons facility in Iraq had produced
2,200 liters of aflatoxins loaded in 122 mm rockets, 400 pound bombs and SCUD
missiles.2
Aflatoxins are secondary metabolites of the fungi Aspergillus flavus from which
their name (A. fla.) is derived. The predominant aflatoxins AFB1, AFB2, AFG1, and
AFG2 are designated B and G due to their blue and green fluorescent color observed
under UV illumination. The most studied and most hepatotoxic aflatoxin is AFB1 (LD50
1.16 mg/kg in rat)3 for which the World Health Organization (WHO) suggests there is no
safe dose.4 Moreover, these compounds are known to be mutagenic, and teratogenic.
Clinical symptoms of aflatoxin exposure include abdominal pain, rash and

5, 6

gastrointestinal bleeding.
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The commonality of these symptoms with those seen in other

illnesses prevent them from providing unambiguous identification of their cause, which
further emphasizes the need for an analytical method which provides more definitive
information and enables a conclusive diagnosis.
The work presented here builds upon previous investigations of aflatoxins in
urine7, 8 in an effort to improve both the sensitivity and dynamic range of those methods.
To improve upon the speed of previous methods, an automated immunoaffinity solid
phase extraction method has been developed in conjunction with LC/MS/MS analysis to
take advantage of the sensitivity, specificity, and ease of quantitation the technique
provides. Figure 1 shows the structures for the four parent aflatoxins of interest and the
metabolites of AFB1 that were chosen for this study.
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Figure 1. Structures of the four parent aflatoxins and the two metabolites of AFB1 monitored in this
study.
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Experimental / Apparatus / Methods
Chemicals and Materials
HPLC grade methanol, acetonitrile and formic acid were purchased from Fisher
Scientific (Fairlawn, NJ). Deionized water was purified in house to yield organic-free
18.3 MΩ.cm water using an E-pure purification system (Barnstead International
Dubuque, IA). Aflatoxin reference standards (AFB1, AFB2, AFG1, AFG2, AFM1 and
AFP1) were purchased from Sigma-Aldrich Chemical Company (St. Louis, MO).
Standard Preparation and Characterization
Aflatoxins and the internal standard AFB2 were dissolved in acetonitrile and
diluted in 85:15 MeOH:H2O (v/v) to a final concentration of 1 ng/μL. Eight calibration
standards, low and high quality controls (QC’s), and a urine blank containing internal
standard were stored in 50 mL polypropylene conical tubes at 4oC. Calibration standards
were prepared in 1 mL of pooled human urine spiked with 25 μL of the stock solution of
AFB2. To all urine samples (unknowns, QC’s, blanks, and standards) an equal amount of
85:15 MeOH:H2O was added. For example, the highest concentration standard was made
by mixing (per 1 mL of urine) 250 μL of the 1 ng/μL aflatoxin mixture, and 25 μL of the
1 ng/μL internal standard for a total volume of 1.275 mL. To the other samples the same
amount of urine and internal standard were used but with varying amounts of aflatoxin
standard and 85:15 MeOH:H2O while maintaining a total volume of 1.275 mL. The final
concentrations of the urine standards were: 0.392, 0.784, 3.92, 7.84, 19.6, 58.8, 118, and
196 ng/mL for the calibration standards, 1.96 and 157 ng/mL for the QC low and high
respectively and the internal standard concentration in all samples was 19.6 ng/mL.
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Extraction
Urine (1 mL) and water (1 mL) were added to glass tubes (10 x 75 mm), and
empty tubes of the same size (for elution) were inserted into the Gilson 215 Liquid
Handler (Middleton, WI) for automated extraction. Custom-made immunoaffinity
columns, (3 mL barrel, 400ng aflatoxin equivalents binding capacity, Vicam, Watertown,
MA) were used for the extraction. The buffer was discarded followed by rinsing the
column twice with water, leaving a small amount of water on top of the resin. The
columns were conditioned with water (2 x 2 mL). After the diluted urine sample was
loaded, the column was washed with water (2 x 2 mL), followed by an air push (3 sec)
using the Gilson solenoid valve. The analytes were eluted from the columns with 85:15
MeOH:H2O with 1% v/v formic acid (2 x 0.5 mL), followed by an air push (30 sec). The
extract was then transferred to an autosampler vial for LC/MS/MS analysis.
LC/MS/MS
Chromatography was performed with an Agilent 1100 HPLC (Wilmington, DE)
equipped with a 3 μm 2.0 x 150 mm phenyl-hexyl column (Phenomenex, Torrance, CA)
at 50ºC. 1 μL injections of the extract were made on the HPLC using a mobile phase
consisting of H2O (0.1% formic acid) (Solvent A) and acetonitrile (0.1% formic acid)
(Solvent B). The mobile phase gradient is given in Table 1a.
Samples were analyzed by positive ion electrospray/tandem mass spectrometry
operating in multiple reaction monitoring (MRM) mode on an API 4000 LC/MS/MS
system (Applied Biosystems, Foster City, CA). The mass spectrometer settings are listed
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in Table 1b. Individual compound specific parameters (i.e. declustering potentials,
entrance potentials, and collision cell exit potentials) were optimized for each analyte.

Tables 1(a) and (b). Instrument parameters for LC (a) and MS (b).

Time
(min)

Rate
(mL/min)

%B

Analyte

Precursor

CE

Product

AFP1

299

33.0

271

AFM1

329

33.0

273

AFG2

331

35.0

313

0

0.325

30

10

0.325

30

10.1

0.325

95

11.5

0.325

95

AFB2

315

37.0

287

11.51

0.325

30

AFG1

329

39.0

243

15.5

0.325

30

AFB1

313

33.7

285

Data Analysis and Recovery
The product ion abundances of the analyte and internal standard were used to
calculate analyte/internal standard ratios for quantitation. Linear regression analysis with
“1/x” weighting was used for curve fitting. All data processing was performed
automatically using Analyst 1.4 software (Applied Biosystems, Foster City, CA).
Extraction efficiencies were calculated as a percentage of the ratio of extracted analyte
peak area and the non-extracted standard peak area. Four extractions over a period of
two days were performed for this study all at a concentration of 7.84 ng/mL. Four
injections of non-extracted standard at an equal concentration were also made. The peak
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areas for the extracted and non-extracted samples were averaged and this average was
used to calculate the ratio for each analyte.
Animal Study
Urine samples were obtained from two male F344 rats (173-6 g body weight).
AFB1 (91 μg/kg body weight) or the vehicle (DMSO) were administered by
intraperitoneal injection (150 μL) on two consecutive days and rats were housed in
metabolic cages. Urine was collected for approximately 18 hours after the second dose
and stored at -20oC. Urine aliquots (1 mL) were treated with 250 μL of 85:15
MeOH:H2O and one mL of this mixture was then extracted. The animal study was
conducted in accordance with John Hopkins University’s Animal Care and Use
Committee requirements which comply with the NRC’s Guide for the Care and Use of
Laboratory Animals.
Results and Discussion
The parent aflatoxins AFB1, AFB2, AFG1 and AFG2 and also AFM1 and AFP1,
two phase I oxidative metabolites of AFB1,9 were selected for analysis. Both AFP1 and
AFM1 are excreted in human urine10 and studies have demonstrated that AFM1 is the
most abundant AFB1 metabolite found in the urine of rats and humans.11 Furthermore,
research involving AFM1 has shown that urinary AFM1 levels reflect exposure in
humans.12 Metabolites of AFB2, AFG1 and AFG2 were not included in this study because
these three compounds are generally not observed in the absence of AFB1 and AFB1 is
the most occurrent aflatoxin found in food.13
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Urine (vs. blood or serum) was chosen as the sample matrix primarily due to its
ease of collection. If victims are in reasonably stable condition, they can provide a urine
sample without the assistance of a medical professional. Minimizing the workload of
hospital staff is critical in a scenario such as a terrorist attack where hospitals will likely
be overwhelmed.
AFB2 was chosen as a chemical analogue internal standard because it behaves
similarly to the other aflatoxins both in the immunoaffinity column (IAC) and in the
analytical method. In addition, AFB2 is chromatographically well-resolved from the
other analytes and is less toxic than AFB1 and AFG1. Chemical analogue internal
standardization was employed for two reasons. One, isotopically labeled standards are
only available for AFB2 and are prohibitively expensive (≈ $2000 for 8.3 μg AFB2 3H).
Two, the upper limit of linearity, ULOL, is determined by occupying the available
binding sites of antibody in the column. The use of isotopically labeled internal
standards for each aflatoxin would result in more aflatoxin being added to the
immunoaffinity column which would lower the ULOL and therefore decrease the
dynamic range of the method.
If AFB2 were in a real world sample, a T-test could be performed to determine if
the internal standard peak areas in unknown samples are significantly higher than the
mean AFB2 peak area in the calibration standards. If this were the case, then since all of
the compounds of interest are equally suitable as chemical analogue internal standards, an
aflatoxin not present in the sample would be added to a separate aliquot of unknown and
then re-extracted. A second alternative would be to measure the concentration of AFB2
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by the method of standard additions. Both of these methods however would be difficult
if the concentration of AFB2 was at or near the limit of detection so a third alternative,
analyzing each unknown in duplicate (one with internal standard, one without), could be
employed.
Immunoaffinity extraction of aflatoxins in various matrices has been reviewed14
and involves non-covalent binding of the toxins to monoclonal antibodies in aqueous
environment followed by release upon denaturing of the antibodies using high organic
content solvents. After a comparison with C18 solid phase extraction in our laboratory,
the immunoaffinity method was chosen due to its increased recovery, selectivity and
cleanliness of extracts. Since the extraction columns were originally manufactured for
food analysis, the antibody used is designed to target only the parent aflatoxins; however,
due to the structural similarities between the parent and metabolites, the metabolites are
efficiently extracted as well. For this reason, the columns can readily be used for clinical
samples.
Automated extraction was utilized as means to increase sample throughput. The
extraction takes 1.67 minutes/sample corresponding to 36 samples/hour. The efficiency
of the automated extraction was measured at a concentration of 7.84 ng/mL in urine. The
extraction efficiencies for each of the five compounds are shown in Table 2. The results
range from 80 – 93% and are in agreement with manufacturer specifications which are
defined for food matrices.
The best chromatographic resolution was obtained using a phenyl-hexyl column.
Figure 2 depicts the separation of all six aflatoxins used in this study extracted from

152
human urine at a concentration of 19.6 ng/mL. The MS/MS fragmentations of the
aflatoxins are shown in Figure 3. It can be seen that both B aflatoxins and the AFB1
metabolites fragment by losing the carbonyl on the cylcopentanone group and that AFM1
further breaks down by losing the two adjacent CH2 groups on the ring. The G aflatoxins
differ by containing a lactone group in place of the pentanone ring structure. These
compounds fragment by the loss of water and the further loss of the outer carbonyl group
and adjacent portion of the ring, as well as the loss of H2. The fragmentation patterns
suggest that the site of protonation for each aflatoxin is the inner carbonyl group. These
fragmentation patterns are based upon interpretation of the MS/MS spectra only as
isotopically labeled experiments were not performed for reasons stated previously.
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Figure 2. MRM extracted ion chromatogram of a 19.6 ng/mL urine extract using the transitions
shown in Table 1b.
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Figure 3d
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Figure 3f
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Figure 3. MS/MS fragmentation spectra for each aflatoxin with arrows indicating the precursor ion.
(a) AFB1, (b) AFB2, (c) AFG1, (d) AFG2, (e) AFM1 and (f) AFP1.

The instrument limit of detection, LOD (S/N = 3/1) for each compound is given in
Table 3. LOD values are reported in femtograms (fg) on column to avoid ambiguity
inherent in using units of concentration such as parts per billion (ppb). This ambiguity
makes it difficult to determine a relative LOD in papers where the pertinent information
to calculate the LOD on column is not included.15, 16 By providing the LOD as fg on
column, the values reported in this manuscript are independent of the volume of urine
extracted and/or injection volume and reflect the amount of sample that is detected by
this method. Table 3 shows the LOD for each analyte in terms of grams on column and
in moles. An LOD of 100 fg is equivalent to a 1 μL injection of non-extracted standard
at 100 fg/μL. These values meet the goal of developing a sensitive method as these

detection limits are more than 10 times lower than those previously reported

17, 18
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for

aflatoxins in urine. The limit of quantitation, LOQ (S/N = 10/1), was calculated in urine
using the same procedure stated above. The LOQ was determined to be 392 fg on
column for all analytes.
Table 3. Limits of detection for each analyte defined as a S/N of 3/1.

Analyte

Femtograms on
Column

Attomoles

AFP1

50

168

AFM1

100

305

AFG2

100

302

AFG1

100

305

AFB1

50
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A wide dynamic range is needed in the analysis of chemical warfare agents for
two reasons. One, since there are no studies in the literature showing the range of
concentrations in a victim exposed to weaponized aflatoxin, having a dynamic range of
nearly three orders of magnitude increases the likelihood that this method will cover
relevant concentrations. Second, the exposure of victims after an event will not be
uniform due to their different proximities to the attack epicenter. To achieve this goal,
custom-made extraction columns with a lager bed size were employed. The dynamic
range of the method was from the LOQ at 0.392 pg – 196 pg on column for each analyte.

159
Procedures that require time consuming concentration steps which may allow for the
detection of lower aflatoxin levels were avoided to increase assay throughput (i.e. one
mL of urine is extracted into one mL of MeOH:H2O with 1% v/v formic acid). Figure 4
shows a calibration curve for all five toxins in human urine. The dynamic range
presented here meets the aforementioned goal of covering a wider range than those
previously reported.8,17

20
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Analyte/IS Area Ratio

15

AFG2
AFP1
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Figure 4. An eight point calibration plot from 0.392 ng/mL to 196 ng/mL in urine using linear
regression with “1/x” weighting.
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As seen in Figure 4, a slight deviation from linearity begins to occur at the highest
point. This is due to the large aflatoxin/antibody ratio at this concentration. This was
examined by analyzing non-extracted standards which showed increased linearity at this
same concentration and at even higher concentrations (data not presented) which verified
that our ULOL is dictated by the binding capacity of the extraction column and not by the
instrument. At concentrations above the ULOL, the number of binding sites becomes a
limiting factor and some unbound aflatoxin is removed during the wash step of the
extraction. This is an important consideration when determining the ULOL of an
extraction method using immunoaffinity columns.
The method was validated by analyzing a calibration curve, two quality controls
(low and high) and a urine blank spiked with internal standard. This experiment was
repeated twenty times over a period of 12 days with no more than two sets being
analyzed in a single day. Eight analysts conducted the experiments during the 12 day
period. Linear regression with “1/x” weighting was used for each analyte to account for
heteroscedasticity in the data. The calibration standards were analyzed in a random order
and the curves for each aflatoxin had an average correlation coefficient ≥ 0.995. The
quality of the method is represented by quality control low and high plots of AFG1
(Figure 5). Similar results were obtained for the four other toxins. The results of the
accuracy and precision of the method for each analyte are shown in Table 4. The range
of the percent accuracy of the means for all five analytes is from 97.0 – 105.6% and the
highest %RSD found was 6.67%. In all but one case the mean is ≤ one standard
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deviation away from the true value. No significant contributions from carryover were
seen in the blank samples.

Figure 5a
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Figure 5. Quality control plots for AFG1, (a) QC Low at 1.96 ng/mL and (b) QC High at 157 ng/mL.
The central line represents the mean, the dashed line is 2 standard deviations and the outer line is 3
standard deviations from the mean.
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Table 4. Validation results depicting the precision and accuracy of the method.

Analyte Concentration Mean
%
Lower
Upper 95%
(ng/mL)
(ng/mL) Accuracy 95% limit
limit
(ng/mL)
(ng/mL)

% RSD

AFB1

1.96

2.01

103

1.95

2.08

6.67

AFB1

157

153

97.5

149

157

5.18

AFM1

1.96

2.01

102

1.95

2.07

6.59

AFM1

157

152

97.0

148

156

5.58

AFG1

1.96

2.07

106

2.02

2.13

5.68

AFG1

157

152

97.0

150

155

3.04

AFP1

1.96

2.03

104

1.97

2.09

6.30

AFP1

157

151

96.5

147

155

5.16

AFG2

1.96

2.06

105

2.02

2.11

4.79

AFG2

157

146

93.5

144

150

5.07

After validation, the method was further tested by analyzing the urine of an AFB1
exposed rat. The dose administered to the rat (91 μg/kg body weight) is well below the
LD50 for rats and corresponds to a dose of several milligrams for a human adult. A dose
of 2-6 mg/day was observed during an outbreak of aflatoxicosis in western India,19 and
similar amounts were consumed in a recent outbreak in Kenya.20 It was expected that
roughly equal amounts of the two metabolites AFM1 and AFP1 and a small amount of
unmetabolized AFB1 may be excreted. No aflatoxins other than the internal standard
were detected in the negative control rat urine sample. AFB1, AFM1 and AFP1 were
respectively detected in urine from the AFB1 dosed rat at 1.38, 48.8 and 41.4 ng/mL.
Four mL of urine was collected indicating a total excretion of 5.52, 195.2 and 165.6 ng
during the 18 hour period. The creatinine levels of the two urines were not measured,
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thus no comparison of the metabolite concentrations with literature values were made.
However, relative to AFP1, the amount of AFM1 was more abundant which is consistent
with previous studies of AFB1 exposure in rats.11, 21 Figure 6 shows the chromatograms
for the negative control and AFB1 dosed rat urine samples.
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Figure 6b
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Figure 6. Chromatograms from the animal study, (a) dosed rat and (b) control rat.

It was also expected that other metabolites of aflatoxin would be present in the
dosed rat urine. Precursor and product ion masses of other AFB1 metabolites18 were used
to build a separate MRM method to detect the presence of these compounds. Metabolites
such as AFB-diol and AFQ1 were found. The presence of AFQ1 was further confirmed
by matching the retention time with a chromatogram obtained previously when AFQ1
was commercially available (data not presented). This method is suitable for monitoring
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other metabolites on a qualitative level, but quantitative analysis is difficult since AFM1
and AFP1 are the only commercially available AFB1 metabolite standards.
Conclusion
The LC/MS/MS method described uses less urine and has lower limits of
detection than previously reported methods. Other advantages of this approach are the
specificity of both immunoaffinity extraction and tandem mass spectrometry, and no
requirement for derivitization. The dynamic range of 0.392 – 196 pg on column
combined with an automated extraction yield rapid results over a wide range of exposure.
This method is well suited to aid forensic and public health laboratories during the
investigation of a terrorist attack by providing confirmation of military/civilian exposure
to weaponized aflatoxin. In addition, the method presented here can be utilized to
diagnose aflatoxicosis22 caused by consumption of a food supply contaminated
intentionally by the hands of terrorists or accidentally during an outbreak.19, 23, 24
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